290|C102924|S|DEFINITION|This gene is involved in both brain development and transcriptional regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b3c236325ae1ad5b8d8eb8162648ec7d|
291|C102924|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
292|C102924|S|OMIM_Number|604616|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||163f3bebe2611f22251ea7db830d8da5|
971|C18583|S|OMIM_Number|607585|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||df2063d1de283dac9ae1e222bbe62b32|
972|C18583|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
973|C18583|S|DEFINITION|This gene is involved in apoptosis, DNA repair and cell cycle regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8c193c3d37a5982e1a34d7fe32717181|
1586|C116683|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
1587|C116683|S|OMIM_Number|602799|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||05b9fa70eeed9aaffc99586b3ebe48ee|
1588|C116683|S|DEFINITION|This gene plays a role in the formation of nucleosomes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ed324994034bd0d8e3e407ff8f3bd4ab|
2714|C104234|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
2715|C104234|S|OMIM_Number|146760|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b620fc26443b1b94e1133730f4822a0f|
2716|C104234|S|DEFINITION|This gene is involved in the immune response.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bfe60e7f7c4ecc3f6027cc98bb17eaa2|
2764|C49476|S|DEFINITION|Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1e15374ee454fc8eda4124147a9d9fba|
2765|C49476|S|DEFINITION|Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4d38972b5bb408f83514911ab6240635|
2766|C49476|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
2767|C49476|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
4150|C26506|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
4151|C26506|S|DEFINITION|This gene is involved in both the activation and detoxification of xenobiotics.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||37914afc4a03015357c850798ed53a43|
4152|C26506|S|OMIM_Number|132810|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a322276c6f7e9e6346b2244eb0d0ad10|
4383|C84219|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
4384|C84219|S|CAS_Registry|728-88-1|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||73a045eabbddb79f04615fa3cf8a8116|
4385|C84219|S|Chemical_Formula|C16H23NO|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a4827c663d4d75a94f0f7149b6e37fde|
4386|C84219|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
4387|C84219|S|FDA_UNII_Code|F5EOM0LD8E|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96fc88866f0ed4fa054929b47fc5eec7|
6006|C18585|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
6007|C18585|S|DEFINITION|This gene is involved in transcriptional regulation and alterations in the gene are associated with acute lymphoblastic leukemia.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c4d41e7ada6e300a4c18f3b78d2b7268|
6008|C18585|S|OMIM_Number|159555|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||31d6f2484fb38feea48c9f8c46ef6f86|
6597|C49469|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
6598|C49469|S|DEFINITION|Published by the College of American Pathologists, the Systematized Nomenclature of Medicine Clinical Terms is a combination of content of SNOMED Reference Terminology and READ codes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||44cddd5364a45a3a495fd0cfbc345046|
7172|C126129|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
7173|C126129|S|OMIM_Number|612002|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fc2f71e5505d946f46e28f6be1ba01d2|
7174|C126129|S|DEFINITION|This gene is involved in the negative regulation of gene transcription.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||40e076c3d2167160110e4b168658afad|
7331|C92518|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
7332|C92518|S|DEFINITION|This gene plays a role in both signal transduction and spindle formation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||915dd3603212e533de212baa3f6ffa51|
7333|C92518|S|OMIM_Number|608973|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||20a1f3b44845c17abe598c2a88a702e2|
7653|C105904|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
7654|C105904|S|DEFINITION|A classification scheme in which gastric adenocarcinomas are separated into diffuse adenocarcinoma, intestinal type adenocarcinoma, mixed adenocarcinoma, or indeterminate type adenocarcinoma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||750b3ecb03b94310772093024cae55b0|
7985|C16048|S|DEFINITION|Sources of information such as libraries, databases, and websites.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5114fb043d4d55524591a8d5411ee46b|
7986|C16048|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
10071|C24383|S|DEFINITION|This gene is involved in coagulation and proteolytic cleavage regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6a3f34802370e87620542efc656d55f9|
10072|C24383|S|OMIM_Number|187930|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||04ac88db7ca41f114e7d4078e7aebca5|
10073|C24383|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
10509|C105563|S|OMIM_Number|300506|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4635c381e4b04a3af3ee85d3220516be|
10510|C105563|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
10511|C105563|S|DEFINITION|This gene plays a role in the function of both T-cells and macrophages.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0f2922dac6f483c0f4ca1320ff3f150f|
12193|C28844|S|FDA_UNII_Code|F94OW58Y8V|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||21cd717f520b9931172eecd1efdc0f1c|
12194|C28844|S|PDQ_Open_Trial_Search_ID|695416|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||78e2ef01121bd8f9cf26fc12540fb226|
12195|C28844|S|DEFINITION|An azalide, derived from erythromycin, and a member of a subclass of macrolide antibiotics with bacteriocidal and bacteriostatic activities. Azithromycin reversibly binds to the 50S ribosomal subunit of the 70S ribosome of sensitive microorganisms, thereby inhibiting the translocation step of protein synthesis, wherein a newly synthesized peptidyl tRNA molecule moves from the acceptor site on the ribosome to the peptidyl (donor) site, and consequently inhibiting RNA-dependent protein synthesis leading to cell growth inhibition and cell death.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||db0c2149b3207ed6f04ee23911cefc96|
12196|C28844|C|SEMANTIC_TYPE|Antibiotic|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c63ed4527017391e92b2722c45a97151|
12197|C28844|S|NSC_Code|643732|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8419fee6e20459b0f6b9cc8e6dd08b48|
12198|C28844|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
12199|C28844|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
12200|C28844|S|PDQ_Closed_Trial_Search_ID|695416|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||78e2ef01121bd8f9cf26fc12540fb226|
12201|C28844|S|CAS_Registry|83905-01-5|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a9d5442ad219d74e9cb59dc3ceaa5527|
12351|C67336|S|Contributing_Source|UCUM|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f75cb6a06fc497e111ba0954018b5091|
12352|C67336|S|DEFINITION|A secondary representation, reproduction, or replica.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c918e9ba51ad5d663aa0897cde54e9a2|
12353|C67336|C|SEMANTIC_TYPE|Physical Object|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||812af603918498bf70efeef5ae940b01|
13187|C99617|S|OMIM_Number|600190|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4783aa429286b8d92dd583e0dd76a92a|
13188|C99617|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
13189|C99617|S|DEFINITION|This gene is involved in transcriptional repression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||989d53e659e692ca0d65b68066e67155|
13612|C18145|S|DEFINITION|An occupational discipline which unites information science with computer science. It is concerned with the development of techniques for the collection and manipulation of data, and the use of such data.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9ef0e8cddb97b747a5671a27614ef34a|
13613|C18145|C|SEMANTIC_TYPE|Occupation or Discipline|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||856118919315e7420b3e7b7900fac932|
15539|C73224|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
15540|C73224|S|FDA_UNII_Code|I0VM4M70GC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7d0439df867807e5ff1445f43fcfbeec|
15541|C73224|S|Chemical_Formula|C25H25N7O3|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||84383bf1a83e64b4aecc784a112deb1c|
15542|C73224|S|CAS_Registry|211914-51-1|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b5adfdb7f00a1c468033b6705bf34f63|
15543|C73224|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
16041|C83554|S|Chemical_Formula|C8H12N2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f7a137f3e437dab993e10336eabd276b|
16042|C83554|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
16043|C83554|S|CAS_Registry|5638-76-6|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||270996e0822593144c215b736f7f1565|
16044|C83554|S|CHEBI_ID|CHEBI:35677|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a07f9ddc5ec66fd57cabd2c61e14e473|
16045|C83554|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
16046|C83554|S|FDA_UNII_Code|X32KK4201D|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f9adbebf1799f9ebc2297704183f5350|
16244|C48276|S|DEFINITION|The systematic arrangement of adverse events based on common characteristics such as properties and outcomes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||38940224cd8c41bcd5a165588dbfb3b8|
16245|C48276|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
18026|C88944|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
18027|C88944|S|DEFINITION|This gene may be involved in embryonic development.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aa65b39ad2d6496d0ee5b3dd48437641|
18508|C11251|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
19904|C38300|S|DEFINITION|Administration of a drug beneath the tongue. The route provides rapid absorption, the drug immediately enters the bloodstream without first passing through the intestinal wall and liver. However, most drugs cannot be taken this way because they may be absorbed incompletely or erratically.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b55712040468ae5be7ec4abb7af159c3|
19905|C38300|S|FDA_Table|Route of Administration (C-DRG-00301)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d0ed5651b285b01d93092cb6025cd1ed|
19906|C38300|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
19907|C38300|C|SEMANTIC_TYPE|Functional Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a79a5d175c8269874d5b5c9162a72cf|
19908|C38300|S|DEFINITION|Administration beneath the tongue. (FDA)|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||36e9fd1b06e4341f63c5efc26e49a2dd|
19909|C38300|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
20340|C17567|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
20341|C17567|S|DEFINITION|This gene plays a role in signal transduction. It is involved in both adhesion and migration of cells.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||eae3bac0537e588e22c4c465e95b3b81|
20342|C17567|S|OMIM_Number|611731|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||05194a8f34ece9d245a64700e71a5304|
20755|C122915|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
20756|C122915|S|OMIM_Number|607786|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e77b03438cde9cf24e2303e5aa734e4d|
20757|C122915|S|DEFINITION|This gene is involved in both cholesterol metabolism and protein degradation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ee933ad779d563cc8b8f30f6aa7c8d53|
21108|C90372|C|SEMANTIC_TYPE|Qualitative Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||74541bf45ab4e848ae54be0d9d3e9ed2|
21109|C90372|S|DEFINITION|A classification of the type of trial agent.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||288d15811df9b33a5539afb2b4239826|
22288|C102827|S|OMIM_Number|604032|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||df5c857190432e2da163790f8f1915c8|
22289|C102827|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
22290|C102827|S|DEFINITION|This gene plays a role in the regulation of translation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5817a4d36597e27530a587e65981312b|
22808|C18022|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
22809|C18022|S|DEFINITION|This gene functions as a tumor suppressor and transcriptional regulator.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b517ca0ba6076cf5b5100edafd8093bc|
22810|C18022|S|OMIM_Number|600160|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||21106609b76cfeba0fc0515c8d602f75|
22871|C222|S|DEFINITION|An ester of alkane sulfonic acid that acts as an alkylating agent.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||88b0bffe5eacbaf22421ae38ec09a789|
22872|C222|C|SEMANTIC_TYPE|Chemical Viewed Structurally|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1baaa83e4106247f54f42f1aefbda1ae|
22873|C222|S|CHEBI_ID|CHEBI:22318|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b3887e1b1e194480fe93f2c8b23736f3|
22966|C19676|S|DEFINITION|DNA Repair Genes encode DNA Repair Proteins, involved in enzymatic restoration of DNA structure after chemical, radiation, or spontaneous damage. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dbb539811e8288cb8de12894d1f8afd2|
22967|C19676|S|Gene_Encodes_Product|DNA Repair Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||753c053374160a4f827397e136d1e23b|
22968|C19676|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
23458|C16732|C|SEMANTIC_TYPE|Occupational Activity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c6a8390c19f864ddf30b80076dab6fdb|
23459|C16732|S|DEFINITION|For information to be useful, not only does it need to be made available at the right time to those who need it such as policy makers, program planners, and health professionals, and patients but it has to be in the right form. Information Dissemination includes both research into means of information distribution and the actual distribution of information.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||df45c3bb24b038efd4d1e099e174d1bb|
24592|C96316|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
24593|C96316|S|DEFINITION|This gene may play a role in malignant melanoma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||973570a6fe26a03c6aaf919e8d2bf30b|
24823|C84712|S|DEFINITION|A syndrome characterized by the presence of rheumatoid arthritis, splenomegaly, and granulocytopenia. Patients are at an increased risk of infection because of the low white cell counts.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6c70acc8f67ad21a1bf8fe0dba256e02|
24824|C84712|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
25215|C43780|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
25216|C43780|S|DEFINITION|A role used to indicate that molecular abnormalities in a gene may be associated with the manifestation of a disease. The role is used to assert a link between a gene and a disease when the association is considered to have clinical relevance. The domain and range for this role are 'Gene' and 'Disease, Disorder or Finding', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dc449908a98dcf8b99522b67fbce60d5|
25501|C63923|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
25502|C63923|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
25503|C63923|S|DEFINITION|The terminology that includes terms pertaining to FDA/USP Substance Registration System (SRS), which is to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for substances in drugs, biologics, foods, and devices.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c752804e4b928adf9da96c3e97d58e43|
25877|C16733|C|SEMANTIC_TYPE|Occupation or Discipline|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||856118919315e7420b3e7b7900fac932|
25878|C16733|S|DEFINITION|The sciences concerned with gathering and manipulating and storing and retrieving and classifying recorded information.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9b2674a1916959edcb5b0cd6a2791089|
26840|C28389|S|DEFINITION|An entity which is used by NCI for administrative, financial or organizational purposes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||66562a6762747b3ad03fb4d783d8192d|
26841|C28389|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
27039|C18516|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
27040|C18516|S|OMIM_Number|164770|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a4e9f7a37e6b88dc9ac62a8f1e6cf165|
27041|C18516|S|DEFINITION|This gene is essential for the regulation of the production, differentiation, and function of macrophages.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0de43d9a2e7cc2d19d85c1eb25345a48|
27649|C24638|S|DEFINITION|This gene plays a putative role in the activation of bioreductive drugs and chemicals.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8f551b73a508e373a03bbca4d95aeb50|
27650|C24638|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
27651|C24638|S|OMIM_Number|606073|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||008ac59725e56dbd12b02205e296d800|
27840|C43781|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
27841|C43781|S|Design_Note|Currently, we only model human genes, but this role has obvious utility in future, if other organisms are modeled as well.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8cf5a010fbda8cbcbc0c58992033ecde|
27842|C43781|S|DEFINITION|A role used to specify the organism of origin for a gene. It may be used to differentiate genes with the same name and functions that originate from different organisms. The domain and range for this role are 'Gene' and 'Organism', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e00d489b13b9f24b665ffe747fb72c93|
28520|C16734|C|SEMANTIC_TYPE|Occupational Activity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c6a8390c19f864ddf30b80076dab6fdb|
28521|C16734|S|DEFINITION|Research regarding the systematic process of collecting and cataloging data so that they can be located and displayed on request.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a88131b325c28d6bc105a908e04669ce|
30266|C43782|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
30267|C43782|S|DEFINITION|A role used to establish a link between a gene and the genetic or molecular abnormalities that have been observed in human cells and tissues associated with cancers (e.g., over- or under-expressed, amplified, translocated). The domain and range for this role are 'Gene' and 'Molecular Abnormality', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8a26d58b5021b1dcdf61a6e3fb48121c|
31191|C13391|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
31192|C13391|S|DEFINITION|Microsatellite repeats that have been used as markers of microsatellite instability. BAT26, a poly(A) tract in MSH2 intron 5, is one example of a BAT locus. Presence of alterations in the BAT26 locus, detected in stool samples, may be an easy and non-invasive detection method for colorectal cancer.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||73a90102c28ae20f798fe52bbde1109c|
31472|C28523|S|DEFINITION|This gene is involved in the regulation of xenobiotic-metabolizing enzymes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4ca59124c242c42aa66d8544d5afb1b5|
31473|C28523|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
31474|C28523|S|OMIM_Number|600253|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||59295f9971c9493065896273613d23ea|
32812|C43783|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
32813|C43783|S|DEFINITION|A role used to link a gene with its physical extent on a chromosome, denoted by the chromosome number and start and end base positions (with numbering beginning at the telomere of the short p arm). The domain and range for this role are 'Gene' and 'Anatomic Structure, System, or Substance', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||eaf683a83f36785b12eb8902bdeb40fb|
32814|C43783|S|Design_Note|The standard for the numbering system is that assigned by the Human Genome Consortium and found at Entrez Gene. The role is considered as supplementary to the role Gene_In Chromosomal_Location|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f91ad84fd995200adb6b20de612efca2|
32984|C43815|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
32985|C43815|S|DEFINITION|Published by the US Veterans' Administration. National Drug File Reference Terminology covers clinical drugs used at the VA.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||38174f76880e189fdea4dfb39bdde2e6|
33880|C449|S|DEFINITION|A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5fd4e5389dfdc91245933883a799fa8a|
33881|C449|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
33882|C449|S|DEFINITION|The molecules inside cells that carry genetic information and pass it from one generation to the next.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dc49bad843d43b2aa16717c51c282147|
33883|C449|S|CHEBI_ID|CHEBI:16991|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||22861ef3ae8463e69c582e1f3499987c|
33884|C449|S|Design_Note|DNA is a double-stranded molecule held together by weak bonds between base pairs of nucleotides. DNA contain the four nucleotide bases adenine (A), guanine (G), cytosine (C), and thymine (T). In nature, base pairs form only between A and T and between G and C; thus the base sequence of each single strand can be deduced from that of its partner.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7320cdfad21404e58df9dc9b4a994906|
33885|C449|S|CAS_Registry|9007-49-2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4b54729b955eeb43a8fc72ee70be7f3b|
33886|C449|S|NSC_Code|77460|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d55f1a4fc4ffb32da5dff45ad5871b96|
33887|C449|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
33888|C449|S|DEFINITION|A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone; associated with the transmission of genetic information.|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b8eeb457f799788918f1a99014f08358|
35125|C17360|S|DEFINITION|This gene is involved in the regulation of cell differentiation, growth and proliferation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f3cfd3f892ad63cba4e926318fa132db|
35126|C17360|S|OMIM_Number|614041|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2a858b536fb92ada34fc84b8aa0c448e|
35127|C17360|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
35669|C62423|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
35670|C62423|S|DEFINITION|A classification system for the endoscopic assessment of reflux esophagitis based on the number and extent of mucosal breaks and their relationships to the mucosal folds and esophageal circumference.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7ca273892aa5baf39d23fcd06e2dba67|
36007|C43784|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
36008|C43784|S|DEFINITION|A role used to assert a relationship between a gene and its general location, specified by chromosomal band position (infrequently by chromosome number or chromosome arm). The domain and range for this role are 'Gene' and 'Anatomic Structure, System, or Substance', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||600ebc6b320069ea123b8a6093252b19|
37517|C45454|S|DEFINITION|A specializing role which may be used to override Gene_Has_Abnormality that has been asserted for the gene class. This role is used to establish a link between a specific allele and genetic or molecular abnormalities that have been observed in human cells and tissues associated with cancer or another disease of interest. The domain and range for this role are 'Gene' and 'Molecular Abnormality', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5ffe278e53e98cafabce87adbd9603ad|
37518|C45454|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
37735|C76733|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
37736|C76733|S|FDA_UNII_Code|368GB5141J|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||21e231e9551df6a28f4c36b07c446551|
37737|C76733|S|CHEBI_ID|CHEBI:8984|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fa2ad387b703341a04ece18689fc21fc|
37738|C76733|S|Chemical_Formula|C12H25O4S.Na|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a4e9b45079d728ccc8cd98239e14a1d9|
37739|C76733|S|CAS_Registry|151-21-3|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9c5f8155b1c302af1c6d0d51b9d7029b|
37740|C76733|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
37741|C76733|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
37742|C76733|C|SEMANTIC_TYPE|Biomedical or Dental Material|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4373024de849fff92e38ad06e7208397|
38660|C43785|S|Design_Note|This role does not imply a cause and effect.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||68131c56681241c005ab99ae95b0acb0|
38661|C43785|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
38662|C43785|S|DEFINITION|A role used to assert that expression or alteration of a gene is correlated with a particular disease or disease state or is predictive of the disease or disease state. The domain and range for this role are 'Gene' and Findings_and_Disorder_Kind, respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||59e36acab38eb52df9bf6fead08d1b68|
39479|C13231|S|DEFINITION|The sequence of DNA present in mature messenger RNA, some of which encodes the amino acids of a protein. Most genes have multiple exons with introns between them.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a2518ed8c260534b56cdb05f906d53e3|
39480|C13231|S|DEFINITION|The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||714b0e0ff44421bffac96379a04663fb|
39481|C13231|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
39950|C122053|S|DEFINITION|This gene plays a role in cell cycle arrest.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a6556e72c097b966e6a00ea40db6d84d|
39951|C122053|S|OMIM_Number|612171|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||74fdf51875f34c9ffe509fc8ce088a18|
39952|C122053|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
40612|C26725|S|DEFINITION|A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||44ceddd18a476d47051a75a1dc0888a6|
40613|C26725|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
40614|C26725|S|DEFINITION|Abnormally low level of functional immunoglobulins in the blood that is not associated with a primary immunodeficiency.|NICHD_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9ea5392ef5625de9d545fa88324972f0|
40615|C26725|S|NICHD_Hierarchy_Term|Secondary Hypogammaglobulinemia|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f7c42d83af87c9dfc6e8702debc42495|
40616|C26725|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
40824|C17362|S|Gene_Encodes_Product|Tumor Suppressor Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||84523e2571f9097a6c54f0f1693c2513|
40825|C17362|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
40826|C17362|S|DEFINITION|A type of gene that makes a protein called a tumor suppressor protein that helps control cell growth. Mutations (changes in DNA) in antioncogenes may lead to cancer.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a210ce010edbe9be3bdbfbca72cd66d0|
40827|C17362|S|DEFINITION|Tumor Suppressor Genes encode proteins whose functions inhibit expression of tumorigenic phenotypes by holding cellular proliferation in check. When inactivated or lost, a barrier to normal proliferation is removed and deregulated growth is possible. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||57bc3c7608b9118feb736e884e89af94|
43922|C105832|S|OMIM_Number|608934|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6bedf0adc9b9c4f7316f563ec33bf5e7|
43923|C105832|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
43924|C105832|S|DEFINITION|This gene plays a role in DNA repair.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a2d31b998a7e04d6ef5221ebb13d1314|
44523|C61432|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
44524|C61432|S|DEFINITION|The North American Industry Classification System (NAICS) was developed as the standard for use by Federal statistical agencies in classifying business establishments for the collection, analysis, and publication of statistical data related to the business economy of the U.S. It was developed in cooperation with the statistical agencies of Canada and Mexico to establish a 3-country standard that allows for a high level of comparability in business statistics among the three countries. It replaces the Standard Industrial Classification (SIC).(http://www.census.gov/epcd/www/naics.html)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c958cd77fdfdfa37084b2ab71a5bab36|
44553|C53403|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
44554|C53403|S|DEFINITION|A code system intended to include all units of measures being contemporarily used in international science, engineering, and business. Its purpose is to facilitate unambiguous electronic communication of quantities together with their units.(from http://aurora.regenstrief.org/UCUM/ucum.html)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fcda3969c3403f61fa3ce0faf1281779|
45855|C45457|S|DEFINITION|A role used for an allele whose location has changed from the wild-type gene chromosomal location. This role is used to assert a new location that differs from the wild-type gene chromosomal location. The domain and range for this role are 'Gene' and 'Anatomic Structure, System, or Substance', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9c1d3d653743d1005b79f8c05cb2f136|
45856|C45457|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
46056|C1329|C|SEMANTIC_TYPE|Research Device|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||944ea5db0ff30a1a743e05509177d0e1|
46057|C1329|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
46058|C1329|S|DEFINITION|Any DNA molecule capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. They are or are derived from plasmids, bacteriophages, or viruses and are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain genetic markers to facilitate their selective recognition.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fa1809d5c00977ccb0e9cf1a29c46817|
46646|C77395|S|Chemical_Formula|C6H14N4O2.C2H6O3S2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||80b86b8ff59654bbdce6b877db7bbb73|
46647|C77395|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
46648|C77395|S|FDA_UNII_Code|62V6QH821R|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ae4fa568b0e5165447fb87c4222f5c8e|
46649|C77395|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
46650|C77395|S|CAS_Registry|106854-46-0|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||81488e05142204d9cee4e6a94c61cdee|
46669|C15439|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
46670|C15439|S|DEFINITION|An online database developed and maintained by the National Cancer Institute. Designed to make the most current, credible, and accurate cancer information available to health professionals and the public, PDQ contains peer-reviewed summaries on cancer treatment, screening, prevention, genetics, and supportive care; a registry of cancer clinical trials from around the world; and directories of physicians, professionals who provide genetics services, and organizations that provide cancer care. Most of this information is available on the Cancer.gov Web site. More specific information about PDQ can be found at http://cancer.gov/cancer_information/pdq/.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8a7881a752d3c33769c0697b082eed41|
46872|C49704|S|DEFINITION|A standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration. The CTCAE contain a grading scale for each adverse event term representing the severity of the event.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cf9fcb9d73d2b7b20c64c009dbdc166c|
46873|C49704|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
47087|C61433|S|DEFINITION|A code scheme established to promote uniformity and comparability of data collected and published by agencies within the U.S. government, state agencies, trade associations, and research organizations. It was developed as an establishment based industry classification system that classified each establishment (defined as a single physical location at which economic activity occurs) according to its primary activity. The SIC covered the entire field of economic activities by defining industries in accordance with the composition and structure of the economy. It has been replaced by the North American Industry Classification System (NAICS).(http://www.census.gov/epcd/www/naics.html)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||db6322791fe25513874f4b30e517a35c|
47088|C61433|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
47889|C17082|C|SEMANTIC_TYPE|Genetic Function|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bb7c414b88545780b816d45eaaa8b729|
47890|C17082|S|DEFINITION|Any type of DNA sequence rearrangement involving possible exchange and frequent loss of segments of DNA by either homologous recombination or non-homologous end-joining of broken DNA strands. Recombination is involved in assorting genes during reproduction, in repairing broken DNA, and in maintaining cell viability at the expense of long-term genomic stability.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7e3170127e82ab064bf983bc86479c90|
48354|C45458|S|DEFINITION|A role used for an allele whose location has changed from the wild-type gene chromosomal location. This role is used to negate an inherited role relationship that is asserted between the parent gene class and a chromosomal location when an allele has moved (e.g., translocation, inversion, etc.). The domain and range for this role are 'Gene' and 'Anatomic Structure, System, or Substance', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8fde5bea92d2a613a14a271a88ca2c86|
48355|C45458|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
50711|C97378|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
50712|C97378|S|OMIM_Number|609173|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2d59999b665af68b73bc4239841b8af2|
50713|C97378|S|DEFINITION|This gene plays a role in mitotic signaling.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ef11f4d42937f504c9d72fe6f425bb10|
51517|C107125|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
51518|C107125|S|OMIM_Number|611066|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||eb7502fb1e5b16587e6e6ca0e2a7855f|
51519|C107125|S|DEFINITION|This gene is involved in the regulation of apoptosis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||56b69bf39b7ab4b1ab039e3ebdfabbd6|
52426|C20211|S|DEFINITION|This gene plays a role in DNA mismatch repair and has been implicated in several cancers.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9fa6a8a6d81acdc019ea2677e8e07dcc|
52427|C20211|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
52428|C20211|S|OMIM_Number|600887|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||40805967d24a30a966b7dccbaf7013b9|
54007|C99623|S|OMIM_Number|605310|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4a11448383944be54272523e6abf9fc4|
54008|C99623|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
54009|C99623|S|DEFINITION|This gene may be involved in keratinocyte regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||97c9efc69dbca78a19937f7e5dda3bde|
54626|C3101|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
54627|C3101|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
54628|C3101|S|DEFINITION|Genetic diseases are diseases in which inherited genes predispose to increased risk. The genetic disorders associated with cancer often result from an alteration or mutation in a single gene. The diseases range from rare dominant cancer family syndrome to familial tendencies in which low-penetrance genes may interact with other genes or environmental factors to induce cancer. Research may involve clinical, epidemiologic, and laboratory studies of persons, families, and populations at high risk of these disorders.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f017d418b301e9408f6d53c7499e7b67|
54629|C3101|S|NICHD_Hierarchy_Term|Genetic Disorder|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||be5bc26bc0552e31cef8778eee237578|
54630|C3101|C|SEMANTIC_TYPE|Congenital Abnormality|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||db8afc77b8778b469ca3940bb67155c9|
54631|C3101|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
55182|C45280|S|DEFINITION|A collection of taxonomic subdivisions directly under Phylum. It is a major group of organisms, e.g. Mammalia, Reptilia, Gastropoda, Insecta, etc that contains a large number of different sublineages, but have shared characteristics in common (e.g. warm-blooded, fur, six legs etc).|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2f382a2037b741371c4c518dbca964a4|
55183|C45280|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
56562|C67065|S|DEFINITION|A dinucleotide repeat on chromosome 5 that serves as a marker for microsatellite instability in colorectal cancers.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8358eb1d7a557914ba3b7279290ef7a4|
56563|C67065|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
56674|C25994|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
56675|C25994|S|DEFINITION|Peptide Hormone Genes encode Peptide Hormones, typically synthesized as larger precursor molecules from which are derived smaller active proteins that function as hormonal signals secreted by one tissue or organ and have physiological effects on other tissues or organs.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b6e517be2b63fb60f768733904cefd4a|
56676|C25994|S|Gene_Encodes_Product|Peptide Hormone|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a6c622f3e1eaf6a0b7356cbb19685f8d|
57876|C34816|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
57877|C34816|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
57878|C34816|S|NICHD_Hierarchy_Term|Congenital Metabolic Disorder|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5bbbfdc5f1a4e8a3cdcd849acd6a9ee4|
57879|C34816|S|DEFINITION|A group of disorders present at birth that involve genetic defects leading to disturbances in carbohydrate, lipid, lysosomal storage or amino acid metabolism in the body.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||807ad43cda42a65213e5dc2e6e79d2d6|
60028|C84943|S|OMIM_Number|610134|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||249b0078bb29f30ed6b3beea5fa54afb|
60029|C84943|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
60030|C84943|S|DEFINITION|This gene plays a role in generating glycoconjugates on glycosaminoglycan precursors.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ff31ef3c99f691744d168196f2ed4b69|
60699|C94784|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
60700|C94784|S|DEFINITION|This gene is involved in the metabolism of glucose and lipids.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a310f665ab71dafe105472d2c5eb653d|
60701|C94784|S|OMIM_Number|605441|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||35da6074d69d23c0b09af7d8f91911ff|
61345|C97323|S|DEFINITION|This gene plays a role in the negative regulation of protein synthesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f0c95bd75329228725de4ed140c54f0f|
61346|C97323|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
61347|C97323|S|OMIM_Number|613635|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||591a51a0e96209cbb43a44071b1eed52|
61848|C97325|C|SEMANTIC_TYPE|Manufactured Object|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b2d37acd2ce8035b9df09639b8aee093|
61849|C97325|S|DEFINITION|A physical object created by hand or machine.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||41e63da7002502d98c8c5c4a072ea5e5|
62448|C83169|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
62449|C83169|S|DEFINITION|The systematic arrangement of entities into groups such that each entity can be assigned the value Never, Current or Former.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||33c7b3290b86d2629876cfd876694f39|
62505|C42883|S|DEFINITION|A set of related records (either written or electronic) kept together.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aa4b86a8487f1943e12256a30d6cb3a9|
62506|C42883|C|SEMANTIC_TYPE|Manufactured Object|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b2d37acd2ce8035b9df09639b8aee093|
63131|C195|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
63132|C195|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
63133|C195|S|PDQ_Closed_Trial_Search_ID|43436|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||104f7cbe857799ba883067a174bc01c1|
63134|C195|S|PDQ_Open_Trial_Search_ID|43436|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||104f7cbe857799ba883067a174bc01c1|
63135|C195|S|DEFINITION|A thiopurine-derivative antimetabolite with antineoplastic and immunosuppressive activities. Produced through the metabolism of mercaptopurine by hypoxanthine-guanine phosphoribosyltransferase (HGPRT), mercaptopurine metabolites 6-thioguanosine-5'-phosphate (6-thioGMP) and 6-thioinosine monophosphate (T-IMP) inhibit nucleotide interconversions and de novo purine synthesis, thereby blocking the formation of purine nucleotides and inhibiting DNA synthesis. This agent is also incorporated into DNA in the form of deoxythioguanosine, which results in the disruption of DNA replication. In addition, mercaptopurine is converted to 6-methylmercaptopurine ribonucleoside (MMPR) by 6-thiopurine methyltransferase; MMPRs are also potent inhibitors of de novo purine synthesis. (NCI04)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||81529b85498a5918af970c57e9776973|
63136|C195|S|DEFINITION|A drug used to treat acute lymphatic leukemia. It belongs to the family of drugs called antimetabolites.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cb2fae52fe98f2169742469aaf2d31d8|
63137|C195|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
63138|C195|S|FDA_UNII_Code|E7WED276I5|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ba9e21a851ecc0638bcbe498a8024d9b|
63139|C195|S|Chemical_Formula|C5H4N4S.H2O|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||51ca08dd71fc8e07a44002447df01bb5|
63140|C195|S|CHEBI_ID|CHEBI:31822|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||714a274271b2f9ab04ded666ddb99260|
63141|C195|S|Accepted_Therapeutic_Use_For|Acute lymphocytic leukemia; Acute myelogenous leukemia; Crohns disease; Hodgkins lymphoma in children; Lymphoblastic lymphoma; Ulcerative colitis|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ac6467ec7c13acf85cdf554342b83564|
63142|C195|S|NSC_Code|755|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ccb0989662211f61edae2e26d58ea92f|
63143|C195|S|CAS_Registry|6112-76-1|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||71cf7033067ec6d54f49a009f4cb7d30|
63144|C195|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
63735|C15241|C|SEMANTIC_TYPE|Manufactured Object|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b2d37acd2ce8035b9df09639b8aee093|
63736|C15241|S|DEFINITION|A collection of DNA molecules, derived from restriction fragments that have been cloned in vectors, that includes all or part of the genetic material of an organism.(On-line Medical Dictionary)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8b33f35710953f16c84ad348a391b169|
64102|C16961|C|SEMANTIC_TYPE|Mental Process|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||091672c0636d6a760b7b215b70aa76a7|
64103|C16961|S|DEFINITION|A branch of artificial intelligence concerned with the identification of visual or audio patterns by computers.For the computer to recognize the patterns, the patterns must be converted into digital signals and compared with patterns already stored in memory.Some uses of this technology are in character recognition, voice recognition, handwriting recognition, and robotics. (High-Tech Dictionary)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a91c71d1bf4be97cfa8c7fc198f0952d|
64242|C66883|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
64243|C66883|S|CHEBI_ID|CHEBI:48561|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||56ccc2015d63ae8e710b4a9f0b1401b0|
64244|C66883|S|DEFINITION|Any agent that binds to and blocks dopamine receptors.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1852c44a73616f4cd84d020b5725ddfa|
64946|C26931|S|DEFINITION|A condition in which the level of immunoglobulins (antibodies) in the blood is low and the risk of infection is high.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f17d3caa485be361f1de0c9f0b897e3e|
64947|C26931|S|DEFINITION|A decreased level of serum immunoglobulins. It may be inherited or acquired. It is caused by decreased or inefficient production of immunoglobulins from B cells or by a decrease in the numbers of B cells themselves. Low levels of immunoglobulins will affect the immune system's ability to combat bacterial infection. Supplementation of immunoglobulins is needed to prevent worsening outcomes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2b9ebb43a99e6f45cef0241d14a258b0|
64948|C26931|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
65581|C25802|S|DEFINITION|Genes that encode cytoplasmic proteins of both prokaryotes and eukaryotes that bind to nascent or unfolded polypeptides and ensure correct folding or transport. Chaperone proteins do not covalently bind to their targets and do not form part of the finished product. Heat-shock proteins are an important sub set of chaperones. Three major families are recognised, the chaperonins (groEL and hsp60), the hsp70 family and the hsp90 family. Outside these major families are other proteins with similar functions including nucleoplasmin, secB and T-cell receptor associated protein.(On-line Medical Dictionary)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f5d553ab2b8172c3c1861c9d6533f2b6|
65582|C25802|S|Gene_Encodes_Product|Chaperone|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||79164f76505c602583220cc87331045e|
65583|C25802|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
68084|C21050|S|DEFINITION|Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene expression at the level of transcription or translation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||74941336cdb974aa3fc5d2091c6f484a|
68085|C21050|C|SEMANTIC_TYPE|Genetic Function|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bb7c414b88545780b816d45eaaa8b729|
69383|C2941|S|DEFINITION|A rare autosomal recessive immunodeficiency disorder characterized by abnormal intracellular protein transport. Chediak-Higashi syndrome (CHS) is characterized by immune deficiency; partial oculocutaneous albinism; a bleeding disorder due to deficient platelet dense bodies; neutropenia; neutrophils with impaired chemotaxis and bactericidal activity; recurrent infection; and abnormal natural killer (NK) cell function. CHS may be associated with hepatosplenomegaly, lymphadenopathy, anemia, thrombocytopenia, roentgenologic changes in bones, lungs and heart, and skin and psychomotor abnormalities; it is often fatal in childhood as a result of infection or an accelerated lymphoma-like phase. CHS occurs in mink, cattle, and mice, as well as man.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||86aafcca1ab79eabafdcc319e14027e7|
69384|C2941|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
69719|C48212|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
69720|C48212|S|OMIM_Number|300228|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0d62f6771bf2f98dad9e74141e113048|
69721|C48212|S|DEFINITION|This gene is a testicular germ cell tumor susceptibility sequence.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||611d24143c67a84e914f25fb8692d279|
71047|C97927|C|SEMANTIC_TYPE|Cell or Molecular Dysfunction|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f731b9e954cc2b7fe23a53516abccdf9|
71048|C97927|S|DEFINITION|A variation in the nucleic acid sequence of a specific gene.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||57b384b8ca180410c8b4f7105f98a33c|
72163|C68386|S|DEFINITION|A phospholipid with a polar choline found in phosphoester linkage to diacylglycerol.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fac203d196d0e18e04504de29720149c|
72164|C68386|S|CHEBI_ID|CHEBI:16110|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ff6c0b7a5764081eb443efb8582827ab|
72165|C68386|S|DEFINITION|Dietary phospholipid containing choline.|CRCH_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f1d2ca7c710f7c468ac3e00fef05c745|
72166|C68386|S|Chemical_Formula|C22H44O2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4ac0e64cd9c1cc6e1aafef10c4994fdf|
72167|C68386|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
72168|C68386|S|Contributing_Source|CRCH|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||791e0ec6993f0a01113a2918fa48f740|
72169|C68386|S|CHEBI_ID|CHEBI:61995|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||36a80736e4a8c039e4fd9cfafe3fddda|
73921|C19195|S|DEFINITION|This gene is involved in mismatch repair and plays a role in several cancers.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1d1ad9a30cd823126b4db09f74ad54ed|
73922|C19195|S|OMIM_Number|600678|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||672138eb9acb8b57c1abe18bb7a20d03|
73923|C19195|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
74835|C21389|S|OMIM_Number|601797|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8ce93ea38b000a97dea90f07f7081d19|
74836|C21389|S|DEFINITION|This gene plays a role in tumor suppression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bdfd63b455228b2b8a0eb8676b387b08|
74837|C21389|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
75915|C25346|S|DEFINITION|A grouping of things based on shared common attributes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||68758a4e348106ea0e38c15d2338f1dc|
75916|C25346|C|SEMANTIC_TYPE|Qualitative Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||74541bf45ab4e848ae54be0d9d3e9ed2|
75961|C104242|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
75962|C104242|S|OMIM_Number|602661|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4ad95717a3fb22b2a4dd15f9fd1efe50|
75963|C104242|S|DEFINITION|This gene is involved in microtubule function and structure.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a02c8760bc8703a3a1dbd24c0a857554|
75980|C19202|S|DEFINITION|The National Cancer Institute, part of the National Institutes of Health of the United States Department of Health and Human Services, is the Federal Government's principal agency for cancer research. The National Cancer Institute conducts, coordinates, and funds cancer research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer. Access the National Cancer Institute Web site at http://www.cancer.gov.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||44d7e8f5eebed8e73be03349fb7be18e|
75981|C19202|S|DEFINITION|The Federal Government's principal agency for cancer research. NCI conducts, coordinates, and funds cancer research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer. Part of the National Institutes of Health of the United States Department of Health and Human Services.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||89caf2849ff0198c81bd60e708023780|
75982|C19202|C|SEMANTIC_TYPE|Health Care Related Organization|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||13a653840ad293d0527832fdb2275c9f|
76855|C13734|C|SEMANTIC_TYPE|Nucleotide Sequence|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5b520cf7246b1ea899fae46e128d2ab5|
76856|C13734|S|DEFINITION|Any DNA sequence involved in the regulation of genetic processes such as transcription and replication.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1e182d352bc6b284e0630d5e3e6f52cc|
78182|C16630|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
78183|C16630|S|DEFINITION|The total gene complement, about 3 billion base pairs of DNA, contained in the human chromosomes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||43aa841ac0727fa7578bb16bac3acdb6|
78526|C126605|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
78527|C126605|S|DEFINITION|This gene is involved in phosphatase inhibition and anchorage-independent cell growth.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ccc6cfa24e09fa4ec24f93f03367bdc6|
78528|C126605|S|OMIM_Number|610643|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3239219de504305df5012d4cbc265f72|
79017|C1334|S|Micronutrient|Y|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||57cec4137b614c87cb4e24a3d003a3e0|
79018|C1334|C|SEMANTIC_TYPE|Chemical Viewed Functionally|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3389b5c5751109d17a1aa8faa18924ab|
79019|C1334|S|DEFINITION|A group of water-soluble vitamins essential for metabolism and normal physiological functions. B6 vitamins, including pyridoxine, pyridoxal, and pyridoxamine, are converted in vivo to pyridoxal phosphate, a cofactor necessary for the synthesis of amino acids, neurotransmitters, and sphingolipids. More than 100 enzymes involved in protein metabolism require vitamin B6 as a cofactor. Vitamin B6 is essential to red blood cell, nervous system, and immune systems functions and helps maintain normal blood glucose levels. Vitamin B6 is found in a wide variety of foods including cereals, beans, meat, poultry, fish, and some fruits and vegetables. (NCI04)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||31b34167c38ce49c047499677739daea|
79020|C1334|S|USDA_ID|415|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||42e7aaa88b48137a16a1acd04ed91125|
79021|C1334|S|DEFINITION|A nutrient in the vitamin B complex that the body needs in small amounts to function and stay healthy. Vitamin B6 helps keep nerves and skin healthy, fight infections, keep blood sugar levels normal, produce red blood cells, and some enzymes work properly. Vitamin B6 is a group of related compounds (pyridoxine, pyridoxal, and pyridoxamine) found in cereals, beans, peas, nuts, meat, poultry, fish, eggs, and bananas. It is water-soluble (can dissolve in water). Not enough vitamin B6 can cause mouth and tongue sores and nervous disorders. Vitamin B6 is being studied in the prevention of hand-foot syndrome (a disorder caused by certain anticancer drugs and marked by pain, swelling, numbness, tingling, or redness of the hands or feet).|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dae1f1964169543ee4a71c34887f6e15|
79022|C1334|S|CAS_Registry|8059-24-3|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||58c2ddd8a957834cd03a995c029cd327|
79023|C1334|S|Nutrient|Y|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||57cec4137b614c87cb4e24a3d003a3e0|
79024|C1334|S|Tolerable_Level|Y|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||57cec4137b614c87cb4e24a3d003a3e0|
79025|C1334|S|Contributing_Source|CRCH|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||791e0ec6993f0a01113a2918fa48f740|
79026|C1334|S|INFOODS|VITB6A|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||534971b3c13a95a64b069ea00d896523|
79027|C1334|S|US_Recommended_Intake|Y|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||57cec4137b614c87cb4e24a3d003a3e0|
79028|C1334|S|CHEBI_ID|CHEBI:27306|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||894283691c45bc08fbaaa27fbcd9cc72|
79029|C1334|S|DEFINITION|Class of water-soluble vitamins that are coenzymes in the metabolism of amino acids, glycogen, and sphingoid bases. (DRI)|CRCH_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2c43ba61ec4fcebc28dd3da4c9491bdb|
79030|C1334|S|Unit|mg|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b351bb9b0af6e4fc678749675c53ad67|
79427|C20921|S|DEFINITION|Signaling Pathway Genes encode proteins or peptides that participate in intracellular signal transduction processes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b10986f21b8b2e2fb368d4cc2484fd8f|
79428|C20921|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
79429|C20921|S|Gene_Encodes_Product|Signaling Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||384eaa0627d613044371c54ee8d2c38d|
80641|C38319|S|OMIM_Number|111300|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aaeceaa059045c5a199051b9687545dd|
80642|C38319|S|DEFINITION|This gene plays a role in erythrocyte regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||80a707360f6b94e432e732fa1f4ccd2d|
80643|C38319|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
81603|C104430|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
81604|C104430|S|OMIM_Number|137240|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7d887b652372411db2de97a2ccda4305|
81605|C104430|S|DEFINITION|This gene plays a role in glucose homeostasis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1f8f28dc26b1fac76e6a8a847aa1cd6f|
83561|C73671|S|OMIM_Number|613198|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d3b9c8bb26d56cfd24f943ea6ba8019e|
83562|C73671|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
83563|C73671|S|DEFINITION|This gene is involved in epigenetic control of gene expression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4e0115880884502def8df25264f9e3d6|
83961|C49487|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
83962|C49487|S|NICHD_Hierarchy_Term|No|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bafd7322c6e97d25b6299b5d6fe8920b|
83963|C49487|S|DEFINITION|The non-affirmative response to a question. (NCI)|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||723b49677fa6127dbbc2a0df90a83544|
83964|C49487|S|DEFINITION|The non-affirmative response to a question.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||66644be544e01286ceac57a2e589fc19|
83965|C49487|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
83966|C49487|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
83967|C49487|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
84036|C28539|S|DEFINITION|This gene plays a role in the transcriptional activation of androgen responsive genes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||31af95480566b4bb2b218b21cd7dff2c|
84037|C28539|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
84038|C28539|S|OMIM_Number|313700|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e60a65c3c4edb6f42b9dfd0a93ce352|
84080|C92970|S|DEFINITION|This gene may play a role in the development of spermatids.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b5971d0e2620a34c76bcf091a6e2840b|
84081|C92970|S|OMIM_Number|300670|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d24264c6ed053ee7b692e77cf7399109|
84082|C92970|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
86389|C49488|C|SEMANTIC_TYPE|Idea or Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2f755f6dc7d9df8a3595549b8e5f7d28|
86390|C49488|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
86391|C49488|S|NICHD_Hierarchy_Term|Yes|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||93cba07454f06a4a960172bbd6e2a435|
86392|C49488|S|DEFINITION|The affirmative response to a question.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||874eb48f8b3d48a1461294057a719de7|
86393|C49488|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
86394|C49488|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
86395|C49488|S|DEFINITION|The affirmative response to a question. (NCI)|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||616a4ab1dc62d8e89d6df9dda8ee1e09|
88981|C3131|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
88982|C3131|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
88983|C3131|S|FDA_Table|Patient Code (Appendix B)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3fa6ef9a096c688f10b6a40a4ee0c8c5|
88984|C3131|S|DEFINITION|Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ef11a14a071eabf80a29d4acea7efc44|
88985|C3131|S|DEFINITION|The inability of the body to produce an immune response.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||136555f0efc9b3d5d37796ca7bfbbae6|
88986|C3131|S|DEFINITION|A deficiency of immune response or a disorder characterized by deficient immune response.|FDA_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4284f8d678b3a089f0b728453e642432|
89102|C25991|S|Gene_Encodes_Product|Signal Transducer and Activator of Transcription|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6889e3a9e6b2b9113b7b828c65acfcc0|
89103|C25991|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
89104|C25991|S|DEFINITION|Signal Transducer and Activator of Transcription Family Genes encode dual function cytoplasmic Signal Transducer and Activator of Transcription (STAT) proteins that are activated by tyrosine phosphorylation in response to a large number of cytokines, growth factors, and hormones. After activation they form homodimers or heterodimers that translocate to the nucleus where they either bind directly to regulatory DNA cis-elements of specific target genes or act together with other DNA-binding proteins in multiprotein transcription complexes to direct transcription. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||caa6f26d6d98a487948f3fc2aa0d3661|
91860|C27873|S|DEFINITION|A broad classification of inherited disorders presenting at birth that affect the initial immunologic response to infection. In these disorders, the primary role of innate immunity to detect and neutralize pathogens which the individual has not been previously exposed is decreased or ineffective.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b879b706d2ae3e39ad18e9d987f7f510|
91861|C27873|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
92847|C18093|C|SEMANTIC_TYPE|Cell or Molecular Dysfunction|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f731b9e954cc2b7fe23a53516abccdf9|
92848|C18093|S|DEFINITION|The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e07b7d958b460dccaeab76ed02201abb|
93618|C11260|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
94446|C67064|S|DEFINITION|A dinucleotide repeat on chromosome 2 that serves as a marker for microsatellite instability in colorectal cancers.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7d3c3e0d5d162b42df11f76e1ee6ad6b|
94447|C67064|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
95709|C106218|S|DEFINITION|This gene is involved in both protein phosphorylation and signal transduction.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||889b5a3018ab9fabf0f461e693b30bd5|
95710|C106218|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
96185|C124092|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
96186|C124092|S|DEFINITION|This gene is involved in checkpoint-mediated cell cycle arrest.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c8312ab714161fc98a8c501f841c6440|
96187|C124092|S|OMIM_Number|608952|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||673db01404ad22494f7f07645070550e|
96299|C47494|S|CHEBI_ID|CHEBI:64198|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||09566dbaed2f86027c126f100b8c901e|
96300|C47494|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
96301|C47494|S|CAS_Registry|59-52-9|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7d9742a8563b9997e0553db08412860d|
96302|C47494|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
96303|C47494|S|FDA_UNII_Code|0CPP32S55X|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||524925c49c2b1f53bbce81d96f11b6f4|
96304|C47494|S|DEFINITION|A metal chelating agent that is used as an antidote in arsenic, gold, lead, mercury and other heavy metal poisoning. Metals form ligands in the body with the sulfhydryl groups of the pyruvate-oxidase enzyme system. This leads to an inhibition of the normal functioning of these enzymes that are dependent on free sulfhydryl groups for their activity. Dimercaprol reverses the enzyme inhibition by chelating the metal and regenerates free sulfhydryl groups, thereby preventing and reversing the metals toxic effects.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fe8d9db4a8695339000028e4cc754db2|
96305|C47494|S|NSC_Code|39515|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f41c67125b3d7164bae64b3ff8d3bc87|
96306|C47494|S|Chemical_Formula|C3H8OS2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cf040ef55f239925b95259dd25c0710f|
96416|C26016|S|DEFINITION|A gene that encodes a protein product that is a component of a larger protein agglomeration or complex. The gene product can be an assembly component of a functional protein complex or a factor involved in stabilization.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8915afa6ea5d225af201bb18433fbc87|
96417|C26016|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
96626|C18482|S|OMIM_Number|120436|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||79244a3f8e11ef3c19f33abbfd1db84f|
96627|C18482|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
96628|C18482|S|DEFINITION|This gene plays a role in DNA mismatch repair.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4f4c8cc34f195015ef52a5fc6849c286|
96819|C13249|S|DEFINITION|The sequence of DNA in between exons that is initially copied into RNA but is cut out of the final RNA transcript and therefore does not change the amino acid code. Some intronic sequences are known to affect gene expression.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0eaec8431f5f55cf147f02c4a49aa8a2|
96820|C13249|S|DEFINITION|Non-coding, intervening sequences of DNA that are transcribed, but are removed from within the primary gene transcript and rapidly degraded during maturation of messenger RNA.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cb4d3b01382cdaa99bc566320868c703|
96821|C13249|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
97917|C114687|S|DEFINITION|This gene plays a role in phospholipid metabolism.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c23fb25aeaf1a5144588c628a37f0b3e|
97918|C114687|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
97919|C114687|S|OMIM_Number|614796|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||58442be0132c8c6e80b1660555177771|
97991|C29951|S|DEFINITION|This gene plays a role in cell proliferation and protein synthesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||10574bf91f3c345fa0e09e47a5678b26|
97992|C29951|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
97993|C29951|S|OMIM_Number|600944|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7c7c4ec7f21b59986242e2536803c1ed|
98378|C97764|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
98379|C97764|S|DEFINITION|This gene may be involved in signal transduction.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6d089fdac0bf59ef0d60780dfb9b33b3|
98915|C18297|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
98916|C18297|S|DEFINITION|A genetic complementation group for X-ray sensitivity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6c1886e5b4b471ea76118f9222489335|
100321|C116594|S|DEFINITION|This gene plays a role in the proliferation and differentiation of hematopoietic precursor cells|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9bc8c5e6f1f60ecbfddf983dc4b4bdae|
100322|C116594|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
100323|C116594|S|OMIM_Number|604713|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b04622e74d070310af698dd1075b665e|
100853|C16438|C|SEMANTIC_TYPE|Molecular Biology Research Technique|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cfda8865f3e70cdb923e199acbd258cf|
100854|C16438|S|DEFINITION|Determination of the relative positions of genes on a DNA molecule (chromosome or plasmid) and of the distance, in linkage units or physical units, between them.(On-line Medical Dictionary)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||55cd7cec473d46774a6cc9117a607016|
100855|C16438|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
102032|C112013|S|DEFINITION|A classification system for grading myasthenia gravis that divides the disease into 5 main classes and several subclasses.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||646ce5a485226455aa64834f1e90d76a|
102033|C112013|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
102191|C118579|S|OMIM_Number|605440|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7dc7239fcb1cd8cb811467db439bb19e|
102192|C118579|S|DEFINITION|This gene may be involved in the regulation of protein degradation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1627de15a3c341a4a1a288d5bdd2c88b|
102193|C118579|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
104230|C17757|S|DEFINITION|This gene is involved in the epidermal growth factor signal transduction pathway.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||afad8639bda682374020372fb6d3a0ad|
104231|C17757|S|OMIM_Number|131550|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||98519ebae0e17b261f3ee4e6d5779a48|
104232|C17757|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
104400|C97933|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
104401|C97933|S|OMIM_Number|610512|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4c6ff4105427c243a602954d9043cde3|
104402|C97933|S|DEFINITION|This gene plays a role in vesicular transport.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||388fbb717e938358691e773f8bfe4a1b|
104536|C43519|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
104537|C43519|S|DEFINITION|This database is a catalog of human genes and genetic disorders authored and edited by Dr. Victor A. McKusick and his colleagues at Johns Hopkins and elsewhere, and developed for the World Wide Web by NCBI, the National Center for Biotechnology Information. The database contains textual information and references. It also contains copious links to MEDLINE and sequence records in the Entrez system, and links to additional related resources at NCBI and elsewhere.(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||90a35b3512cf3f3c64d547f0fcccbe0e|
107774|C106086|S|DEFINITION|This gene is involved in the response to mechanical stimuli.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||385835a6a3dd628f9c6ef5729fd1bed0|
107775|C106086|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
107776|C106086|S|OMIM_Number|613629|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3ed6a458eac34e88b8e3f52bcb5c9512|
109201|C11266|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
109222|C54668|S|DEFINITION|Short region of DNA in which the frequency of the CG sequence is higher than in other regions.(Biology-text.com)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||03dc95297d712ab46fc4ea7f2f031206|
109223|C54668|C|SEMANTIC_TYPE|Nucleotide Sequence|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5b520cf7246b1ea899fae46e128d2ab5|
111191|C459|S|Design_Note|This category represents drug products, not their individual ingredients.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||74cbd07e2f2873c1ed9f7d850443c7fb|
111192|C459|S|DEFINITION|A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||67026e1b76d335aa5d012702865aebc2|
111193|C459|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
111194|C459|S|DEFINITION|A legal drug that is used to prevent, treat, or relieve symptoms of a disease or abnormal condition.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ff8ce26be996d69bf4ddb1968a27e730|
111805|C11267|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
113796|C21344|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
113797|C21344|S|DEFINITION|Genes that code for growth factors.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5a5a549eda19e9b6c4cc7ca271614f77|
113798|C21344|S|Gene_Encodes_Product|Growth Factor|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||00edf99feb029eb2204356aca2540687|
115197|C105105|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
115198|C105105|S|DEFINITION|This gene is involved in cell-cell adhesion.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7cbd12bb96934fea75c6e7ba85ad0418|
115199|C105105|S|OMIM_Number|611002|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7cf9aa1061c8764899eaa5dd7fcfcd63|
115809|C66877|S|CAS_Registry|180683-37-8|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1c5650b3f1802d71bd48fd3be6f3279e|
115810|C66877|S|Chemical_Formula|C36H47N5O4.H2O|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8b4e4759ab2316b6a76affe81887e62d|
115811|C66877|S|DEFINITION|A synthetic hydroxyaminopentane amide agent that selectively inhibits the protease of both human immunodeficiency virus 1 and 2. The incorporation of a basic amine into the hydroxyethylene backbone improves its aqueous solubility and its oral bioavailability.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bfa956b79aa797ad19c49935452350a3|
115812|C66877|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
115813|C66877|S|FDA_UNII_Code|5W6YA9PKKH|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||02f81f6310daf942a0f20717186520d8|
115814|C66877|S|DEFINITION|A drug that interferes with the ability of a virus to make copies of itself.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6b24b51c65d9de952d665df281a40e92|
115815|C66877|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
116756|C28607|S|DEFINITION|This gene plays a role in the modulation of ligand-specific receptor-mediated endocytosis, and also plays a regulatory role in cholesterol synthesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0b90bbd6e5ce3e8f543164f282e94130|
116757|C28607|S|OMIM_Number|606945|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6327e60127d0fbf7a37a3386670e9f4e|
116758|C28607|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
117588|C113522|S|OMIM_Number|147790|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2439e45bed88aba88043150760aa8638|
117589|C113522|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
117590|C113522|S|DEFINITION|This gene plays a role in immune function.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b9848d478330a9c8e0043b1c6b146495|
121096|C25969|S|DEFINITION|Cytoplasmic Protein Genes encode Cytoplasmic Proteins that are typically localized in the cell interior, generally excluding the plasma membrane, mitochondria, and the nucleus. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||12077d593b39c105dede7d220afdc370|
121097|C25969|S|Gene_Encodes_Product|Cytoplasmic Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4c8fd10602393a8bdb97315e7084831f|
121098|C25969|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
121284|C26738|S|Contributing_Source|MedDRA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1ba896ae50594408113d26bfe99ff078|
121285|C26738|S|DEFINITION|Inflammation of the urinary bladder.|NICHD_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d10daafe6d44bbc8787cf2ddfeba36d4|
121286|C26738|S|DEFINITION|Inflammation of the urinary bladder.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d10daafe6d44bbc8787cf2ddfeba36d4|
121287|C26738|S|NICHD_Hierarchy_Term|Cystitis|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||42f11197bebbdef31437b53b8f59e476|
121288|C26738|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
121289|C26738|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
122224|C104651|S|OMIM_Number|608677|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||801c81ff12aa7aa6befe1190fddc023f|
122225|C104651|S|DEFINITION|This gene is involved in both ubiquitination and cell signaling.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3c1c9f4c38a21cb607feba0f0b83467b|
122226|C104651|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
122317|C16277|S|Design_Note|Two or more genes are said to be alleles if they occupy the same DNA sequence at a locus on homologous chromosomes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f6d326f3caacfc4154b4975d53b30418|
122318|C16277|C|SEMANTIC_TYPE|Functional Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a79a5d175c8269874d5b5c9162a72cf|
122319|C16277|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
122320|C16277|S|DEFINITION|Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process. (NCI)|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c5435c2ad8c49258ceef215bdc278773|
122321|C16277|S|DEFINITION|Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4d4aa95d823891e4386b056d51e4aef2|
122322|C16277|S|DEFINITION|One of two or more DNA sequences occurring at a particular gene locus. Typically one allele (normal DNA sequence) is common, and other alleles (mutations) are rare.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1b98904e171c52adb02c99d7110987bf|
123359|C116977|S|DEFINITION|Terminology that is used to support NCI's Clinical Trials Reporting Program (CTRP), a database that captures the required reporting data for all NCI-sponsored clinical trials.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a00d07a7a694648c9aee41b014d9d3d6|
123360|C116977|C|SEMANTIC_TYPE|Functional Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a79a5d175c8269874d5b5c9162a72cf|
125927|C116978|S|DEFINITION|A set of terminology that includes the medical products used in NCI-sponsored clinical trials.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ffa79b3084f883f81ee07655922e06ed|
125928|C116978|C|SEMANTIC_TYPE|Functional Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a79a5d175c8269874d5b5c9162a72cf|
126118|C102517|S|DEFINITION|This gene is involved in guanine nucleotide exchange.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||982d2ab33102014f90a7f285ff9f8d39|
126119|C102517|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
126120|C102517|S|OMIM_Number|612139|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||65556322b107d58e988aaa7c267f89e0|
127898|C65168|C|SEMANTIC_TYPE|Professional or Occupational Group|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||49410f963f702d28c3534c4c41e6417f|
128539|C15238|S|DEFINITION|Application of genetic material (usually DNA) into cells in order to permanently correct an inherited disease or acquired disease.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||365e7b9ebd35c415b6a3560bdc6dac0d|
128540|C15238|S|Design_Note|Gene therapy techniques attempt to replace a faulty or missing gene associated with a particular disease, mediate localized delivery of a protein producing specified therapeutic effects, or introduce new cellular functions.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ea8bf09a02540914041393fac0114850|
128541|C15238|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
128542|C15238|S|DEFINITION|Treatment that alters a gene. In studies of gene therapy for cancer, researchers are trying to improve the body's natural ability to fight the disease or to make the cancer cells more sensitive to other kinds of therapy.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9ca1fdbb0a1da1e1c63730c1422a4abc|
128543|C15238|S|DEFINITION|Treatment of human disease by gene transfer.|CTEP-SDC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ab0c983ed4648c1924659b1592f24843|
128544|C15238|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
128545|C15238|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
128546|C15238|S|DEFINITION|Application of genetic material into cells in order to correct an inherited or acquired disease.|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0d723eb46951b42a75c0cc9797bc45f3|
133580|C47776|C|SEMANTIC_TYPE|Indicator, Reagent, or Diagnostic Aid|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4a9b2c2bb9ea50d8bc4fac6e1ea8f98f|
133581|C47776|S|FDA_UNII_Code|N0A3Z5XTC6|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8c50ec871390211327f4ac1534367654|
133582|C47776|S|DEFINITION|A synthetic muscarinic antagonist with actions similar to atropine and with an anticholinergic property. Upon ocular administration, tropicamide binds to and blocks the muscarinic receptors in the sphincter and ciliary muscle in the eye. This inhibits the responses from cholinergic stimulation, producing dilation of the pupil and paralysis of the ciliary muscle. Tropicamide is a diagnostic agent and is used to produce short-duration mydriasis and cycloplegia.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||65582703d6c1facbfc3dadf64ec0cd22|
133583|C47776|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
133584|C47776|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
133585|C47776|S|CAS_Registry|1508-75-4|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bb556bc997ecd7f63afb65da6f2ff19a|
133586|C47776|S|Chemical_Formula|C17H20N2O2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0d1aee5fd05e649502c5fd63848d7d6a|
133587|C47776|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
133775|C16812|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
133776|C16812|S|DEFINITION|A group of linked loci, collectively termed H-2 complex in the mouse and HLA complex in humans, that codes for cell-surface histocompatibility antigens and is the principal determinant of tissue type and transplant compatibility.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e38fd7a1190028ea67acf5c7f396f35e|
134646|C17425|S|DEFINITION|This gene plays a role in cell adhesion and cytoskeletal remodeling. It is also involved in suppression of cell growth.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e6b01f0d04146287e153a7424b9ccde6|
134647|C17425|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
134648|C17425|S|OMIM_Number|607379|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8d03ea445f8e9e87da969ced102d83e5|
135489|C48669|S|DEFINITION|The act of issuing printed materials.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c5c238743c076ede26cfff46d854f451|
135490|C48669|C|SEMANTIC_TYPE|Activity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ecfc2dffe568c10a67dbc6d3724cfde2|
136023|C18481|S|OMIM_Number|609309|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b7085ecb9b32320b1717c30c5430c97f|
136024|C18481|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
136025|C18481|S|DEFINITION|This gene plays a role in DNA mismatch repair mutations in the gene result in hereditary nonpolyposis colorectal cancer-1.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a752a3c54c853b59ba077d6a6a639d4a|
136083|C92962|S|OMIM_Number|300493|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6535241430567ba05e220a86698e5b92|
136084|C92962|S|DEFINITION|This gene plays a role in sperm differentiation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d97424f38665d365bf826c6d6e3649de|
136085|C92962|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
136885|C84407|S|OMIM_Number|605053|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||58ead19fa0004f095f044a9f49a53d8b|
136886|C84407|S|DEFINITION|This gene plays a role in both translational silencing and viral infection.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||676772d4cf78f567a9d910015dc5657d|
136887|C84407|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
137434|C61992|S|CAS_Registry|486-12-4|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ea0fb3e05b778e79e2a67dec7c9bc033|
137435|C61992|S|Chemical_Formula|C19H22N2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1e26162730f97fd6c3bd54815e817cde|
137436|C61992|S|FDA_UNII_Code|2L8T9S52QM|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3ea1d02add45a02f7772715009c22611|
137437|C61992|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
137438|C61992|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
137853|C21550|S|DEFINITION|Cytokines are soluble glycoproteins released by cells of the immune system, which act nonenzymatically through specific receptors to regulate immune responses. Cytokines resemble hormones in that they act at low concentrations and bind with high affinity to a specific receptor.(Health On the Net Allergy Glossary; http://www.hon.ch/Library/Theme/Allergy/Glossary/allergy.html)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e76b4175ca32bdc5f441076103fe54b3|
137854|C21550|S|Gene_Encodes_Product|Cytokine|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||66addfa56062542968e38db756398062|
137855|C21550|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
138246|C17964|S|DEFINITION|The science of using computers, databases, and math to organize and analyze large amounts of biological, medical, and health information. Information may come from many sources, including patient statistics, tissue specimens, genetics research, and clinical trials.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||10df8f5cbda0030f4312fc1ee8d5e69c|
138247|C17964|C|SEMANTIC_TYPE|Biomedical Occupation or Discipline|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1cf1233b26ad9682dbe0588c6062e35f|
138248|C17964|S|DEFINITION|Bioinformatics derives knowledge from computer analysis of biological data. These can consist of the information stored in the genetic code, but also experimental results from various sources, patient statistics, and scientific literature. Research in bioinformatics includes method development for storage, retrieval, and analysis of the data. Bioinformatics is a rapidly developing branch of biology and is highly interdisciplinary, using techniques and concepts from informatics, statistics, mathematics, chemistry, biochemistry, physics, and linguistics. It has many practical applications in different areas of biology and medicine. (M. Nilges and Jens P. Linge, Unite de Bio-informatique Structurale, Institut Pasteur, Paris)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ba554129e93584f2eeb0e63038aef2e4|
139241|C11270|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
140336|C102563|S|DEFINITION|A classification system developed to establish a consensus approach for pretreatment risk stratification of neuroblastomas.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4b6fc181b942bf1dfa71a0c8c2dabd1d|
140337|C102563|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
140680|C17965|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
140681|C17965|S|DEFINITION|This gene plays a role in cell cycle control, regulation of transcription and the maintenance of genomic stability. It is also involved in the inhibition of mammary cell growth.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d8da4d04bde6c8a10d05d83e2845afaf|
140682|C17965|S|OMIM_Number|113705|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3379c935dc778439eb0c5b52c6ccd0bd|
140971|C92964|S|OMIM_Number|300669|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||53db982eda13d347b31b49d5172f8e51|
140972|C92964|S|DEFINITION|This gene may be involved in spermatid development.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bdd995c8142e8a8ebf73dc425a652912|
140973|C92964|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
141030|C24353|S|OMIM_Number|126150|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ce4268e0883a2195816b7f387f8d081a|
141031|C24353|S|DEFINITION|This gene plays a role in macrophage-mediated cellular proliferation and growth regulation in fibroblasts and smooth muscle cells.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9b502b5cd90df16c68394816481439f6|
141032|C24353|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
142312|C11271|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
143611|C24866|S|DEFINITION|This gene plays a role in the mediation of cytokine production and immunity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4e5750e077e1e16b7dc2a232604ab64c|
143612|C24866|S|OMIM_Number|603031|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a1f3c7557484333e5b4e9ed7d3329dad|
143613|C24866|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
143664|C17756|S|OMIM_Number|164870|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||97e147b55c7b8f6e9d79100fd40d68a0|
143665|C17756|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
143666|C17756|S|DEFINITION|This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8cae8b73feba32ee17ecc7652e7c2979|
143726|C17827|C|SEMANTIC_TYPE|Occupational Activity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c6a8390c19f864ddf30b80076dab6fdb|
143727|C17827|S|DEFINITION|Cataloging, grouping, and flagging data for ready retrieval.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7312c6810f3218af3abfb3c96a5c3de4|
143905|C125582|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
143906|C125582|S|DEFINITION|This gene is involved in the establishment of cell polarity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1024a8e2f063f0b0cfbda0532a96806e|
143907|C125582|S|OMIM_Number|607733|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2de0e3ec0db2dba61d602276057ea7db|
146227|C45460|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
146228|C45460|S|DEFINITION|A specializing role which may be used for an allele whose encoded product functions differently (qualitatively or quantitatively) from the function asserted on its parent. It specializes the function of the wild type gene/gene product. The domain and range for this role are 'Gene' and 'Biological Process', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||884b864f739190dd1e1cfa88f2581bf3|
146300|C17967|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
146301|C17967|S|Gene_Encodes_Product|ABC Transporter|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cb4725407e31f9798ba6b6eee57d09ad|
146302|C17967|S|DEFINITION|Mammalian P-glycoproteins are encoded by the MDR gene family and belong to the ATP-binding cassette vectorial transport protein class; the CFTR chloride channel is also a family member. The human multidrug resistance 1 (MDR1) gene responds to environmental stress, including various anticancer agents. It is a major determinant in the development of resistance to a large number of cancer chemotherapeutic agents. MDR1 and MDR2 P-glycoproteins are large apical cell membrane proteins overproduced in multidrug-resistant (MDR) cancer cells resistant to diverse hydrophobic drugs. P-glycoproteins act as pumps able to extrude drugs from cells at the cost of ATP hydrolysis. MDR is primarily due to increased drug extrusion from the resistant cell. Defense against xenobiotics may be a natural function of these P-glycoproteins.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d2ac22d0858d4e4f421fa7acc3e81dc7|
146636|C92966|S|DEFINITION|This gene may play a role in sperm maturation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e6182b23d52e43d44051e69e12755ff2|
146637|C92966|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
146761|C114424|S|OMIM_Number|606779|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||588d51f2523504d13d10f1f6412b63d5|
146762|C114424|S|DEFINITION|This gene plays a role in both actin filament dynamics and protein dephosphorylation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d9004c65258c43128a606c37fe61c9ce|
146763|C114424|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
147154|C18591|S|DEFINITION|This gene is involved in mismatch repair and mutations in the gene result in hereditary non-polyposis colon cancer 4.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||780fb8178fea5ad8c983a645a252fc05|
147155|C18591|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
147156|C18591|S|OMIM_Number|600259|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||44f3e6951b45ff7f6bf2a9bc5797aec1|
147219|C112899|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
147220|C112899|S|DEFINITION|This gene plays a role in both transcriptional regulation and histone methylation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6b8f5ef8a19626eda5eb53cae65f9d00|
147221|C112899|S|OMIM_Number|612033|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6246a14e2f8be6d524aafc1bb871d13f|
147896|C28603|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
147897|C28603|S|DEFINITION|This gene plays a role in signal transduction and immunoregulation. It is also involved in cell communication, migration, growth and proliferation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2af7e98400a3b1c4e91841deb0e057b1|
147898|C28603|S|OMIM_Number|147570|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4d502a1b208a0303e995e051756ab73f|
148661|C45461|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
148662|C45461|S|DEFINITION|A role used to assert the observed level of activity associated with an allele in a given biological process, compared to the wild-type gene. The domain and range for this role are 'Gene' and 'Property or Attribute', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5ce2894738d260f58eb2fecbd41bec05|
149453|C83675|S|FDA_UNII_Code|661FH77Z3P|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2bb41c8885a7f3e2767d89c9f7ee6dd1|
149454|C83675|S|Chemical_Formula|C20H24N2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||efa9f6efd953be150af7b2aa666d6a24|
149455|C83675|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
149456|C83675|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
149457|C83675|S|CAS_Registry|5636-83-9|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c003c132a7f0db7b3ce0290cce670c6c|
149776|C102933|S|DEFINITION|This gene plays a role in phospholipid metabolism.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c23fb25aeaf1a5144588c628a37f0b3e|
149777|C102933|S|OMIM_Number|614241|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5012052654f61b9b85211b70f32c8ae3|
149778|C102933|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
149893|C17487|C|SEMANTIC_TYPE|Immunologic Factor|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6d164910819b81a287d635fc7dec7f87|
149894|C17487|C|SEMANTIC_TYPE|Receptor|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||551c2471bfb3cefe5ef9d94d39d589ad|
149895|C17487|S|DEFINITION|A family of low affinity receptors that bind to the Fc region of gamma immunoglobulin (IgG) monomers and aggregates. These receptors are expressed on the surface of natural killer cells, neutrophils, monocytes and macrophages. IgG binding initiates antibody-dependent cellular cytotoxicity and induces phagocytosis of antigen-antibody complexes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||859905c9eb6f627a93c65dd6d0412c2d|
150891|C93105|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
150892|C93105|S|DEFINITION|This gene plays a role in the regulation of apoptosis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3298711b7f54b395c93d544827c8b7b2|
150893|C93105|S|OMIM_Number|606838|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7dfafefc7250c7391df12f50d805b4ce|
151067|C21555|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
151068|C21555|S|OMIM_Number|134637|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5ff8ad078ac383e2c4be6e2a16c5d083|
151069|C21555|S|DEFINITION|This gene is involved in the mediation of cellular surface receptors and apoptotic signals.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2ad3b6d110c0683bd7c9c67e0cd45c9|
151441|C45462|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
151442|C45462|S|DEFINITION|A role used to assert a relationship between a specific allele (product; enzyme) and drug-metabolizing efficacy. The domain and range for this role are 'Gene' and 'Drug, Food, Chemical or Biomedical Material', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b1f28556f7a484496c4f504f508cee1e|
151772|C101126|S|OMIM_Number|181590|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||12e6534c8bc3b23612198c3821adcd4f|
151773|C101126|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
151774|C101126|S|DEFINITION|This gene plays a role in both cellular proliferation and embryonic development.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3ffe565d18b9997d1340d52a9b7bdadd|
152145|C62653|S|DEFINITION|A number of individual items packaged as a unit.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||43379ab35e24901e37b0cdea50c92ab9|
152146|C62653|C|SEMANTIC_TYPE|Biomedical or Dental Material|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4373024de849fff92e38ad06e7208397|
152147|C62653|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
152148|C62653|S|Contributing_Source|NCPDP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||60678b3a51570245d162eb4ced613b3b|
152149|C62653|S|DEFINITION|A number of individual items packaged as a unit.|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||43379ab35e24901e37b0cdea50c92ab9|
152669|C48224|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
152670|C48224|S|DEFINITION|A morphologic classification system of malignant tumors, usually relating to disease progression and clinical outcome. It is based upon the presence or absence of several morphologic parameters, including tumor cell necrosis, cytologic atypia, nuclear pleomorphism and mitotic figures, the architectural infiltrating patterns, and the degree of tumor cell differentiation. Malignant tumors usually are graded I-III.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||177efb3f9ae51f5d0698fa7779072249|
152928|C80699|S|DEFINITION|A gene that encodes a microRNA, which participates in the regulation of gene expression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||01debde6a0c4a73dcdc2c311bcc22b47|
152929|C80699|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
155837|C15518|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
157664|C99759|S|OMIM_Number|607672|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||603f0e90d106f04c1d00d694f074469a|
157665|C99759|S|DEFINITION|This gene is involved in cytokine signaling.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2a8150f5f310216d5f81e4e5a8f86319|
157666|C99759|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
157667|C24359|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
157668|C24359|S|DEFINITION|This gene is involved in the differentiation and proliferation of cells.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2c63ccec74359977196efecc1aefb4c3|
157669|C24359|S|OMIM_Number|131530|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||030481698d85c27166f7bb3a8121c110|
158026|C16452|S|DEFINITION|The exchange of information between objects, people, or groups.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||876209231af57588290f555d38ad8c58|
158027|C16452|C|SEMANTIC_TYPE|Social Behavior|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||02af0da58721336dd7d8e233c8759e3b|
158396|C28967|S|DEFINITION|A combination of agents containing dacarbazine and mesna.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||10d6c198dfdd0e600d7302ae5457899b|
158397|C28967|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
158442|C16641|C|SEMANTIC_TYPE|Amino Acid, Peptide, or Protein|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4eccd96bc9e6975d7cbf89de08c26de0|
158443|C16641|C|SEMANTIC_TYPE|Enzyme|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d6ed799db7d7773b5db5b239976b449c|
158444|C16641|S|DEFINITION|A class of enzymes that catalyze the reaction of glutathione with an acceptor molecule (an arene oxide) to form an S-substituted glutathione; a key step in detoxification of many substances; start of the mercapturic acid pathway.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b2fccda3fe7779e77c903a18e8fe0ac3|
158445|C16641|S|DEFINITION|A family of enzymes involved in metabolism and in making toxic compounds less harmful to the body.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a97fc01fd58c36b52353852765a3b01|
158492|C15519|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
158857|C3507|S|Contributing_Source|CTEP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e2faf9f33eb4861faf8e5218b0f240ec|
158858|C3507|S|NICHD_Hierarchy_Term|Immune System Disorder|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||801652ea4d63dbeaf18e99470b016454|
158859|C3507|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
158860|C3507|S|DEFINITION|A disorder resulting from an abnormality in the immune system.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1b4c6a52bf4864b42234ff98c1102716|
158861|C3507|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
158862|C3507|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
160117|C54259|S|DEFINITION|A gene that encodes a product, termed an antigen, which stimulates the immune system and results in the production of antibodies.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fbe3dead49f093d9bbb146d4f1842cd9|
160118|C54259|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
161734|C29277|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
161735|C29277|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
161736|C29277|S|CAS_Registry|129618-40-2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cc9a01d07010ebacfbb79be28f665c36|
161737|C29277|S|Chemical_Formula|C15H14N4O|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1f1f5e15532a6a69069acdf800c124c2|
161738|C29277|S|NSC_Code|641530|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ce52a16b3bf012baec0683fae366a692|
161739|C29277|S|CHEBI_ID|CHEBI:63613|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||03fbaf2d16f8aae35bd4eb90e868e96c|
161740|C29277|S|FDA_UNII_Code|99DK7FVK1H|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a97ff72d772672467aa41e45df8bdeba|
161741|C29277|S|DEFINITION|A benzodiazepine non-nucleoside reverse transcriptase inhibitor. In combination with other antiretroviral drugs, nevirapine reduces HIV viral loads and increases CD4 counts, thereby retarding or preventing the damage to the immune system and reducing the risk of developing AIDS.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||df787f1dc4ade634b18ab94fcc61b024|
161882|C20128|S|OMIM_Number|191740|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d0b5cb871f9ce4faeb1e671a46698b3c|
161883|C20128|S|DEFINITION|This gene is involved in controlling serum levels of bilirubin and in glucuronidation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b0711d91724bbe41e001f5df04383ba5|
161884|C20128|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
162219|C4799|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
162220|C4799|S|DEFINITION|A broad classification of disorders where circulating numbers of B lymphocytes are decreased or ineffective. Complement components and the production of antibodies may also be deficient.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0643136e07f61892a21dbb9855f02afd|
162397|C20338|S|DEFINITION|Telomere Maintenance Genes encode specialized proteins bound to telomeric DNA repeats and directly involved in maintaining/protecting chromosome telomere ends to prevent a damage response that halts cell proliferation. Telomerase, which lengthens telomeric DNA by RNA-templated addition of repeated DNA sequences, is regulated by proteins that bind to the telomeric DNA repeats and to additional proteins to assemble a higher-order telomeric complex. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8dcb27e52dc1c92da53d4ea3e955ed2c|
162398|C20338|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
162679|C97237|S|OMIM_Number|608212|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||808898ee69e7e21ff7e065ad7b030ce5|
162680|C97237|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
162681|C97237|S|DEFINITION|This gene is involved in inflammation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f0d4d17bd47497c2e8ac2d93acf8bae5|
163585|C85009|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
163586|C85009|S|DEFINITION|A rare, autosomal dominant disorder caused usually by mutations in the KIT gene. It is characterized by abnormalities in the development of melanocytes. It presents with multiple symmetrical hypopigmented or depigmented patches of skin and a midline patch of white hair.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b0682207a3941160b6e3b03482794f33|
163764|C82845|S|DEFINITION|The National Library of Medicine's controlled vocabulary thesaurus. It consists of sets of terms naming descriptors in a hierarchical structure that permits searching at various levels of specificity.(Medical Subject Headings (MeSH) Fact Sheet)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f1018ecce2505d100a2aa4fe526b6a89|
163765|C82845|C|SEMANTIC_TYPE|Functional Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a79a5d175c8269874d5b5c9162a72cf|
164016|C75580|S|OMIM_Number|608148|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bb94088276e3ab691f5ab540f7fba02b|
164017|C75580|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
164018|C75580|S|DEFINITION|This gene plays roles in apoptosis and development.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||25cc3c038600e4266d8d8c7aab8f9bc7|
165303|C61889|S|CAS_Registry|86-21-5|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||714eeaa4f7ff0b8a1bf9d31b99f5e5b8|
165304|C61889|S|Chemical_Formula|C16H20N2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d9ab1345798f886c0697797eb3ca21d1|
165305|C61889|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
165306|C61889|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
165307|C61889|S|FDA_UNII_Code|134FM9ZZ6M|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||589d798764f4696936ed704692a66c9b|
165498|C106364|S|OMIM_Number|611877|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||44be343247d850de780a65bd672a732f|
165499|C106364|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
165500|C106364|S|DEFINITION|This gene plays a role in both signaling and cytoskeletal modeling.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fa61b3ce48279a413c8218790f30aae3|
165541|C18155|C|SEMANTIC_TYPE|Nucleotide Sequence|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5b520cf7246b1ea899fae46e128d2ab5|
165542|C18155|S|DEFINITION|Refers to Sequence Tagged Sites (STS) that are represented in mRNA. They are derived as 300-500 bp single-pass mRNA sequence reads from many of the genes expressed in a given tissue and/or at a given developmental stage. They represent a snapshot of gene expression in a given place or time.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bf615e9d06e8fe923105eebc8b697377|
165674|C43786|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
165675|C43786|S|DEFINITION|A role used to designate the type of biomarker a gene is; it points to a small tree of biomarker types (e.g., Disease Marker, Metabolic Marker, Prognostic Marker). The domain and range for this role are 'Gene' and 'Diagnostic or Prognostic Factor', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f02a540907efe5bcfb64b14d53f5276d|
166003|C63490|S|Design_Note|Source: Physician's Cancer Chemotherapy Drug Manual 2006 (Head and Neck)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||34df50703210d7b77cd0176eb09e670f|
166004|C63490|S|DEFINITION|A regimen consisting of paclitaxel, ifosfamide, mesna and cisplatin used for the treatment of advanced-stage testicular cancer; also used for the treatment of unresectable and recurrent squamous cell head and neck cancer.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ec314dbf791096ee83b365b0d06078df|
166005|C63490|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
166196|C43788|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
166197|C43788|S|DEFINITION|A role used to assert a relationship between a gene and a biological process in which its encoded gene product(s) participate. The domain and range for this role are 'Gene' and 'Biological Process', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a17204c7301dc14abf760ac67bb4b529|
167380|C2991|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
167381|C2991|S|DEFINITION|In medicine, a health problem with certain characteristics or symptoms.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||21c6a91ce8e90e615d3a9b9684d100eb|
167382|C2991|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
167383|C2991|S|DEFINITION|Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2c1771779c606ebcd348506335e62f5c|
167384|C2991|S|NICHD_Hierarchy_Term|Disease or Disorder|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||df3b00bd93a5fdaba2e3b3695a5bb238|
168262|C20462|S|DEFINITION|Apoptosis Regulation Genes encode Apoptosis Regulator proteins, which either promote or impede the initiation, progress, or rate of apoptosis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||60b1d33ea88e823599954abfbfb0119d|
168263|C20462|S|Gene_Encodes_Product|Apoptosis Regulator|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||78126ef7142fecf53a36962727241dad|
168264|C20462|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
168303|C43787|S|Design_Note|In NCI Thesaurus, pathways are derived from BioCarta and KEGG and are associated with genes and proteins that comprise these pathways.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9b9ea92dca82b98fe23dd051822f2c06|
168304|C43787|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
168305|C43787|S|DEFINITION|A role used to assert a relationship between a gene and a biochemical pathway in which its encoded gene product(s) participate. This relationship is used only when gene has been implicated in a pathway by the curated source (Biocarta, KEGG or PID). The domain and range for this role are 'Gene' and 'Biochemical Pathway', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9243174cf496d6310712f13f1bc8fca0|
168678|C43789|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
168679|C43789|S|DEFINITION|A role used to assert a relationship between a gene product and the gene that encodes it. The domain and range for this role are 'Gene Product' and 'Gene', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||86474c7f8a72d55aa3c9b785260f561c|
168680|C43789|S|Design_Note|The reciprocal relationship is represented in the property Gene_Encodes_Product|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d3d3fae5aaf107897caef98c7f54262c|
169230|C113304|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
169231|C113304|S|DEFINITION|A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d0712c44ab9fee9d905b28f83df0960b|
171088|C287|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
171089|C287|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
171090|C287|S|Chemical_Formula|C9H8O4|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||71685b9ed7290697128084fbf2e3c935|
171091|C287|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
171092|C287|S|NSC_Code|406186|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f1e5de64a5f1c19db0e91c8dcebc6d85|
171093|C287|S|PDQ_Open_Trial_Search_ID|39152|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b6b3485c6734a0d18d966d2ca4311499|
171094|C287|S|FDA_UNII_Code|R16CO5Y76E|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c1584e356322ab57ad316bc448e8727e|
171095|C287|S|CAS_Registry|50-78-2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e7675e3fc46b9cbbb12adeffbfc71a63|
171096|C287|S|DEFINITION|An orally administered non-steroidal antiinflammatory agent. Acetylsalicylic acid binds to and acetylates serine residues in cyclooxygenases, resulting in decreased synthesis of prostaglandin, platelet aggregation, and inflammation. This agent exhibits analgesic, antipyretic, and anticoagulant properties.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||16ff02d26136d9d0e943d87c98b8fa7d|
171097|C287|S|PDQ_Closed_Trial_Search_ID|39152|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b6b3485c6734a0d18d966d2ca4311499|
171098|C287|S|Accepted_Therapeutic_Use_For|Mild to moderate pain; fever; prevention of arterial and venous thrombosis|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ae8ba1889802f9d20e1202da78d34296|
171099|C287|S|DEFINITION|A drug that reduces pain, fever, inflammation, and blood clotting. Aspirin belongs to the family of drugs called nonsteroidal anti-inflammatory agents. It is also being studied in cancer prevention.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9037cde1d9ba9baebec4705b42887341|
171100|C287|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
171101|C287|S|CHEBI_ID|CHEBI:15365|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c3c06a7185330d3c6778daf845ba2812|
171238|C25790|S|Gene_Encodes_Product|Immunoprotein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||eb865aa605c99fd96d35a23fc3cd086a|
171239|C25790|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
171240|C25790|S|DEFINITION|Immunoprotein Genes encode proteins whose activities affect or play a role in immune system functions.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c502fa5e14ae7d3197090e06212dfd48|
171538|C13397|S|DEFINITION|A duplex of DNA is formed by two complementary chains that are arranged in an anti-parallel manner. B-DNA is about 20 Angstrom in diameter and a right-handed double helix with a wide major groove easily accessible to proteins and narrow minor groove. B-DNA is the most common DNA conformation in vivo and the favored conformation at high water concentrations. Base pairs are nearly perpendicular to the helix axis and sugar pucker is C2'-endo.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d8a82ac795573129ece6699dea868b41|
171539|C13397|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
171540|C13397|C|SEMANTIC_TYPE|Biologically Active Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f73bee4df25325311c725e8884117d4b|
172945|C13202|S|DEFINITION|One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||66eb800a0786444a3c60a6a97775902a|
172946|C13202|C|SEMANTIC_TYPE|Cell Component|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||afcd33fc081d5ab9a93b7a1b25b24a0a|
172947|C13202|S|DEFINITION|Part of a cell that contains genetic information. Except for sperm and eggs, all human cells contain 46 chromosomes.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b2dfefb84643bd22b1123be6e0c99d9f|
173033|C74239|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
173034|C74239|S|Chemical_Formula|C16H20N2O4S2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||62f7b39ecdc3ed5f889606b7bc9845c0|
173035|C74239|S|CAS_Registry|1098-97-1|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||811ac643782d9f998a3ca6228aa23f6e|
173036|C74239|S|FDA_UNII_Code|AK5Q5FZH2R|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||866a69b87a1767913caf2a9e688415f9|
173037|C74239|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
174190|C25791|S|DEFINITION|Immunoglobulin Family Genes encode structurally-related Immunoglobulin Family Proteins containing one, or more, 100-aa Immunoglobulin domain that includes a conserved intradomain disulfide bond and may be involved in protein-protein or protein-ligand interactions. Immunoglobulin Family members include hundreds of functionally diverse proteins, such as Immunoglobulins, the muscle kinase titin, and receptor tyrosine kinases. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b8b30888f5fa8f9288e6302be2b6c86f|
174191|C25791|S|Gene_Encodes_Product|Immunoglobulin Family Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1fc530ea96f064233c15df6eb7feeca7|
174192|C25791|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
175017|C18250|S|OMIM_Number|123829|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1aa742244fdca9f9772a39b368452a3e|
175018|C18250|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
175019|C18250|S|DEFINITION|This gene is involved in G1 stage cell cycle progression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b1cf140be73bd68760e8b8e4957cf5c1|
176465|C20780|S|OMIM_Number|610856|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ce9544573002742eda59340d711b5d41|
176466|C20780|S|DEFINITION|This gene may play a role in breast-specific transcription.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4d25f7aafee7731a6fce953fa40f589e|
176467|C20780|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
177302|C85999|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
177303|C85999|S|HGNC_ID|HGNC:3582|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a07c6a440cdcd024b298fc886d0b53ce|
177304|C85999|S|OMIM_Number|607139|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||71c1e9b56333e52c4c02ab4ece670bff|
177305|C85999|S|EntrezGene_ID|2175|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||211c1e0b83b9c69fa9c4bdede203c1e3|
177306|C85999|S|DEFINITION|Human FANCA wild-type allele is located in the vicinity of 16q24.3 and is approximately 79 kb in length. This allele, which encodes Fanconi anemia group A protein, may play a role in the regulation of both DNA repair and the cell cycle. Mutation of the gene is associated with Fanconi anemia.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4bef4d4d4b1d95f3d6eda05bc5053877|
177307|C85999|S|GenBank_Accession_Number|Z83067|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d5b682fcb5e0107eaf6170f44e18926|
179453|C95997|S|OMIM_Number|131310|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1f13ca8a13d3a789978cab668e094652|
179454|C95997|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
179455|C95997|S|DEFINITION|This gene is involved in transcriptional regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7cf36f00495e2eacd33d6d1a7398524f|
180764|C81746|S|OMIM_Number|612743|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8d05ff63f79501e432622225a6d4a9b1|
180765|C81746|S|DEFINITION|This gene is involved in the regulation of gene expression and plays a role in the development of plasma cell myeloma and glioma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||269df09aaaf7f90dab00700d505fe841|
180766|C81746|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
181377|C76417|S|CAS_Registry|2971-90-6|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fa929f58cc4027b4ff01ff537d326030|
181378|C76417|S|FDA_UNII_Code|8J763HFF5N|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d8a413207de05bdf812ee86f57c4eb34|
181379|C76417|S|Chemical_Formula|C7H7Cl2NO|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||350776736ecef09d8514e87ec64d7009|
181380|C76417|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
181381|C76417|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
181951|C18261|S|DEFINITION|This gene is involved in transcriptional repression and protein degradation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8f28e034f894c16d05c33792416bcc77|
181952|C18261|S|OMIM_Number|608537|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||71bbb35375a8ad6da18b9f28847d6c8d|
181953|C18261|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
183645|C105964|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
183646|C105964|S|DEFINITION|This gene plays a role in sumoylation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||15f04ebc834682270bbf04bbfe6467ad|
184888|C27351|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
184889|C27351|S|DEFINITION|A group of non-neoplastic and neoplastic disorders resulting from the deregulation and/or deficiency of immune system functions. It includes autoimmune disorders (e.g., lupus erythematosus, dermatomyositis, rheumatoid arthritis), congenital and acquired immunodeficiency syndromes including the acquired immune deficiency syndrome (AIDS), and neoplasms (e.g., lymphomas and malignancies secondary to transplantation).|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6cde7bbc2834dae1973cdf66ac55322c|
185703|C60711|C|SEMANTIC_TYPE|Research Activity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||464ff854066bb2974b28a6a0aab7ade0|
185704|C60711|S|DEFINITION|An information system, RENI (REgistry Nomenclature Information System) is the extended electronic version of the publications 'International Classification of Rodent Tumours'. The system was initially developed to support the RITA (Registry of Industrial Toxicology Animal-data) project, however, since 1998 it is accessible via the Internet. Besides the nomenclature and diagnostic criteria, RENI contains more than 1,500 histopathological images and for most of the references direct links to the corresponding abstracts in PUBMED are provided. (from RITA)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||39ae6ea1535d1512508bea4313f46809|
186094|C18590|S|OMIM_Number|600258|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bbea2b5fa5788ad8429661a2c4b900b1|
186095|C18590|S|DEFINITION|This gene is involved in mismatch repair and mutations in the gene result in hereditary non-polyposis colon cancer 3.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||335892d55d20a25b356d5951b6ee66e0|
186096|C18590|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
186221|C21281|S|DEFINITION|Enzyme Genes encode Enzymes, biological molecules (usually proteins) that possess catalytic activity. Catalytic RNA and catalytic DNA molecules have also been identified. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||118bdc51c5f0040b71e7cb13d93e933f|
186222|C21281|S|Gene_Encodes_Product|Enzyme|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d6ed799db7d7773b5db5b239976b449c|
186223|C21281|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
188151|C61953|S|CHEBI_ID|CHEBI:63623|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7f6207859b63b87a62f3aa0e599054aa|
188152|C61953|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
188153|C61953|S|CAS_Registry|304-55-2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ac6ecf78a4790b54eb20259d23344d62|
188154|C61953|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
188155|C61953|S|FDA_UNII_Code|DX1U2629QE|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0fa0287bdc89ba9a7a3ac8258906e79b|
188156|C61953|S|Chemical_Formula|C4H6O4S2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||00e0b09f3dd23e1316ffaf47d9852e39|
188157|C61953|S|DEFINITION|An orally active mercaptodicarboxylic acid, with heavy metal chelating activity. As a strong chelator, succimer is able to bind to heavy metals, such as lead, in the bloodstream, thereby forming a water-soluble complex that can be eliminated via urinary excretion. This prevents heavy metal poisoning. In addition, succimer is able to chelate the alpha particle emitter and radionuclide polonium Po 210 ((Po-210), thereby increasing its excretion and reducing the toxic effects of Po-210.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||21d959fd933840c1aaed1ff3aaad24da|
189198|C21132|S|DEFINITION|This gene plays a role in the stimulation of B cells in immune responses.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cdabc7952ed012683d4251c3fbe85771|
189199|C21132|S|Design_Note|TNFSF5 symbol withdrawn, see CD40LG instead|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6c2f54748580e52cb2c1f306a3ccf8f4|
189200|C21132|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
189201|C21132|S|OMIM_Number|300386|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0477d3da16cb08766b45682299b8a211|
189753|C13297|C|SEMANTIC_TYPE|Nucleotide Sequence|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5b520cf7246b1ea899fae46e128d2ab5|
189754|C13297|S|DEFINITION|A DNA sequence at which RNA polymerase binds and initiates transcription.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aee2cf5b95a14772d09c8cddf2a0321a|
191356|C101355|S|DEFINITION|This gene plays a role in the dephosphorylation of proteins.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4e2a0fa9ccf6a8f8b891599b41f1c66c|
191357|C101355|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
191358|C101355|S|OMIM_Number|609396|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||885963e074956b4e7371b1bb3dc5ae80|
192456|C70767|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
192457|C70767|S|DEFINITION|A set of units that can be used to quantitatively specify and characterize entities, objects, phenomena, or events.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||78c4ffc856a28a1e948899bbcd233451|
192885|C813|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
192886|C813|S|DEFINITION|A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1b5e24041412a5b6b42bc7931e57ccca|
192887|C813|S|Design_Note|Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a24c3881608006a243f9821f743f9f9a|
192888|C813|S|DEFINITION|A type of RNA found in cells. Messenger RNA molecules carry the genetic information needed to make proteins. They carry the information from the DNA in the nucleus of the cell to the cytoplasm where the proteins are made.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cf850173bc266c8f2d2585668f131a13|
192889|C813|S|DEFINITION|A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1b5e24041412a5b6b42bc7931e57ccca|
192890|C813|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
192891|C813|S|CHEBI_ID|CHEBI:33699|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a6ffc1693961e730373889bdef954882|
193223|C75501|S|DEFINITION|This gene may be involved in the electron transport cascade.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a7119699246fcdbedd07f7ed9cfbae02|
193224|C75501|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
193225|C75501|S|OMIM_Number|300056|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a7c82f5f6d4a11d33f88cc5341905bf4|
194155|C118210|S|DEFINITION|This gene plays a role in the biosynthesis of isoprenoids.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||661e00d1a07a197bc8c1488102cdcbec|
194156|C118210|S|OMIM_Number|134629|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7af2d4ddd9dd786f0e6d422073e0f06b|
194157|C118210|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
195148|C26682|S|Contributing_Source|CTCAE|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d677d75471bba07941e8a2fc481349ae|
195149|C26682|S|NICHD_Hierarchy_Term|Abdominal Pain|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||61aa04805ad33ce9497b7700a39eb1fb|
195150|C26682|S|DEFINITION|A disorder characterized by a sensation of marked discomfort in the abdominal region.|CTCAE_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||723e354f57db5add610095f9cb327010|
195151|C26682|S|Contributing_Source|MedDRA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1ba896ae50594408113d26bfe99ff078|
195152|C26682|S|FDA_Table|Patient Code (Appendix B)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3fa6ef9a096c688f10b6a40a4ee0c8c5|
195153|C26682|S|DEFINITION|Discomfort in the central region of the body located between the chest and the groin.|NICHD_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||22e10be6a52f766bac5e68f994517f66|
195154|C26682|S|DEFINITION|Painful sensation in the abdominal region.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c2ded913543ae431c65ba1125f38ca7d|
195155|C26682|C|SEMANTIC_TYPE|Sign or Symptom|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e306aba312ccb3c9124be6efd3dc7973|
195156|C26682|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
195157|C26682|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
196230|C96899|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
196231|C96899|S|DEFINITION|This gene is involved in the production of IgE and B cell differentiation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7137bb9893a3d68aa001a3a378fbeec9|
196232|C96899|S|OMIM_Number|151445|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f6d300eb840dc66581df7bd5d038a86a|
196628|C106221|S|OMIM_Number|608162|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||78c231f3192da0f938e939dae40b9e60|
196629|C106221|S|DEFINITION|This gene plays a role in the regulation of cell-mediated immunity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8c271ab6fd7a0da5495b783f03713f31|
196630|C106221|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
198188|C48670|S|DEFINITION|The abuse potential category to which an active ingredient, or combination of active ingredients, is assigned, as regulated by both the United States Drug Enforcement Administration (DEA) and the United States Food and Drug Administration.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||343b5d08ff81f9ff89f78f965228d1e7|
198189|C48670|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
198266|C20189|S|DEFINITION|A distinguishing quality or prominent aspect of a person, object, action, process, or substance.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a8d514413af73f550a3341ed8fad27c5|
198267|C20189|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
198268|C20189|S|NICHD_Hierarchy_Term|Property or Attribute|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e63908e33223cd1613fd5b5d6bc93c34|
198269|C20189|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
198487|C26360|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
198488|C26360|S|DEFINITION|MAP kinase gene products act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. (LocusLink)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8f186d15acd681f2e8ef97b477b51df3|
198489|C26360|S|Gene_Encodes_Product|Mitogen-Activated Protein Kinase|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0519022384710592cb927a1fe996ef5e|
198981|C3235|S|NICHD_Hierarchy_Term|Metabolic Disease|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6446a6b73251bbcaf2df2add5a114b12|
198982|C3235|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
198983|C3235|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
198984|C3235|S|DEFINITION|A congenital (due to inherited enzyme abnormality) or acquired (due to failure of a metabolic important organ) disorder resulting from an abnormal metabolic process.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2083d9388739f3a0cdcd204d8ff13f50|
198985|C3235|S|DEFINITION|A condition in which normal metabolic processes are disrupted, usually because of a missing enzyme.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||486813001997c38237cb77d7f3e768a1|
199960|C96022|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
199961|C96022|S|DEFINITION|This gene is involved in T cell activation and proliferation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1b2cd93826977d7ab77bad990b65edc0|
199962|C96022|S|OMIM_Number|605402|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5cc7a3abca145fe3392fd28d34b07bcb|
200835|C21295|S|Gene_Encodes_Product|Ligand Binding Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0a960bc593be3dcfc2349a7900b5c009|
200836|C21295|S|DEFINITION|Ligand Binding Protein Genes encode Ligand Binding Proteins, a large class of diverse proteins for which a major function appears to be (typically high affinity) binding of some ligand for solubility, transport, bioactivity regulation, or other nonenzymatic process. Ligand interaction often alters protein molecular conformation and function. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2ea45688510c5f6632ff4cb033da793|
200837|C21295|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
202332|C17119|S|DEFINITION|To form and release a substance. In the body, cells secrete substances, such as sweat that cools the body or hormones that act in other parts of the body.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1199732fb24ade620bbe1a7c6a2b7fe0|
202333|C17119|S|DEFINITION|Production by a cell or aggregation of cells (a gland) of a physiologically active substance and its movement out of the cell or organ in which it is formed. Discharge across the cell membrane, into the intracellular space or ducts, of endogenous substances resulting from the activity of intact cells of glands, tissues, or organs.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||32aa80c12a2b952d9f527fba1b9e2dce|
202334|C17119|C|SEMANTIC_TYPE|Cell Function|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a681c7b2e4269038379329ba9312a2eb|
203367|C639|C|SEMANTIC_TYPE|Chemical Viewed Structurally|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1baaa83e4106247f54f42f1aefbda1ae|
203368|C639|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
204616|C18004|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
204617|C18004|S|DEFINITION|A systematic method for clinicopathologic evaluation of tumors.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b9f5e87ade2690614db5874f9669ca64|
205198|C95850|S|DEFINITION|This gene is involved in protein acetylation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||939bcdfc8994a6c5016f0f487a5130f5|
205199|C95850|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
205200|C95850|S|OMIM_Number|300013|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fab74d41785ff4e45f32547159d1f222|
205616|C43520|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
205617|C43520|S|DEFINITION|The Gene Ontology (GO) project is a collaborative effort to address the need for consistent descriptions of gene products in different databases. The goal of the Gene Ontology project is to produce a controlled vocabulary that can be applied to all organisms even as knowledge of gene and protein roles in cells is accumulating and changing. GO provides three structured networks of defined terms, molecular function, biological process, and cellular component, to describe gene product attributes.(from http://www.geneontology.org/)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8a0dfeb0d5ae81b63fc8ccc134b5ed52|
206256|C97331|S|DEFINITION|Creations of the mind, such as those created by musicians, authors, artists, and inventors.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b259054732371ae40536f4982dfb79ec|
206257|C97331|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
207421|C16936|S|Gene_Encodes_Product|Oncoprotein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2e8fca05944c7c034c3c09a54eec46c|
207422|C16936|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
207423|C16936|S|DEFINITION|A gene that is a mutated (changed) form of a gene involved in normal cell growth. Oncogenes may cause the growth of cancer cells. Mutations in genes that become oncogenes can be inherited or caused by being exposed to substances in the environment that cause cancer.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0020a0f0a49bb3d1d6710433a2398a2f|
207424|C16936|S|DEFINITION|A gene that normally directs cell growth. If mutated or overexpressed in a dominant fashion, it can release the cell from normal restraints on growth. It alone or in concert with other changes, converts the cell into a tumor cell. Alterations can be inherited or caused by an environmental exposure to carcinogens.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||45cfdf63754c1e979c6c2d704e3c36b6|
208079|C95853|S|OMIM_Number|603385|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||31c552522ad6788c7f16ae520ee0c6cc|
208080|C95853|S|DEFINITION|This gene plays a role in the modulation of protein neddylation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8db63538bc2689c4923f80a639efec32|
208081|C95853|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
208311|C38187|S|DEFINITION|Genes which encode peptides that are released by both neurons and non-neuronal cells. Protein products of neuropeptide genes are intracellular messengers that function as neurotransmitters or hormones|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||61f4bef5c941ddc8bd602457e8d8eee8|
208312|C38187|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
209586|C3239|C|SEMANTIC_TYPE|Cell or Molecular Dysfunction|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f731b9e954cc2b7fe23a53516abccdf9|
209587|C3239|S|DEFINITION|A chromosomal abnormality consisting of the absence of one chromosome from the normal diploid number.(WordNet)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0757ca50e3828cd440e9e6bb64f7945e|
209837|C116704|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
209838|C116704|S|DEFINITION|This gene may be involved in transcriptional regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9940964b26b719322efae168e258abcc|
210289|C29938|S|Gene_Encodes_Product|Enzyme Inhibitor Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||95ba428b2baadfe42c8d45d1ac02b71a|
210290|C29938|S|DEFINITION|Enzyme Inhibitor Genes encode Enzyme Inhibitor Proteins, biological molecules that block or suppress the catalytic activity of enzymes. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||06420f10757a8e4b6d21ac7695c878e0|
210291|C29938|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
211316|C24328|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
211317|C24328|S|OMIM_Number|124010|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||87c069beae473463a44393905bea6aa3|
211318|C24328|S|DEFINITION|This gene plays an role in the metabolism of numerous clinically-relevant drugs. It is also involved in the oxidation of both endogenous substrates and xenobiotics.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ef5f9737363a3ae4ab6e2ef96ad9793f|
211464|C89328|S|NICHD_Hierarchy_Term|Pediatric Disorder|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2669b2ebb57fb697967bc0161278ef05|
211465|C89328|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
211466|C89328|S|DEFINITION|A non-neoplastic or neoplastic disorder which occurs during childhood.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b05a192691cf0477a601c96e503e451b|
211467|C89328|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
212323|C105007|S|DEFINITION|This gene is involved in protein degradation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9afcf6156ba9879825b4aa3bf484def0|
212324|C105007|S|OMIM_Number|602329|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2d0c8050d795037d228b06268263a58e|
212325|C105007|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
214699|C15639|S|DEFINITION|A formal ranking system of the strength of evidence linked to a reported result.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||593c8129fb60c70adfcabe35078c2f5c|
214700|C15639|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
214701|C15639|S|DEFINITION|A ranking system used to describe the strength of the results measured in a clinical trial or research study. The design of the study (such as a case report for an individual patient or a randomized double-blinded controlled clinical trial) and the endpoints measured (such as survival or quality of life) affect the strength of the evidence.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aef9ab0630d95a52258c22d78e336e7f|
217397|C16612|S|DEFINITION|A functional unit of heredity which occupies a specific position on a particular chromosome and serves as the template for a product that contributes to a phenotype or a biological function.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ece7c895f06f97ef2b5736f3e2e2368d|
217398|C16612|S|DEFINITION|The functional and physical unit of heredity passed from parent to offspring. Genes are pieces of DNA, and most genes contain the information for making a specific protein.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||75a41bf1d8837930d3d7d0cf70bc87dd|
217399|C16612|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
217400|C16612|S|Design_Note|The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5800892a90414d8fbbc986e43a71a78a|
217593|C20181|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
217594|C20181|S|DEFINITION|An organizational header for concepts representing mostly abstract entities.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1339acef087dd7d1f2271751e7ddae77|
220530|C17061|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
220531|C17061|S|DEFINITION|A family of oncogenes that are highly homologous with the retrovirus-associated DNA sequences (ras) originally isolated from Harvey and Kirsten murine sarcoma viruses. Mutated or overexpressed forms of the human ras genes are associated with constitutive ras GTPase activity, increased cellular proliferation, and cell transformation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||24205e4c0ebab8159efda4739acbc756|
222910|C119637|S|DEFINITION|This gene is involved in both protein ubiquitination and Golgi membrane dynamics.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||209ac437480bee52a305b4154859e4d0|
222911|C119637|S|OMIM_Number|610876|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3eb5ac82c98257ad98cb4bf31217252d|
222912|C119637|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
223691|C116028|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
223692|C116028|S|DEFINITION|This gene plays a role in both T-cell expansion and natural killer cell-mediated cytotoxicity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||042a77efa12d5ee0d9682a18fb846d0d|
223693|C116028|S|OMIM_Number|612087|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4d060b04f23999ec0fc1b8b477aa77cf|
224566|C29609|S|USDA_ID|507|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2d6cc4b2d139a53512fb8cbb3086ae2e|
224567|C29609|S|Contributing_Source|CRCH|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||791e0ec6993f0a01113a2918fa48f740|
224568|C29609|S|DEFINITION|A non-essential sulfur-containing amino acid in humans, related to cystine, Cysteine is important for protein synthesis, detoxification, and diverse metabolic functions. Found in beta-keratin, the main protein in nails, skin, and hair, Cysteine is important in collagen production, as well as skin elasticity and texture. Also required in the manufacture of amino acid taurine, Cysteine is a component of the antioxidant glutathione, and plays a role in the metabolism of essential biochemicals such as coenzyme A, heparin, and biotin. (NCI04)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d731e3c4b47d53b5c0342ced57fa2d77|
224569|C29609|S|Unit|g|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b2f5ff47436671b6e533d8dc3614845d|
224570|C29609|S|CAS_Registry|52-90-4|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8a2a068cc8899c9dc1005d475f617192|
224571|C29609|S|FDA_UNII_Code|K848JZ4886|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1f559f4a130f1c45bbb815b4b5e42d43|
224572|C29609|S|Chemical_Formula|C3H7NO2S|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fe3cc07c406f88f7a92f638f87949265|
224573|C29609|S|CHEBI_ID|CHEBI:17561|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||65b81e9dd737b0763d2edb5feed15517|
224574|C29609|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
224575|C29609|C|SEMANTIC_TYPE|Amino Acid, Peptide, or Protein|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4eccd96bc9e6975d7cbf89de08c26de0|
224576|C29609|S|INFOODS|CYS_G|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||df246f2409f76ec34420b5f0458c07f2|
224577|C29609|S|DEFINITION|Amino acid with side chain -CH2SH.|CRCH_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f4698c84fc52fedea148b5184e2d014b|
225546|C1908|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
225547|C1908|S|DEFINITION|An organic or inorganic substance, element, isotope, food or other materials derived from microorganism, plant, or animal sources. They can be used for the prevention, diagnosis, treatment or research of disease states, for industrial purposes, or for the promotion or maintenance of organism viability or health.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||64cc80ac12564bd543d80647d2700ef3|
226461|C12218|S|DEFINITION|A combination of multiple drugs used in standard or clinical trial treatments. The order, dosage or dosing interval of the individual ingredients may not be specified.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ca4538491ff49af7049f88032db76360|
226462|C12218|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
227866|C80068|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
227867|C80068|S|DEFINITION|This gene is involved in immunoglobulin diversity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b43d8a6ddd6449144e897c0beee0fdd5|
227868|C80068|S|OMIM_Number|179615|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||86329785ca071ec4b43e3d0937e0d104|
228228|C29767|C|SEMANTIC_TYPE|Chemical Viewed Functionally|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3389b5c5751109d17a1aa8faa18924ab|
228229|C29767|S|DEFINITION|Any agent that promotes ejection of mucus or exudate from the lungs, bronchi and trachea by decreasing mucus viscosity or by increasing the secretion of mucus in a dry, unproductive cough.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||38d31ff93a824b5690e11b3205f7cc98|
228982|C12219|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
228983|C12219|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
228984|C12219|S|DEFINITION|A human biological structure, fluid or other substance; excludes single molecular entities.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||660189f7c6fb558a61564b18e4843025|
228985|C12219|S|NICHD_Hierarchy_Term|Anatomic Structure, System, or Substance|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3ee95bb100b16b445f0ca81e9591ddeb|
229125|C24823|S|OMIM_Number|300642|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5f63ba390b8a76b2973b4bf46d8c2e8d|
229126|C24823|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
229127|C24823|S|DEFINITION|This gene plays a role in the regulation of cancer cell growth.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2cafc3074b99e694d6fd174a8e1cc85d|
230174|C7057|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
230175|C7057|S|DEFINITION|A condition that is relevant to human neoplasms and non-neoplastic disorders. This includes observations, test results, history and other concepts relevant to the characterization of human pathologic conditions.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3457f51777610223ab2a067d01aedc87|
230273|C3910|C|SEMANTIC_TYPE|Cell or Molecular Dysfunction|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f731b9e954cc2b7fe23a53516abccdf9|
230274|C3910|S|DEFINITION|A molecular or cytogenic abnormality which occurs in either human disease states or disease models.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4d2a2526c11630e449082e74161e3432|
230761|C63489|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
230762|C63489|S|Design_Note|Source: NCCN Guidelines 2007|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||16e774c5a7628c0c03543caac2217094|
230763|C63489|S|PDQ_Closed_Trial_Search_ID|657053|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a3437aec54ee2d21e0741234544cb45a|
230764|C63489|S|PDQ_Open_Trial_Search_ID|657053|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a3437aec54ee2d21e0741234544cb45a|
230765|C63489|S|DEFINITION|An abbreviation for a chemotherapy combination used to treat ovarian and testicular germ cell cancers that have spread. It includes the drugs vinblastine sulfate (Velban), ifosfamide (Ifex), cisplatin (Platinol), and mesna.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||406abacaeff1e36e677d62f7b36cfdc8|
230766|C63489|S|DEFINITION|A regimen consisting of vinblastine, ifosfamide and cisplatin used for the treatment of advanced-stage germ cell gonadal cancers.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fd47e3a39df50db1a1a345efecc5400a|
230767|C63489|S|Design_Note|Source: NCCN Guidelines 2007 (testicular)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||772db8db5294405ac3d88455869c3252|
231170|C28774|S|Design_Note|There are at least 7 isoforms of stromal cell-derived factor 1, which are products of alternative splicing.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||891be61d6c7636dffc81c9e7cc329fc0|
231171|C28774|S|DEFINITION|Stromal cell-derived factor 1 (93 aa, ~11 kDa) is encoded by the human CXCL12 gene. This protein is involved in signal transduction and chemotaxis of T-lymphocytes, and monocytes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4192239c1027ada4e933f5c77613835b|
231172|C28774|S|Swiss_Prot|P48061|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7df5a61d1df135ec3786968168df6a4e|
231173|C28774|C|SEMANTIC_TYPE|Immunologic Factor|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6d164910819b81a287d635fc7dec7f87|
231174|C28774|S|OMIM_Number|600835|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1196fd6c643d57fdac19d04d1d6f5d1c|
231175|C28774|C|SEMANTIC_TYPE|Amino Acid, Peptide, or Protein|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4eccd96bc9e6975d7cbf89de08c26de0|
233436|C113579|S|OMIM_Number|601752|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d7a0a283671228a7b367028e83d890a2|
233437|C113579|S|DEFINITION|This gene is involved in platelet activation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dbf926dd0217501dbde15a753a0e8ff8|
233438|C113579|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
234398|C54362|S|DEFINITION|A gene that plays a role in the control of gene expression at the level of RNA transcription.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||97ac40fb91a59478de26b2afa55694fa|
234399|C54362|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
235039|C21240|S|DEFINITION|Genes that encode products which participate in translation, a complex mechanism that occurs on ribosomes. During this process, a peptide or protein is synthesized by utilizing an mRNA transcript to specify the sequence of amino acids in the resulting polypeptide. There are numerous translation process genes, as the synthesis of polypeptides requires ribosomal RNA, transfer RNA, GTP and proteins involved specifically in the activation of amino acids, initiation of synthesis, elongation and termination of synthesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aea9a97ddd02ec0620c97919a040eca2|
235040|C21240|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
235098|C20135|S|OMIM_Number|147370|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cd14ec673077aaf075159ad0e473d899|
235099|C20135|S|DEFINITION|This gene is involved in the regulation of apoptosis and cell proliferation and plays a role in cellular transformation and malignancy.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1bc9ba14aba53d435925424e155f7aca|
235100|C20135|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
235246|C54401|S|Design_Note|Several severe human genetic disorders are associated with imprinted genes such as Beckwith-Wiedemann, Prader-Willi and Angelman syndromes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f7151af4fbb6b4d24715ac8d1879c53a|
235247|C54401|S|DEFINITION|A gene that does not exhibit equal expression of both alleles due to repression or inactivation, resulting in the genetic non-equivalence of mammalian paternal and maternal genomes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c68707341fdd9b19f143a5598b90a9a0|
235248|C54401|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
235741|C89415|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
235742|C89415|S|DEFINITION|Terminology to support the work of the National Council for Prescription Drug Programs.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e291c75bb848cca60cfb8dbb47a900a6|
235874|C3266|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
235875|C3266|S|NICHD_Hierarchy_Term|Hereditary Neoplastic Syndrome|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c98af985329c94b263c1a4c702e0b919|
235876|C3266|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
235877|C3266|S|DEFINITION|Describes the clinical manifestations associated with a mutation conferring cancer susceptibility.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3310c9d87ddf7118a28a327e7feb57e3|
235878|C3266|S|DEFINITION|The inherited predisposition toward getting a tumor.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3418814d49786054a3532e32671e5ebd|
235879|C3266|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
236830|C61726|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
236831|C61726|S|CHEBI_ID|CHEBI:45240|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e8074632735ace5a5686f649ab3806e1|
236832|C61726|S|FDA_UNII_Code|52QK2NZ2T0|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||92e314ae6aa462e343a7e3e02030e42e|
236833|C61726|S|Chemical_Formula|C36H72NO8P|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9b1b3d9df69f6a4df99f3287a6875dc1|
236834|C61726|C|SEMANTIC_TYPE|Biomedical or Dental Material|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4373024de849fff92e38ad06e7208397|
236835|C61726|S|CAS_Registry|18194-24-6|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7c844abb61fe76645084612441fab6be|
236836|C61726|S|DEFINITION|A myristoylated phosphatidylcholine, and a synthetic phospholipid used in liposomes and lipid bilayers with drug delivery property.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cadef46948ad05ba76b1dcd05809bfd6|
236837|C61726|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
237743|C19540|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
237744|C19540|S|DEFINITION|Normal genes, that when altered or inappropriately expressed, contribute to malignant transformation, tumor progression, or metastasis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||eb02f90e067bf02247cc1004f63982a8|
237814|C20778|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
237815|C20778|S|OMIM_Number|610893|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bfd923bfaf69b0dbef19713234da9960|
237816|C20778|S|DEFINITION|This gene plays a role in membrane transport regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6217229b08dfbf1bf4c3f3d88d25d2a4|
238529|C18394|S|DEFINITION|This gene plays a role in chromatin remodeling and regulation of transcription.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||09a743cc49ead30cf735bf3bf0d41154|
238530|C18394|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
238531|C18394|S|OMIM_Number|601607|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a2de900237653bc9c9d17262bf6e8d82|
241902|C101306|S|DEFINITION|This gene may be involved in inflammation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7468e758b698fb9f72f53659c4a927c1|
241903|C101306|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
241904|C101306|S|OMIM_Number|609650|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7fdd032dd430413d3458b3030ac559e3|
243293|C24696|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
243294|C24696|S|OMIM_Number|176871|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c99b095bf6ab47ad0e773e1775dcf1fb|
243295|C24696|S|DEFINITION|This gene plays a role in the negative regulation of protein synthesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f0c95bd75329228725de4ed140c54f0f|
243692|C63611|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
243693|C63611|S|DEFINITION|A classification system for grading pathological remission based purely on microscopic assessment. It classifies patients into five groups with significantly different disease-free and overall survival and grades pathological remission in both the primary tumor and the axillary lymph nodes, with comparison of negative nodes with those that have already responded to chemotherapy.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||567a3c62e341820d2061c47edd9569d4|
243741|C24769|S|OMIM_Number|601392|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||61332f33d501af1ccc2e885d1bc86664|
243742|C24769|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
243743|C24769|S|DEFINITION|This gene is involved in the regulation of cellular calcium levels and in the proliferation of monocytes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8b277d33eda68cb020934986b37f1d9b|
244783|C26592|S|OMIM_Number|126430|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||00e86c44202a3f01a5d3e3543dcc8d55|
244784|C26592|S|DEFINITION|This gene plays a role in DNA replication, chromosome recombination and the regulation of DNA topology during transcription.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8c1062bc42337c40888301ec2652b5f4|
244785|C26592|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
245950|C61738|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
245951|C61738|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
245952|C61738|S|CAS_Registry|469-21-6|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0314c04a8e3df97fc9bd997078ca525b|
245953|C61738|S|FDA_UNII_Code|95QB77JKPL|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fe8e41b593151142e527ed788cd48282|
245954|C61738|S|CHEBI_ID|CHEBI:51380|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6bf9a35f15c0e5e827803bef279b28e8|
245955|C61738|S|DEFINITION|A first generation ethanolamine with antiinflammatory, sedative and antihistamine properties. Doxylamine competitively inhibits the histamine 1 (H1) receptor, thereby preventing the action of endogenous histamine as well as the subsequent release of pro-inflammatory mediators from basophils and mast cells. This agent acts as an inverse agonist that combines with, and stabilizes the inactive form of the H1-receptor, shifting the H1 receptor equilibrium toward the inactive state. This results in downregulation of nuclear factor-kappaB (NF-kappaB) and NF-kappaB dependent antigen presentation, chemotaxis, as well as expression of cell-adhesion molecules and pro-inflammatory cytokines.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c01b485dbcc064365507daf8a71af613|
245956|C61738|S|Chemical_Formula|C17H22N2O|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||729d955e6d9ab1759e7f40460cb3faaf|
247932|C97375|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
247933|C97375|S|DEFINITION|This gene plays a role in both nucleotide hydrolysis and signal transduction.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ccdf25bd8008c75a80bf40e197ad7fd2|
247934|C97375|S|OMIM_Number|613165|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8297ce8b7d5683d90a2d759bc7ff68fa|
250977|C16792|S|DEFINITION|The principles, practice, or study of library administration.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||038b47daa8befd571434107f1a495209|
250978|C16792|C|SEMANTIC_TYPE|Occupation or Discipline|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||856118919315e7420b3e7b7900fac932|
251370|C17270|C|SEMANTIC_TYPE|Enzyme|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d6ed799db7d7773b5db5b239976b449c|
251371|C17270|C|SEMANTIC_TYPE|Amino Acid, Peptide, or Protein|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4eccd96bc9e6975d7cbf89de08c26de0|
251372|C17270|S|DEFINITION|A type of enzyme that transmits signals in cells and that helps control cell growth. Some tumors have higher-than-normal levels of phosphatidylinositol-3 kinase.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||475256ddf5fdad2840eeaab26ddc139b|
251373|C17270|S|DEFINITION|An enzyme that catalyzes the conversion of phosphatidylinositol to phosphatidylinositol 3-phosphate. This is the first committed step in the biosynthesis of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. This pathway is thought to play a critical role in DNA repair, V(D)J recombination and cell cycle checkpoints. (from LocusLink)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||79aebe3392612f4f115955fdb0b1594c|
252117|C43243|S|Contributing_Source|NCPDP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||60678b3a51570245d162eb4ced613b3b|
252118|C43243|C|SEMANTIC_TYPE|Biomedical or Dental Material|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4373024de849fff92e38ad06e7208397|
252119|C43243|S|DEFINITION|A tablet intended for oral administration.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||81884a4cb340238969ab96e0b35bad5d|
252449|C28656|S|DEFINITION|This gene plays a role in the signal transduction processes that are involved in pregnancy.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9c76666d1a4dc9beaece2ed9395346|
252450|C28656|S|OMIM_Number|607311|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||13fc144ddbf8ca8faca4e646a8ccada8|
252451|C28656|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
252502|C17973|S|OMIM_Number|180385|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||68c3eaac7589746efa69150f7e4269ce|
252503|C17973|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
252504|C17973|S|DEFINITION|This gene plays a crucial role in hematopoietic development and is involved in transcriptional activation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9358d0f6ebcfdbb2940c198a47760841|
253731|C101593|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
253732|C101593|S|OMIM_Number|612974|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aa73ba4854b95c8397108c4b785bbf81|
253733|C101593|S|DEFINITION|This gene plays a role in mTOR-mediated signaling.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||92637f3d84adfbcdb3d5e211dcfed448|
253789|C49121|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
253790|C49121|S|DEFINITION|A classification of subtypes of ischemic stroke based on clinical features and the results of ancillary diagnostic studies.The TOAST classification denotes five subtypes of ischemic stroke: 1) large-artery atherosclerosis, 2) cardioembolism, 3) small-vessel occlusion, 4) stroke of other determined etiology, and 5) stroke of undetermined etiology.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f0c7f14a70dc066c6dd77ffad43524b5|
254267|C112278|S|DEFINITION|The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860).|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6462555e9f4b6857ed2f3a6e897fa69d|
254268|C112278|S|DEFINITION|The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860).|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6462555e9f4b6857ed2f3a6e897fa69d|
254269|C112278|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
254270|C112278|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
254302|C78157|S|DEFINITION|This gene may play a role in angiogenesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||adb3204f6ffae1355b2e720d648e7fe0|
254303|C78157|S|OMIM_Number|606064|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a27126a8e51d67437a4b9f03655f3f6b|
254304|C78157|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
255583|C116385|S|DEFINITION|A structured reporting scheme for multiparametric prostate cancer imaging and diagnosis. Prostate images are obtained using multiple MRI techniques including T2 weighted images, a dynamic contrast-enhanced study (DCE), diffusion weighted imaging (DWI), and possibly spectroscopy (MRS). Each lesion receives a score from 1 to 5 for each individual imaging parameter, as well as an overall 1-5 grading score reflecting the likelihood of clinically significant cancer, with 1 being most probably benign and 5 being highly suspicious of malignancy.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f8c088392fec6c4655d94c4ca54db2c1|
255584|C116385|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
257793|C104782|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
257794|C104782|S|DEFINITION|This gene plays a role in regulating cell proliferation, apoptosis, motility, and neurite retraction.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f6b6d58a29b01f6c540a6a59f56fd7d6|
257795|C104782|S|OMIM_Number|605146|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d6a5af09844ff631aea12b7f4905281f|
259392|C122738|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
259393|C122738|S|DEFINITION|This gene may be involved in the regulation of actin stress fibers in nonmuscle cells.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a73be785899ef90ba659bb3cc75f3023|
259394|C122738|S|OMIM_Number|609370|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2475c743ce6cc58bf9446bb1ea138af5|
259556|C192|S|CAS_Registry|19767-45-4|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a1fc9a1c2ea6685efd5543fca0f2bee|
259557|C192|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
259558|C192|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
259559|C192|S|Accepted_Therapeutic_Use_For|Ifosfamide-induced hemorrhagic cystitis, prophylaxis|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||859183e57022a8854873bcc83cec548f|
259560|C192|S|PDQ_Open_Trial_Search_ID|39759|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d2cec4ae765e49fa93728f323ca5894e|
259561|C192|S|NSC_Code|113891|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||818efb7d312c7baa2a0af45c3c959837|
259562|C192|S|PDQ_Closed_Trial_Search_ID|39759|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d2cec4ae765e49fa93728f323ca5894e|
259563|C192|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
259564|C192|S|Chemical_Formula|C2H5O3S2.Na|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||94d46c9131a3227b7aa7f9daa8de7ad5|
259565|C192|S|DEFINITION|A drug that helps protect the kidneys and bladder from the toxic effects of anticancer drugs such as ifosfamide and cyclophosphamide.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8281fd143e23c56374e6a871a3305eec|
259566|C192|S|DEFINITION|A sulfhydryl compound that is used to reduce the incidence of hemorrhagic cystitis associated with certain chemotherapeutic agents. Mesna is converted to a free thiol compound in the kidney, where it binds to and inactivates acrolein and other urotoxic metabolites of ifosfamide and cyclophosphamide, thereby reducing their toxic effects on the urinary tract during urinary excretion. (NCI04)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9b627341cf5b7a7ac6614d658038a162|
259567|C192|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
259568|C192|S|FDA_UNII_Code|NR7O1405Q9|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f6146c88980d5b495f40f085bdd7dfef|
260715|C119707|S|DEFINITION|This gene plays a role in telomere maintenance.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4c1e5bd8f50b098455ba4da039045d62|
260716|C119707|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
260717|C119707|S|OMIM_Number|609377|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||31d43d17065f679385329a4b9c7d2b89|
261469|C47462|S|FDA_UNII_Code|319X2NFW0A|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||09ba56ee0a32a31fb51a97a7f759c60f|
261470|C47462|S|CHEBI_ID|CHEBI:40265|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||591dcad1503562d975d6fd911364d526|
261471|C47462|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
261472|C47462|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
261473|C47462|S|Chemical_Formula|C40H80NO8P|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d49f7cad9e710fec8cd93cc32174d9ac|
261474|C47462|S|DEFINITION|A lung surfactant agent that is used as a replacement for endogenous lung surfactant. Colfosceril palmitate is effective in reducing the surface tension of pulmonary fluids, thereby increasing lung compliance properties to prevent alveolar collapse and improve breathing. This drug is used in the treatment of neonatal respiratory distress.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4165c44e7e6c59eb0d80613c6824bcff|
261475|C47462|S|CAS_Registry|63-89-8|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||464f337087c6198f06a60ea141a1f06f|
262046|C84736|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
262047|C84736|S|DEFINITION|An autosomal recessive inherited type of glycogen storage disease caused by deficiency of the glycogen debranching enzyme. It results in the accumulation of structurally abnormal glycogen in the heart, skeletal muscles, and/or liver.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||94130a5f61214dde5cb9600a86055a33|
262383|C114663|S|DEFINITION|This gene is involved in phospholipid transport.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||70b36174b9fad73406206caddbb6d0f2|
262384|C114663|S|OMIM_Number|605867|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||faeee48a6709a2678ea7984681be2077|
262385|C114663|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
264516|C17661|S|DEFINITION|A gene which produces an easily assayed phenotype. Often used for expression studies of heterologous promoters.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96231c9110fce3c3df3071d2617d5ea0|
264517|C17661|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
265592|C61730|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
265593|C61730|S|FDA_UNII_Code|GFO928U8MQ|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a21b3d487d6306edec9d843b7faad64|
265594|C61730|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
265595|C61730|S|CAS_Registry|3737-09-5|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||442bc5ace73fbf4295df2f62b4a5b383|
265596|C61730|S|CHEBI_ID|CHEBI:4657|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aecd192f58e175c07ef3eaa296193f1c|
265597|C61730|S|DEFINITION|A class IA anti-arrhythmic agent with cardiac depressant property. Disopyramide blocks the fast sodium channel in normal cardiac cell membranes within atrial and ventricular tissues. This slows the rate and amplitude of phase 0 depolarization and thus prolongs the duration of the action potential, thereby reducing cell excitability and conduction velocity. Further, disopyramide directly decreases the rate of diastolic (phase 4) depolarization in cells with normal or augmented automaticity. Disopyramide also blocks potassium channel and results in prolonged QT interval, thus increases the effective refractory period. This agent also possesses anticholinergic property.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||018c3982d7d916c52b5cb96f7edfe225|
265598|C61730|S|Chemical_Formula|C21H29N3O|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d2cade05440d701a4ce7d87de5973631|
266182|C16629|S|DEFINITION|The complete genomic content of an organism, and possibly the full DNA sequence of that organism. It is contained in a set of chromosomes in eukaryotes, a single chromosome in bacteria, or a DNA or RNA molecule in viruses.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0c291afdc0d358941b93413ff2b3b4e2|
266183|C16629|S|DEFINITION|The complete genetic material of an organism.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8d022807bb5fa7fa794daee7c853fcae|
266184|C16629|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
266297|C122199|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
266298|C122199|C|SEMANTIC_TYPE|Quantitative Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||de1de795bfc7600997f00ff33f9620df|
266299|C122199|S|DEFINITION|An area unit equal to one millimeter squared used as a denominator to build a derived unit expressed as a ratio.|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||61b5f5c6d82fc26c20843b245d3e0205|
266300|C122199|S|DEFINITION|An area unit equal to one millimeter squared used as a denominator to build a derived unit expressed as a ratio.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||61b5f5c6d82fc26c20843b245d3e0205|
266979|C17497|S|OMIM_Number|186770|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4f34643d388c50db57f3dba146358e74|
266980|C17497|S|DEFINITION|T-cell leukemia homeobox protein 1 (330 aa, ~34 kDa) is encoded by the human TLX1 gene. This protein plays a role in the modulation of transcription.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b0e8cdbb994bfd677e32c80c058863be|
266981|C17497|S|Design_Note|T-cell leukemia homeobox protein 1 binds to the DNA sequence 5'-GGCGGTAAGTGG-3'. (UniProt)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1239dd12e30ba2685dd2e60615dbc036|
266982|C17497|C|SEMANTIC_TYPE|Biologically Active Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f73bee4df25325311c725e8884117d4b|
266983|C17497|C|SEMANTIC_TYPE|Amino Acid, Peptide, or Protein|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4eccd96bc9e6975d7cbf89de08c26de0|
266984|C17497|S|Swiss_Prot|P31314|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aa4f1f05e40cd55e01866c4bdfe89d22|
267312|C102483|S|OMIM_Number|186945|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a292a4b3657cf531490ed1dfa50d02d4|
267313|C102483|S|DEFINITION|This gene is involved in both signaling and protein folding.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||66f88d420d202a1aebcd7137f40a7267|
267314|C102483|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
268623|C114657|S|DEFINITION|This gene is involved in tumor induction of immune responses.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4335747d8f465c2c9b9d4b7cd484f96d|
268624|C114657|S|OMIM_Number|602132|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6eebf82329d839985c9ada26d5eb5e73|
268625|C114657|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
269693|C103219|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
269694|C103219|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
269695|C103219|S|DEFINITION|Rules created by Robert Sidney Cahn, Christopher Kelk Ingold and Vladimer Prelog to name stereoisomers in organic chemistry.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8f51013225462e330f709c070a28fff5|
269729|C53489|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
269730|C53489|S|DEFINITION|A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||adbab913ea30f2b465dce84ea09b252b|
269731|C53489|S|DEFINITION|A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1b3341051b2aee396a82b4a2308cd7a|
269732|C53489|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
272241|C17938|S|DEFINITION|Inherited; having to do with information that is passed from parents to offspring through genes in sperm and egg cells.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||244cc51f83de6c114d47746b2f070d64|
272242|C17938|S|DEFINITION|Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||539c1ca9efd884eaac30a87107029f78|
272243|C17938|C|SEMANTIC_TYPE|Functional Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a79a5d175c8269874d5b5c9162a72cf|
272252|C38349|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
272253|C38349|S|OMIM_Number|133430|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||94492bfd6b633e33d35668b4f9b12090|
272254|C38349|S|DEFINITION|This gene is involved in ligand-activated transcriptional activity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5589531fdbf217553948e1ddb477fac7|
274890|C71891|S|DEFINITION|An extension of the ICD-9 created by the U.S. National Center for Health Statistics so that the system could be used to capture more morbidity data. This extension included a section of procedure codes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b8c1a0f8b8e1b770abb534260ab0d574|
274891|C71891|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
275059|C28510|S|Gene_Encodes_Product|Fusion Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6a9d29e7c0524bd2de1a018a2c499fad|
275060|C28510|S|DEFINITION|A gene made by joining parts of two different genes. Fusion genes may occur naturally in the body by transfer of DNA between chromosomes. For example, the BCR-ABL gene found in some types of leukemia is a fusion gene. Fusion genes can also be made in the laboratory by combining genes or parts of genes from the same or different organisms.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fc3d66fe7e89cb29430a06e706c716ff|
275061|C28510|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
275062|C28510|S|DEFINITION|A hybrid gene created by joining portions of two different genes (to produce a new protein) or by joining a gene to a different promoter (to alter or regulate gene transcription). These can be created by chromosomal aberration or by laboratory methods.(from On-line Medical Dictionary and NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6979b59b436f6a7ead8aa5ff07bcf2a6|
275822|C126470|S|DEFINITION|This gene plays a role in microtubule dynamics.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||25ee584c2a5bfc5ca43b186a60c55918|
275823|C126470|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
275824|C126470|S|OMIM_Number|600526|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0aa351cd3d21e58453691620b7b56768|
277267|C17023|S|DEFINITION|Oncogenes are altered forms of normal cellular genes called proto-oncogene. Many proto-oncogenes are homologous to viral oncogenes and involved in the control of cell proliferation or differentiation. Mutations, amplifications or rearrangements of proto-oncogenes lead to upregulated or deregulated cell growth and allow them to function as oncogenes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ba505a3902e3decc947d363c15620e6a|
277268|C17023|S|DEFINITION|A gene involved in normal cell growth. Mutations (changes) in a proto-oncogene may cause it to become an oncogene, which can cause the growth of cancer cells.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c7bd8927bb84d9459b131178e1d65fcd|
277269|C17023|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
279340|C63448|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
279341|C63448|S|Design_Note|Source: NCCN Guidelines 2007|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||16e774c5a7628c0c03543caac2217094|
279342|C63448|S|DEFINITION|A regimen consisting of cyclophosphamide, vincristine, doxorubicin and high-dose methotrexate (CODOX-M) alternating with ifosfamide, etoposide and high-dose cytarabine (IVAC), used as a treatment for aggressive forms of non-Hodgkin's lymphoma; also used as primary treatment for AIDS-related and high-risk Burkitt's lymphoma. Intrathecal cytarabine and methotrexate are included in this regimen as either prophylaxis or treatment for central nervous system (CNS) involvement.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a92b36f1a6bdc14e04f8a5db915cdd0b|
279930|C18350|S|DEFINITION|This gene is involved in signal transduction and negative regulation of apoptosis. It also plays a role in glucose transport, glycogen synthesis, protein synthesis and neuronal survival.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||354bccb409ae6276355ca822196d391e|
279931|C18350|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
279932|C18350|S|OMIM_Number|164730|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3e451cba150bf59312a66ecf2c1a4e25|
282007|C17396|S|DEFINITION|Short (200 to 500 base pairs) DNA sequence that is operationally unique and has a single occurrence in the human genome and whose location and base sequence are known and therefore they can be used as landmarks in genome mapping.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceab6551e118a657082b99a2af46ee07|
282008|C17396|C|SEMANTIC_TYPE|Nucleotide Sequence|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5b520cf7246b1ea899fae46e128d2ab5|
285108|C28570|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
285109|C28570|S|DEFINITION|This gene plays a role in transcriptional regulation and hematopoiesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||320b672b9bda6fb3ed7fd106e07827c5|
285110|C28570|S|OMIM_Number|133435|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ab72f9fa5f5145af7ac35b8fa80d5223|
285997|C28193|S|DEFINITION|A set of symptoms or conditions that occur together and suggest the presence of a certain disease or an increased chance of developing the disease.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||93b53b686bb503ef1c0efbb687c50926|
285998|C28193|S|NICHD_Hierarchy_Term|Syndrome|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||48d8d6f5a3efbf52837d6b788a22859a|
285999|C28193|S|DEFINITION|A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||39809d3dcbc3e07a835269fe8032cf86|
286000|C28193|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
286001|C28193|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
286445|C24488|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
286446|C24488|S|OMIM_Number|146732|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||26fee5cac6b065839da6a8fda3b7b8df|
286447|C24488|S|DEFINITION|This gene plays an inhibitory role in the regulation of extravascular tissue growth.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||23718173dcbb878bcbaaa6d19b253a70|
287507|C18017|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
287508|C18017|S|DEFINITION|The T-cell antigen receptors consist of a heterodimer of integral membrane glycoproteins. Two distinct receptors exist, alpha/beta and gamma/delta. Alpha/beta receptors are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented in association with MHC gene products. Gamma/delta receptors, found in association with CD3, directly recognize proteins and non-proteinacious phospho-ligands. Alpha/beta and gamma/delta are non-covalently associated with CD3-gamma, -delta, -epsilon, and -zeta proteins, forming the TCR-CD3 complex, which activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70. The genes for T-cell receptor subunits are encoded by distinct gene elements that are assembled by somatic rearrangement during T-cell development. Translocations and inversions of these loci are observed in human T-cell leukemias and lymphomas.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||abd306423f40612f819d71fa98a504c0|
287838|C16620|S|DEFINITION|Genes of viral origin.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7e335c844e043afa856e1884be4a193f|
287839|C16620|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
287866|C17248|S|DEFINITION|Genetic Variation consists of deviation(s) in the nucleotide sequence of the genetic material of an individual from that typical of the group to which the individual belongs, or deviation(s) in the nucleotide sequence of the genetic material of offspring from that of its parents.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6a442cb79877426c931d08ae8c5de5ab|
287867|C17248|C|SEMANTIC_TYPE|Nucleotide Sequence|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5b520cf7246b1ea899fae46e128d2ab5|
289660|C65545|S|CAS_Registry|138729-47-2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ccd1ed0064850f6f2f005b837b52ae91|
289661|C65545|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
289662|C65545|S|PDQ_Open_Trial_Search_ID|538994|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0aceb18bb6253af17bfcfc19b797889a|
289663|C65545|S|PDQ_Closed_Trial_Search_ID|538994|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0aceb18bb6253af17bfcfc19b797889a|
289664|C65545|S|FDA_UNII_Code|UZX80K71OE|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c64404cb13fb29ba5923888f84953d8d|
289665|C65545|S|Chemical_Formula|C17H17ClN6O3|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1fe71ebd73fa49f3b93d25ea325f28d3|
289666|C65545|S|Accepted_Therapeutic_Use_For|Insomnia|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||866d815adb055e7d4ed23ac402b221f1|
289667|C65545|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
289668|C65545|S|DEFINITION|A nonbenzodiazepine, cyclopyrrolone and active stereoisomer of zopiclone with hypnotic and sedative activity and without significant anxiolytic activity. Although the exact mechanism of action remains to be fully elucidated, eszopiclone is able to bind to and activate the omega-1 subtype of the alpha subunit of the gamma-aminobutyric acid-benzodiazepine GABA receptor complex (GABA-A), a chloride ionophore complex in the central nervous system (CNS). This leads to the opening of chloride channels, causing hyperpolarization, inhibition of neuronal firing, and enhancement of the inhibitory effect of GABA. This eventually leads to a hypnotic effect and allows for an induction of sleep.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||60cfe636ca0f68c37c629a4434ed5155|
289669|C65545|S|CHEBI_ID|CHEBI:53760|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b0163100e8bb6905f141371d9bd86421|
290239|C74915|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
290240|C74915|S|DEFINITION|An on-line community database for the development and support of integrated zebrafish genetic, genomic and developmental information, the maintenance of the definitive reference data sets of zebrafish research information, linkage of this information to corresponding data in other model organism and human databases, and the facilitation of the use of zebrafish as a model for human biology in order to serve the needs of the research community.(http://zfin.org/zf_info/dbase/db.html)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96f3c54b2285f592713a80a8736ab3ff|
290432|C15426|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
290433|C15426|S|DEFINITION|An information set with a regular structure. Although it can be applied to any set of information the term was invented to refer to computerized data, and is used almost exclusively in computing.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0ebb72da938426cb8ebcfb0cf2acb22d|
291364|C11179|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
291911|C89338|S|NICHD_Hierarchy_Term|Neurodevelopmental Disorder|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8524279d04942779c4f585726aa26bd6|
291912|C89338|S|DEFINITION|Conditions characterized by impaired central nervous system function occurring in childhood.|NICHD_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||08fd14c95069b8e287e032d0e18c9e3a|
291913|C89338|S|DEFINITION|A childhood disorder that has a neurological basis and manifests as a developmental disability.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d21f7fbe86a394948dea9c23b71152d|
291914|C89338|S|Contributing_Source|MedDRA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1ba896ae50594408113d26bfe99ff078|
291915|C89338|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
291916|C89338|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
293347|C2080|C|SEMANTIC_TYPE|Chemical Viewed Functionally|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3389b5c5751109d17a1aa8faa18924ab|
293348|C2080|S|DEFINITION|Agents administered before, with, or after cancer therapy to reduce or prevent damage or toxicity to the normal cells. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8375e9515e8e65c0e0bd0a53e7cfc918|
293997|C537|S|PDQ_Open_Trial_Search_ID|39474|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1d5fe42fe9d32afaa94d6b020be8384c|
293998|C537|S|DEFINITION|A drug used to treat certain mental and neurological disorders. It is also being studied in the treatment of nausea and vomiting caused by some cancer treatments. It is a type of antiemetic and a type of antipsychotic.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0d9312083ad7aa32a03f5a17203b6330|
293999|C537|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
294000|C537|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
294001|C537|S|CHEBI_ID|CHEBI:5613|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8ae3661d9579614f79886e8a8e4adafc|
294002|C537|S|Chemical_Formula|C21H23ClFNO2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4268a83e3cea1adc410e3b6be23528f4|
294003|C537|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
294004|C537|S|PDQ_Closed_Trial_Search_ID|39474|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1d5fe42fe9d32afaa94d6b020be8384c|
294005|C537|S|DEFINITION|A phenylbutylpiperadine derivative with antipsychotic, neuroleptic, and antiemetic activities. Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the mesolimbic system of the brain, thereby eliminating dopamine neurotransmission and leading to antidelusionary and antihallucinagenic effects. Antagonistic activity mediated through D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) accounts for its antiemetic activity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||482f34b04329d5128ccdfa6fb79a0768|
294006|C537|S|CAS_Registry|52-86-8|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||19c244fc44cd32cbbbab7cbe23ad01c2|
294007|C537|S|FDA_UNII_Code|J6292F8L3D|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||861a97d0179306917fa2e1e27e76e82d|
294008|C537|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
294009|C537|S|NSC_Code|170973|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||edec8e8c05a0db847b86f184a56e8f62|
294459|C1457|S|DEFINITION|A cloning vector based upon elements of yeast chromosomes. At a minimum these include: yeast telomeres, a yeast centromere, and a yeast autonomously replicating sequence (ARS). Such vectors are propagated in yeast and then transferred into a target eukaryotic cell where the yeast sequences can be recognized and will maintain the molecule through cell division. These vectors can maintain extremely large amounts of foreign DNA. YACs are maintained as linear molecules|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1b3347b88614f445033162ca3fdb21f1|
294460|C1457|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
295810|C18609|S|DEFINITION|This gene plays a role in cellular hematopoiesis and differentiations. Mutations in the gene are associated with several diseases, including acute myelogenous leukemia, gastrointestinal tumors, and mast cell disease.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ac5bb71a9aec91e3a48fddd7c024fbe7|
295811|C18609|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
295812|C18609|S|OMIM_Number|164920|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ed2dca463268c3445c80f4bf0c53a6ab|
296935|C21518|S|DEFINITION|These genes encode more than 30 proteins of the complement system engaged in host defense. This system provides both an independent immune system capable of attacking microbes as well as other foreign material and an adjunct to the antibody system. Once activated, the complement system fires in a cascade-like fashion in which one component activates the next. Both swift and powerful, millions of complement components can deposit on an invading microbe within only a few minutes. Such a potent system requires strict regulation to avoid host injury. Membrane cofactor protein (MCP) is one critical regulator aimed at controlling inadvertent complement activation on host cells and nearly every cell examined expresses MCP on its cell membrane.(http://research.medicine.wustl.edu)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4cf989ffc25bd6d176dda0f4c703bbf4|
296936|C21518|S|Gene_Encodes_Product|Complement Component Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a26c784617a03ddfe6e0dd690709a88c|
296937|C21518|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
297073|C200|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
297074|C200|S|DEFINITION|A drug usually used to reduce the thickness of mucus and ease its removal. It is also used to reverse the toxicity of high doses of acetaminophen.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||566f00a399682a3a5c454e3de259fd55|
297075|C200|S|DEFINITION|A synthetic N-acetyl derivative of the endogenous amino acid L-cysteine, a precursor of the antioxidant enzyme glutathione. Acetylcysteine regenerates liver stores of glutathione. This agent also reduces disulfide bonds in mucoproteins, resulting in liquification of mucus. Some evidence suggests that acetylcysteine may exert an anti-apoptotic effect due to its antioxidant activity, possibly preventing cancer cell development or growth. In addition, acetylcysteine has inhibited viral stimulation by reactive oxygen intermediates, thereby producing antiviral activity in HIV patients. (NCI04)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||357f707ea226d79421e170d7ec8f5cf5|
297076|C200|S|CHEBI_ID|CHEBI:28939|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a2e7efc65d64175fbe9018cf52942357|
297077|C200|S|FDA_UNII_Code|WYQ7N0BPYC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d1c160fa84ac4016994c72538af446e1|
297078|C200|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
297079|C200|S|PDQ_Open_Trial_Search_ID|39130|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||696ea2c7271f939ccafc511902e85604|
297080|C200|C|SEMANTIC_TYPE|Amino Acid, Peptide, or Protein|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4eccd96bc9e6975d7cbf89de08c26de0|
297081|C200|S|Accepted_Therapeutic_Use_For|Acetaminophen Overdose|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4f5843c68541359851d52bc7dc6bc5fe|
297082|C200|S|CAS_Registry|616-91-1|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||56963a9588f6d4a0e5b10d87091fcaa8|
297083|C200|S|Chemical_Formula|C5H9NO3S|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||56e22942a3f05c86fa41b58232f0c296|
297084|C200|S|PDQ_Closed_Trial_Search_ID|39130|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||696ea2c7271f939ccafc511902e85604|
297085|C200|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
297086|C200|S|NSC_Code|111180|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||83be8af1a341e5e79c59a9699d665c4a|
297626|C20370|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
297627|C20370|S|DEFINITION|Replication Initiation Genes encode proteins directly involved in initiation of DNA replication. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b4e6dc21280e66c1d02112a732848ed2|
298027|C15429|C|SEMANTIC_TYPE|Research Activity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||464ff854066bb2974b28a6a0aab7ade0|
298028|C15429|S|DEFINITION|A scientific study of nature that sometimes includes processes involved in health and disease. For example, clinical trials are research studies that involve people. These studies may be related to new ways to screen, prevent, diagnose, and treat disease. They may also study certain outcomes and certain groups of people by looking at data collected in the past or future.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||25bd2af135455e5f8544c337d7d16849|
298029|C15429|S|DEFINITION|Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2133c195e7dbbc2a96a036ddba1b1a62|
298275|C2082|S|DEFINITION|Agents administered before, with, or after cancer therapy to reduce or prevent damage or toxicity to the urinary tract. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9afa9d7c48b2e9d9c8a62c3e923cf5d7|
298276|C2082|C|SEMANTIC_TYPE|Chemical Viewed Functionally|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3389b5c5751109d17a1aa8faa18924ab|
298575|C16624|C|SEMANTIC_TYPE|Biomedical Occupation or Discipline|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1cf1233b26ad9682dbe0588c6062e35f|
298576|C16624|S|DEFINITION|The study of genes and heredity. Heredity is the passing of genetic information and traits (such as eye color and an increased chance of getting a certain disease) from parents to offspring.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||212a48b634c94ff055fe2e1b2fe672b3|
298577|C16624|S|DEFINITION|The branch of biology that deals with heredity, especially the mechanisms of hereditary transmission and the variation of inherited characteristics among similar or related organisms|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||78c3b5828bcec944a3cb3d800849c448|
299388|C113414|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
299389|C113414|S|DEFINITION|A stretch of DNA at a particular chromosomal location that contains or is linked to genes that are associated with the expression of a variable phenotypic trait.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||27219f881da6eac8e6cdf0ce86018230|
300410|C66555|S|CAS_Registry|139-88-8|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8010cb8e7b98dcc098408980928eac7b|
300411|C66555|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
300412|C66555|S|Chemical_Formula|C14H29O4S.Na|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||484edf4cd1cffda50564e207fdfafe0f|
300413|C66555|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
300414|C66555|S|DEFINITION|An anionic surfactant used as a sclerosing agent. Upon injection into a varicose vein, sodium tetradecyl sulfate (STS) interacts with lipids on the vein walls thereby causing intimal inflammation, destruction of the vein, and thrombus and fibrous tissue formation. This eventually leads to occlusion of the injected vein.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d413dc423453d67751fbe45ac1ceb969|
300415|C66555|S|FDA_UNII_Code|Q1SUG5KBD6|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aca92a168cb29abeebe3226257daec81|
300941|C688|C|SEMANTIC_TYPE|Hazardous or Poisonous Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||75e90e81201b9a26195ed3b1d6fdc965|
300942|C688|S|DEFINITION|A substance that is poisonous to nerve tissue.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1667d9f1e00c02f4e24c37082075988b|
300943|C688|S|CHEBI_ID|CHEBI:50910|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fb0b52e2e03d82c111da2139dc0ba719|
301104|C20194|S|DEFINITION|Regulatory Genes encode products that regulate or circumscribe the activity of diverse cellular functions.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||58095c3c967cf9f4995867dcfc813a50|
301105|C20194|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
301106|C20194|S|Gene_Encodes_Product|Regulatory Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7e6769d8b3896c059bd88544efdd9e7d|
301107|C20194|S|Design_Note|Most sources use "Regulatory Gene" to represent those involved only in regulation of transcription. We use it in a broader sense.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f196d274fb1243a97d781d5b82f5b17b|
301610|C104878|S|DEFINITION|This gene is involved in regulation of gene expression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9409d1dd558be7cdb7f5f2e9e43201a6|
301611|C104878|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
301612|C104878|S|OMIM_Number|609385|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0a883f22936795bfeb6d2496784f046a|
301613|C114571|S|OMIM_Number|611949|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e1b963999381338081894712e0e38b1|
301614|C114571|S|DEFINITION|This gene is involved in lysophospholipid metabolism.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||de1207d1e6f0e06798d230c27da99215|
301615|C114571|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
301890|C61962|S|Contributing_Source|CRCH|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||791e0ec6993f0a01113a2918fa48f740|
301891|C61962|S|FDA_UNII_Code|1EQV5MLY3D|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6d3c5c34611711e531030aac6e645481|
301892|C61962|S|Unit|g|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b2f5ff47436671b6e533d8dc3614845d|
301893|C61962|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
301894|C61962|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
301895|C61962|S|DEFINITION|Non-protein amino acid with sulfonic acid group.|CRCH_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5bd4eb36640db8dee585d8e7a76f537e|
301896|C61962|S|Chemical_Formula|C2H7NO3S|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d5f4ec6923e0a51aaea9dfc1dbcf9b8f|
301897|C61962|S|CAS_Registry|107-35-7|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7c56a1566482b9423624061057bf0ede|
301898|C61962|S|CHEBI_ID|CHEBI:15891|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||55abd67a91027761c57a3f7967a13457|
302311|C22187|S|DEFINITION|A condition that is relevant to either disease states or models of disease in experimental organisms.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d1c00b94635ae636092deb247ddcebf1|
302312|C22187|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
303040|C99660|S|DEFINITION|This gene plays a role in cell-cell signaling.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4f8b74ce65ee373c41087432385c7d70|
303041|C99660|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
303042|C99660|S|OMIM_Number|176290|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9e79e4abe8e9ae4be67a9ca73b06d3aa|
304451|C63440|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
304452|C63440|S|DEFINITION|A regimen consisting of mesna, ifosfamide, mitoxantrone and etoposide used to treat relapsed or refractory Hodgkin's and Non-Hodgkin's lymphoma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a37ba08829f518fc48746d4b23751338|
304453|C63440|S|Design_Note|Source: NCCN Guidelines 2007|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||16e774c5a7628c0c03543caac2217094|
304579|C80020|S|DEFINITION|This gene is involved in transcription and mRNA splicing.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1076e4c7921cd25432f1746646f91a67|
304580|C80020|S|OMIM_Number|605078|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7250a99e58e255c86102dbb4b54269cd|
304581|C80020|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
304957|C22188|S|DEFINITION|A non-human biological structure, fluid or other substance; excludes single molecular entities.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d111be672bbbee27eb96517cc4132c46|
304958|C22188|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
305002|C52275|S|GO_Annotation|drug resistance\GO_ID\GO:0009315\GO_Source\CGAP\GO_Evidence\TAS\GO_Source_Date\29-SEP-2003|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2d7aa7ed85125c60ea55a319cdfaa574|
305003|C52275|S|GenBank_Accession_Number|NM_004996|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||eeb6d3464fca4e385494cd2f6d28814e|
305004|C52275|S|HGNC_ID|HGNC:51|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5335e533dd05be2289ae2c7b5bb4a5b9|
305005|C52275|S|GO_Annotation|membrane fraction\GO_ID\GO:0005624\GO_Source\CGAP\GO_Evidence\TAS\GO_Source_Date\29-SEP-2003|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2208bb39351d7f57228c7e52a6610bb|
305006|C52275|S|EntrezGene_ID|4363|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c0a62e133894cdce435bcb4a5df1db2d|
305007|C52275|S|GO_Annotation|integral to plasma membrane\GO_ID\GO:0005887\GO_Source\CGAP\GO_Evidence\TAS\GO_Source_Date\29-SEP-2003|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2f168e748163ed32e85dfbd86874f9ab|
305008|C52275|S|GO_Annotation|transporter activity\GO_ID\GO:0005215\GO_Source\CGAP\GO_Evidence\TAS\GO_Source_Date\29-SEP-2003|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0a643e97226c3a54791a54f28376071e|
305009|C52275|S|DEFINITION|Human ABCC1 wild-type allele is located in the vicinity of 16p13.1 and is approximately 193 kb in length. This allele, which encodes multidrug resistance-associated protein 1, is involved in multispecific organic anion transport.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||80a95ba83b17a0de6fabb88f359384d6|
305010|C52275|S|Gene_Encodes_Product|Multiple Drug Resistance-Associated Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b4cc5851984fed245009c58558f1b7df|
305011|C52275|S|GO_Annotation|transport\GO_ID\GO:0006810\GO_Source\CGAP\GO_Evidence\TAS\GO_Source_Date\29-SEP-2003|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d24a0766ec0cc0a7f38e1dfb04c5711c|
305012|C52275|S|OMIM_Number|158343|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||479c4124632d01806362327f1168dcad|
305013|C52275|S|GO_Annotation|ATP binding\GO_ID\GO:0005524\GO_Source\CGAP\GO_Evidence\TAS\GO_Source_Date\29-SEP-2003|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||792faba2ea442ea5fe45776377f37577|
305014|C52275|S|GO_Annotation|ATP-binding cassette (ABC) transporter activity\GO_ID\GO:0004009\GO_Source\CGAP\GO_Evidence\TAS\GO_Source_Date\29-SEP-2003|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||535d050b0677085a97b68a2938083313|
305015|C52275|S|Design_Note|Expressed in lung, testis, and peripheral blood mononuclear cells, the 200 kb human MRP1 Gene (ABC family) at 16p13.1 - telomeric to MYH11 - contains thirty-one exons that encode a plasma membrane drug-efflux transporter associated with multidrug resistance. A 7.8-8.2 kb mRNA is transcribed and several variant transcripts maintain the open reading frame. MRP1 contains a high proportion of class 0 introns. Conservation of intron/exon organization and sequence suggest that MRP-related transporters evolved by fusion from a shared common ancestor with CFTR and MDR1 encoding polytopic membrane proteins. MRP1 also appears to regulate LTC4 transport, which promotes chemotaxis to CCL19 and dendritic cell migration to lymph nodes. MRP1 is over expressed in a multidrug-resistant SCLC cell line.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||47ea5a8be380224eefdbb7a4d746f036|
305016|C52275|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
305291|C69186|S|DEFINITION|A set of standard terms for communications regarding medical imaging.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3352f83f90ff723880204bbe69899c27|
305292|C69186|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
309001|C40415|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
309002|C40415|S|DEFINITION|Nonfunctional DNA sequences that are very similar to the sequences of known genes. Many seem to have arisen as functional gene duplications that subsequently underwent mutation and loss of function. Others are structurally similar to mRNA and seem to have arisen by a reverse transcription event followed by integration into the genome. Some pseudogenes are transcribed and may play a role in regulation of its homologous gene.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0136930c2b8c449f4eaf4091851aec3f|
309269|C85413|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
309270|C85413|S|DEFINITION|A classification system defining a neuroblastoma as having a favorable or unfavorable prognosis, based on histopathologic criteria.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7407bcf952b28c22b926735b48d80ef4|
310331|C63515|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
310332|C63515|S|Design_Note|Source: NCCN Guidelines 2007|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||16e774c5a7628c0c03543caac2217094|
310333|C63515|S|DEFINITION|A regimen consisting of doxorubicin, ifosfamide and methotrexate used for the treatment of unresectable soft tissue sarcoma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fd9e1f6fdfcd39ce9c07777e4bbc7d57|
311631|C89330|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
311632|C89330|S|DEFINITION|A disorder diagnosed in childhood that is marked by either physical or mental impairment or both, which in turn affects the child from achieving age related developmental milestones.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||20082e1dd73b6da1c0896f66910cc180|
311633|C89330|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
311634|C89330|S|NICHD_Hierarchy_Term|Developmental Disorder|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c7632728da5bd088c188f05c088ce9e8|
312225|C86550|S|DEFINITION|Human FANCD2 wild-type allele is located in the vicinity of 3p26 and is approximately 76 kb in length. This allele, which encodes Fanconi anemia group D2 protein, plays a role in the mediation of homolog pairing in meiosis, cell cycle checkpoint regulation and the modulation of DNA repair. Mutation of the gene is associated with Fanconi anemia.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7864df183d112142cdc578d30260b5a6|
312226|C86550|S|GenBank_Accession_Number|AF340183|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||73aa38cf7df2a5a8e7135bc99f4c23b2|
312227|C86550|S|HGNC_ID|HGNC:3585|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7b980a91a3372f5b449741cf0d8ef222|
312228|C86550|S|EntrezGene_ID|2177|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bb1662b7c5f22a0f905fd59e718ca05e|
312229|C86550|S|OMIM_Number|613984|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7d6a9ae83ce362ae656b42db7a4af676|
312230|C86550|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
313735|C61672|S|CHEBI_ID|CHEBI:52010|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d4486a8db0417e41e5e194191ee597c2|
313736|C61672|S|Chemical_Formula|C16H19ClN2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9b5714a118f668ceb7a604d97da40c68|
313737|C61672|S|FDA_UNII_Code|3U6IO1965U|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||debc1d39e2ed2d6b857f3dff8973c1bd|
313738|C61672|S|CAS_Registry|132-22-9|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b66e1e4e3513b60e1da4c5e2bacc1c36|
313739|C61672|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
313740|C61672|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
313983|C111973|S|DEFINITION|This gene may play a role in transcriptional regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1b3a2648c1b39292b0789f6de9ed597|
313984|C111973|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
314657|C106058|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
314658|C106058|S|DEFINITION|This gene plays a role in both histone acetylation and transcriptional regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4768be34c8d34c87abbcc23ae7bd27bc|
314659|C106058|S|OMIM_Number|610335|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||545c131db4e0dd306e089cdaa7990afc|
318267|C76139|S|FDA_UNII_Code|19QM69HH21|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||68bd9992845c32cf5aa132def3f4135f|
318268|C76139|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
318269|C76139|S|Chemical_Formula|C9H13N2O2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fd173dbaa3d5a0d435078419edc2febc|
318270|C76139|S|CAS_Registry|155-97-5|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1171763a9c0b3037fec0b98feba75fd2|
318271|C76139|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
318738|C114952|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
318739|C114952|S|DEFINITION|This gene plays a role in the regulation of both gene expression and embryo morphogenesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1e1792970235a160531858f0252ce9c1|
318740|C114952|S|OMIM_Number|131290|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bde8824adfa836c3a9150e97b036912b|
318786|C43388|S|OMIM_Number|605878|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||11e470ec8030cc0ffb6f54f94c04ba04|
318787|C43388|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
318788|C43388|S|DEFINITION|This gene is involved in regulation of transcription and plays a role in cell organization/biogenesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||074bb8523fd75da8e86a9e605bf848a6|
319106|C92666|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
319107|C92666|S|DEFINITION|This gene is involved in the regulation of cellular morphology, extracellular matrix deposition and cell cycle progression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||56d21aa8f5b2f41f5ceda8f3ae6dc596|
319108|C92666|S|OMIM_Number|182120|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c958d1725948a4fd11d162712d1c92b|
319186|C17457|C|SEMANTIC_TYPE|Biomedical Occupation or Discipline|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1cf1233b26ad9682dbe0588c6062e35f|
319187|C17457|S|DEFINITION|The study of the flow and regulation of genetic information between DNA, RNA, and protein molecules.(On-line Medical Dictionary)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||31828b97f1da9e504004433f657fadc8|
319558|C61860|S|NSC_Code|526046|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||726ea789d8321e4d7a1b59146229e7d3|
319559|C61860|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
319560|C61860|S|CAS_Registry|100-55-0|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2cb224eb4e18279a93ae0ebea0e18aa3|
319561|C61860|S|FDA_UNII_Code|9TF312056Y|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f61b45b73c292184d961d209f4126ab1|
319562|C61860|S|Chemical_Formula|C6H7NO|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||02ef6e9330ab5590c5eadc6c02ad8819|
319563|C61860|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
319887|C38570|S|DEFINITION|This gene plays a role in signal transduction, angiogenesis and platelet aggregation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||12162701e7343fe52d544e25cb112585|
319888|C38570|S|OMIM_Number|163729|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d7e50b46957636a005e98bdabc8ad199|
319889|C38570|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
321527|C18120|S|OMIM_Number|600185|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bb36be6c0294fcbe69f55a98abdccc24|
321528|C18120|S|DEFINITION|A gene on chromosome 13 that normally helps to suppress cell growth. A person who inherits an altered version of the BRCA2 gene has a higher risk of getting breast, ovarian, or prostate cancer.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||41dffc200c7a31999e62319e311f25e0|
321529|C18120|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
321530|C18120|S|DEFINITION|This gene is involved in cell cycle control, DNA repair and the maintenance of genomic stability. It also plays a role in the proliferation of embryonic cells.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||17e22c54f54e8b129a6311c4796ed8f8|
321688|C124955|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
321689|C124955|S|DEFINITION|This gene is involved in binding to calcium and phospholipids.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||113053f3c79d12e3b4e11997e579a8da|
321801|C26791|S|NICHD_Hierarchy_Term|Hemorrhage|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||555f9fa2c98107886d006edf2633ebc8|
321802|C26791|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
321803|C26791|S|Contributing_Source|MedDRA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1ba896ae50594408113d26bfe99ff078|
321804|C26791|C|SEMANTIC_TYPE|Finding|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d60fa52f375e62bd2309f7040bc53665|
321805|C26791|S|DEFINITION|In medicine, loss of blood from damaged blood vessels. A hemorrhage may be internal or external, and usually involves a lot of bleeding in a short time.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c4f9bafc2284a20e887fedc9e5323c6e|
321806|C26791|S|FDA_Table|Patient Code (Appendix B)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3fa6ef9a096c688f10b6a40a4ee0c8c5|
321807|C26791|S|Use_For|Pooling of blood|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a542b2340798b556836c4809765f612d|
321808|C26791|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
321809|C26791|S|DEFINITION|The presence of extravascular erythrocytes.|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||88cb06b163adc25bd7eb7e46fa277e49|
321810|C26791|S|Use_For|Blood pooling|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||85ade772170e0fbceb2f5299cc6d7c8e|
321811|C26791|S|DEFINITION|Loss of blood.|NICHD_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||39d80eadfb80c7caa5c949fa8a5ec67c|
321812|C26791|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
321813|C26791|S|DEFINITION|The flow of blood from a ruptured blood vessel.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||00bafaab6c738ac96d7e68bfc0cba40d|
322012|C25161|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
322013|C25161|S|DEFINITION|A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||82618287f97d39f026dfb7ea280ee440|
322312|C96812|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
322313|C96812|S|DEFINITION|A role used to assert a direct relationship between a molecular abnormality and a gene. The domain and range for this role are 'Molecular Abnormality' and 'Gene', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e37a7eeac172f3ce793fabf9a8b86006|
322764|C3421|S|DEFINITION|The presence of an extra chromosome, resulting in a total of three copies of that chromosome instead of the normal 2 copies (e.g., trisomy 21, or Down syndrome).|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||784e9e3912884c710724c46c3cd00e63|
322765|C3421|C|SEMANTIC_TYPE|Cell or Molecular Dysfunction|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f731b9e954cc2b7fe23a53516abccdf9|
322766|C3421|S|DEFINITION|A chromosomal abnormality consisting of the presence of one chromosome in addition to the normal diploid number.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4eb5943d3262eae6a4085c5c54c24c55|
324518|C68754|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
324529|C95268|S|DEFINITION|This gene plays a role in the Krebs cycle.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3a1ea641058d75bfd324c55c13cbb1f1|
324530|C95268|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
324531|C95268|S|OMIM_Number|136850|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f48f1f51b9574dafed6215ab8ba4a462|
324853|C1860|C|SEMANTIC_TYPE|Research Device|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||944ea5db0ff30a1a743e05509177d0e1|
324854|C1860|S|DEFINITION|Based upon the natural F plasmid of E. coli. Inserts up to 300 Kb can be cloned and stably maintained as circular molecules.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||425c5f3afc798edce0306a89d8c36839|
324855|C1860|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
324945|C746|C|SEMANTIC_TYPE|Chemical Viewed Structurally|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1baaa83e4106247f54f42f1aefbda1ae|
324946|C746|S|DEFINITION|Any of a group of isomeric compounds that are monomethyl derivatives of pyridines derived from coal tar, horse urine, and bone oil.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7322c39ac77c18f864d12b107fe4dcbc|
324947|C746|S|NSC_Code|3409|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||20125fd9b2d43e340a35fb0278da235d|
325343|C124254|S|OMIM_Number|611317|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c6f412bfa1be108b657ab1f95bd5b14|
325344|C124254|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
325345|C124254|S|DEFINITION|This gene plays a role in the regulation of phosphoinositide-3-kinase gamma activity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2207d5caa7c62504bffba161f102700e|
325526|C17188|S|DEFINITION|Transmission of information over distances via electronic means.(MeSH)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bf0fbedccda2a7d5aa2951f428d0207e|
325527|C17188|C|SEMANTIC_TYPE|Machine Activity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3a1025eab4c7457dfd0291fb398dcb06|
328414|C17469|C|SEMANTIC_TYPE|Occupation or Discipline|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||856118919315e7420b3e7b7900fac932|
328415|C17469|S|DEFINITION|The theories and techniques of naming, describing, and classifying organisms, and the study of the relationships of taxa.(from On-line Medical Dictionary)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b09cdff3a75fc8ce53692368e09bdf52|
328719|C754|S|DEFINITION|A small cellular inclusion consisting of a ring of DNA that is not in a chromosome but is capable of autonomous replication.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9dd879b1bea917736b7beb78ddcae95e|
328720|C754|S|DEFINITION|A small cellular inclusion consisting of a ring of DNA that is not in a chromosome but is capable of autonomous replication.|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9dd879b1bea917736b7beb78ddcae95e|
328721|C754|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
328722|C754|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
329589|C45374|C|SEMANTIC_TYPE|Nucleotide Sequence|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5b520cf7246b1ea899fae46e128d2ab5|
329590|C45374|S|DEFINITION|The sequence of nucleotide residues along an RNA or DNA chain.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9382a28bed6cfcab1aaadb27e28b1a5d|
329895|C96815|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
329896|C96815|S|DEFINITION|A role used to assert a direct relationship between a gene and a disease. This restriction should only be used when an abnormality in a gene a causative event for a disease. The domain and range for this role are 'Gene' and 'Disease or Disorder', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ab11e4404e277cb9bcab0d333ef36d37|
330276|C26039|S|Gene_Encodes_Product|Membrane Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||67014741c4c36a37ff143af14133664f|
330277|C26039|S|DEFINITION|A gene that encodes a protein that is associated with any of the cell membranes. These may be intrinsic, transmembrane proteins or peripheral proteins.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||09589238034d24adab9aec8ebabf8a4a|
330278|C26039|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
330473|C104257|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
330474|C104257|S|OMIM_Number|608060|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||988d2bbeb4d6372af111788c72ef33dd|
330475|C104257|S|DEFINITION|This gene plays a role in the repression of transcription.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||33ad37ad35aeb717a053d4074b12301e|
330932|C18301|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
330933|C18301|S|DEFINITION|This gene plays a role in regulation of transcription and cell organization. It is involved in both embryonic hematopoiesis and adult erythropoiesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d1cc753fb0e6ef29aa4a458f99a048a7|
330934|C18301|S|OMIM_Number|187040|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dad1502ea339721fe1114575f31f8362|
331002|C119652|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
331003|C119652|S|OMIM_Number|614718|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b03f1ca22fd6db2234dcf2b0ea40439a|
331004|C119652|S|DEFINITION|This gene plays a role in both mitotic spindle formation and chromosome segregation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||155cb741710c62ec13f456e2acaa6a98|
331791|C114957|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
331792|C114957|S|DEFINITION|This gene is involved in transcriptional modulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||84c8d1b94b17c79f0102d29a9d4e9d55|
331793|C114957|S|OMIM_Number|604420|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b205e5bc293792ed7ef97aa50b8c7425|
332900|C96816|S|DEFINITION|A role used to assert a direct relationship between a disease, disorder or finding and a gene. This restriction can be used when a polymorphism or an abnormality in a gene is either a clinical marker for, a causative event for, or predisposes a subject to a disease. The domain and range for this role are 'Disease, Disorder or Finding' and 'Gene', respectively.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5cb2a9dfb75a33aef8520b3e32967af4|
332901|C96816|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
334236|C102802|S|OMIM_Number|605093|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c1c086b537b76e04015874044777ebe3|
334237|C102802|S|DEFINITION|This gene plays a role in T-cell activation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ce20ec08cb8fca5b16e00e1defa48c79|
334238|C102802|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
335514|C18500|S|OMIM_Number|607093|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0aa44cab3040c12551e638f2bc0d5942|
335515|C18500|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
335516|C18500|S|DEFINITION|This gene is involved in folate metabolism and methionine biosynthesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1c44730a1d308b49baf7f79bf7a93b73|
337572|C18312|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
337573|C18312|S|DEFINITION|This gene plays a regulatory role in transcription and in matrix metalloproteinase activity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||781bc1d76d66ffff2b3ea286d30f5caf|
337574|C18312|S|OMIM_Number|600618|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7a9ee0cff5515f6e928a63a072cda79a|
338325|C11137|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
338979|C18369|S|DEFINITION|Oncogene TIM encodes a predicted 60 kD protein containing a DBL homology domain, shared by several signal transducing regulators of small GTP-binding proteins. TIM is thought to control cytoskeletal organization through regulation of small GTP-binding proteins. The human gene is located at 7q33-q35.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||736fbb1f36ce438840d18cef9e59e7f4|
338980|C18369|S|GenBank_Accession_Number|U02082|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f5c2b72b6f2e468a1359c73c3fce5454|
338981|C18369|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
338982|C18369|S|OMIM_Number|600888|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||136da744b796d3e2ed03e8356d080080|
339168|C19442|S|DEFINITION|Any mechanism of mass communication.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2187acd050bbfba504af87e7909ef2cc|
339169|C19442|C|SEMANTIC_TYPE|Manufactured Object|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b2d37acd2ce8035b9df09639b8aee093|
339763|C1917|C|SEMANTIC_TYPE|Nucleic Acid, Nucleoside, or Nucleotide|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2e973b74df89a59c9aab3edf2887600b|
339764|C1917|S|NSC_Code|8933|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||90918ccd19a67747cadd8dbf8368c742|
339765|C1917|C|SEMANTIC_TYPE|Research Device|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||944ea5db0ff30a1a743e05509177d0e1|
339766|C1917|S|DEFINITION|A cloning vector based upon the bacteriophage P1, with capability in accepting larger DNA inserts. It is used for introduction of foreign or recombinant DNA into E. coli. Hold a larger insert than plasmids or cosmids. PACs are maintained as circular molecules. These vectors contain sequences necessary for packaging by P1 particles, as well as other P1 required elements. Inserts up to 100Kb can be cloned in PACs.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1185cdc0df991678a89b155b88c5bb8b|
339870|C28835|S|FDA_UNII_Code|4MT4VIE29P|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b305e3e5de2c02560683fadab50fac8d|
339871|C28835|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
339872|C28835|S|CAS_Registry|229975-97-7|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||37ef4ab45251d9880be676f2daf387fd|
339873|C28835|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
339874|C28835|S|Chemical_Formula|C38H52N6O7.H2O4S|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c2c55e86fc65318f2e7c532db1bd7be8|
339875|C28835|S|CHEBI_ID|CHEBI:31243|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dc748dc4e11150532e920b8968d2e4a8|
339876|C28835|S|DEFINITION|A sulfate salt form of atazanavir, an aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e9a94534f874c732eafea55d821c53cf|
340367|C63511|S|DEFINITION|A regimen consisting of doxorubicin, ifosfamide, dacarbazine and mesna used to treat unresectable soft tissue sarcoma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5cd3f71b4fdaf0a64b0047a6f804b2f8|
340368|C63511|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
340369|C63511|S|Design_Note|Source: NCCN Guidelines 2007 and PDQ|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||898122c17d1bd99883d1103570c69d61|
341072|C49471|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
341073|C49471|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
341074|C49471|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
341075|C49471|S|DEFINITION|A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2c645e3d386e048790b222e957d81c67|
341076|C49471|S|DEFINITION|A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e0cc68e541ff506c4614a312e22b013b|
342027|C88934|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
342028|C88934|S|OMIM_Number|300791|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9f75fc51d915de2cdaf80d64774b28ac|
342029|C88934|S|DEFINITION|This gene is involved in intracellular signaling.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4c094bf8988be1d7f908ab2da83f82a4|
342116|C20633|S|DEFINITION|A series of biochemical reactions which occurs in a known sequence and can result in all or part of the initiation, progression or completion of a biological process or function.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f9fdfce02ff86f93476cb82e76ee2748|
342117|C20633|C|SEMANTIC_TYPE|Functional Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a79a5d175c8269874d5b5c9162a72cf|
342118|C20633|S|DEFINITION|A series of actions among molecules in a cell that leads to a certain end point or cell function.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4a6ebe1148d7b7a8e40d37aa09b3ff87|
342139|C17359|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
342140|C17359|S|OMIM_Number|191170|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7532b6d6f9b4bb21d78a3653ab8d8825|
342141|C17359|S|DEFINITION|This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9461fb31ae589307403706887776a8bc|
342723|C119719|S|DEFINITION|This gene is involved in binding to viral ribonucleic acids.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e3831cd3664c1e68bf4a2c1e3be9b9b5|
342724|C119719|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
342725|C119719|S|OMIM_Number|606951|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aca90257b2361232479278766d7cb085|
343083|C27551|S|DEFINITION|A term that refers to the classification of a disorder according to the anatomic site that is involved in the pathologic process.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9e49e0b91019da9eb05fcdc152c4c300|
343084|C27551|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
343157|C21007|S|DEFINITION|Any physical or mental impairment that interferes with an individual's ability to perform desired activities.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||80c869aa53b577b61785d502fdfc3834|
343158|C21007|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
343159|C21007|C|SEMANTIC_TYPE|Organism Attribute|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||00093cd15be969a316a673f771fbf47b|
343160|C21007|S|FDA_Table|Patient Code (Appendix B)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3fa6ef9a096c688f10b6a40a4ee0c8c5|
343508|C49472|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
343509|C49472|S|DEFINITION|A book of synonyms.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1630b3060a228fbe8af216c1bb06b31|
346196|C63726|S|DEFINITION|A regimen consisting of paclitaxel, ifosfamide, mesna and carboplatin used as salvage therapy for the treatment of advanced-stage testicular cancer; also used for the treatment of unresectable and recurrent squamous cell head and neck cancer.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||10f775b05820091e4abeba81eed04b17|
346197|C63726|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
346198|C63726|S|Design_Note|Source: Physician's Cancer Chemotherapy Drug Manual 2006 (Head and Neck)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||34df50703210d7b77cd0176eb09e670f|
347802|C63514|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
347803|C63514|S|OMIM_Number|607273|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7ac7d4a51ee69eae31e30cef6d6817aa|
347804|C63514|S|DEFINITION|This gene may play a role in tumor suppression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a97136eb8de557abe0bc1d30ccb376c3|
348588|C26323|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
348589|C26323|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
348590|C26323|S|NICHD_Hierarchy_Term|Hematologic Disorder|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ac208a4f6ab58ee2c78a9a2ab01e2f66|
348591|C26323|S|DEFINITION|A neoplastic or non-neoplastic disorder that affects the production and proliferation of the hematopoietic cells including lymphoid cells, the synthesis of hemoglobin, and/or the mechanisms of coagulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2351f74c6547b2ad9a23841081b08c4b|
349139|C49474|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
349140|C49474|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
349141|C49474|S|DEFINITION|A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization. The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bf79156ea3b6dbbf61fec5d4c502af64|
349142|C49474|S|DEFINITION|A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||822a7994d3656328ac9b09696cb56723|
349388|C28567|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
349389|C28567|S|OMIM_Number|123890|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c3a15103c85994aa5025b7939b3e6b9d|
349390|C28567|S|DEFINITION|This gene is involved in T-cell mediation and receptor signal transduction.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||aa45b58fa213bce1ba4cef24171a82ee|
349921|C28470|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
349922|C28470|S|OMIM_Number|300841|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4816b1a836bf603c9d9ff7dfa38a40d2|
349923|C28470|S|DEFINITION|This gene plays an important role in blood coagulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b7caf7df98025841e18687a1a27ff47d|
350427|C26170|C|SEMANTIC_TYPE|Chemical Viewed Functionally|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3389b5c5751109d17a1aa8faa18924ab|
350428|C26170|S|CHEBI_ID|CHEBI:50267|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||242927bb61b08e1bb347fb64f90cbef2|
350429|C26170|S|DEFINITION|A class of agents used in prophylactic or curative therapy to attenuate the negative side effects of toxins or drugs. Protective agents belong to various chemical classes, acting through various pharmacological mechanisms. They may neutralize exogenous poisons, coat mucosa for protection against physical or chemical damage, offer antioxidant protection against free radicals or ionizing radiation, or induce endogenous detoxifying enzymes. (NCI04)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||395282b3d2cdb15ee9eca7f00760b0f6|
350962|C119607|S|DEFINITION|This gene plays a role in the regulation of both protein ubiquitination and degradation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1e412c993df8774dd3510148513463ef|
350963|C119607|S|OMIM_Number|608727|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c3f7652ef4a01c3bdd1d54e72211655|
350964|C119607|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
352197|C102440|S|OMIM_Number|610528|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b51947811c74493bae8739bc964cb6d9|
352198|C102440|S|DEFINITION|This gene plays a role in both chromatin remodeling and transcriptional regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8cde65077d445a4b1c1b7889f98ed254|
352199|C102440|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
353561|C113546|S|DEFINITION|This gene is involved in galactocerebroside synthesis.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5966643314cca5992b768b3e24c3f564|
353562|C113546|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
353563|C113546|S|OMIM_Number|601291|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||82519b448329e33ef24404d503c95432|
355579|C20521|S|DEFINITION|One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. IL-1-alpha, one form of IL-1, is made mainly by one type of white blood cell, the macrophage, and helps another type of white blood cell, the lymphocyte, fight infections. It also helps leukocytes pass through blood vessel walls to sites of infection and causes fever by affecting areas of the brain that control body temperature. The other form of IL-1, IL-1-beta, acts the same as IL-1-alpha. IL-1-alpha made in the laboratory is used as a biological response modifier to boost the immune system in cancer therapy. IL-1-alpha is a type of cytokine.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cf73e9f27a42ea7d961c964e485b5d6d|
355580|C20521|S|Swiss_Prot|P01583|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3b664d255dc84a0b3b696914f854077f|
355581|C20521|S|DEFINITION|Interleukin-1 alpha (271 aa, ~31 kDa) is encoded by the human IL1A gene. This protein is involved in B-cell maturation and proliferation, thymocyte proliferation and the stimulation of inflammation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||52b847d2af32774dc9c6637f62231f24|
355582|C20521|C|SEMANTIC_TYPE|Immunologic Factor|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6d164910819b81a287d635fc7dec7f87|
355583|C20521|C|SEMANTIC_TYPE|Amino Acid, Peptide, or Protein|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4eccd96bc9e6975d7cbf89de08c26de0|
355584|C20521|S|OMIM_Number|147760|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||83ffbae4513631fc2a53b3f43053d0e1|
357507|C115310|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
357508|C115310|S|OMIM_Number|613484|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||654144e728b8c8c95e7b27bd77582eff|
357509|C115310|S|DEFINITION|This gene plays a role in hormone-mediated transcriptional regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0b25847078f9fc9a3fc87764e48c6a29|
357694|C27955|S|DEFINITION|An adverse effect of a drug used therapeutically or diagnostically.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4928220c23604e8ce1ea9bf79f853073|
357695|C27955|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
357696|C27955|C|SEMANTIC_TYPE|Finding|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d60fa52f375e62bd2309f7040bc53665|
357857|C100104|S|NICHD_Hierarchy_Term|Sign or Symptom|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e306aba312ccb3c9124be6efd3dc7973|
357858|C100104|C|SEMANTIC_TYPE|Finding|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d60fa52f375e62bd2309f7040bc53665|
357859|C100104|S|DEFINITION|Objective evidence of disease perceptible to the examiner (sign) and subjective evidence of disease perceived by the subject (symptom).|CDISC_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||99f9dc00aa9b329bc83ab6dd5eb674a3|
357860|C100104|S|Contributing_Source|CDISC|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1d245cb7749da8c9e37cca6aecd80b4|
357861|C100104|S|DEFINITION|Objective evidence of disease perceptible to the examining practitioner (sign) and subjective evidence of disease perceived by the patient (symptom).|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||267fae2760e84b497f8dcc2700bd16ca|
357862|C100104|S|Contributing_Source|NICHD|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ceba57665f81ac36e781425f5be59939|
358501|C13267|S|DEFINITION|Nucleolar organizer regions (NORs), which are loops of DNA containing ribosomal RNA genes, have been shown to correlate with cell proliferation and malignant transformation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b438db705cbcdd4251598d17ad71e3c1|
358502|C13267|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
358831|C26548|S|Design_Note|In NCI Thesaurus: includes Proteins, Functional RNAs, Protein Complexes, and Riboprotein Complexes|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||19f963eabb9552b84d7eba5f536fb153|
358832|C26548|S|DEFINITION|A protein, RNA or a complex that contains proteins and/or RNA.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8802514f7ad1cae67ff730a83c1d2459|
358833|C26548|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
359045|C117466|C|SEMANTIC_TYPE|Idea or Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2f755f6dc7d9df8a3595549b8e5f7d28|
359046|C117466|S|DEFINITION|This interventions domain model reflects protocol-specified study treatment administrations, as collected.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5f106aa0b35b46944dc5ad4cc2a937f5|
361005|C25390|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
361006|C25390|S|DEFINITION|A numerical scale used to compare variables with one another or with some reference number; a number used to select an element of a list, vector, array or other sequence.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||66d38864a225f3a872814bbb7a99b54e|
361233|C118998|S|OMIM_Number|610791|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bd1d4ac634e93da2719197dd3d9f48ff|
361234|C118998|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
361235|C118998|S|DEFINITION|This gene is involved in the transport of large neutral amino acids.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||57a19b7321704df1dbb4ee6d8efca24f|
361250|C20157|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
361251|C20157|S|DEFINITION|Genes from any non-human organism.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d6df263987f2a58240e5a900cb8a3ff3|
362098|C1316|S|FDA_UNII_Code|8HW4YBZ748|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c8cd2282e77f02b683057a867a5ae337|
362099|C1316|S|PDQ_Open_Trial_Search_ID|41295|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f3a589d86446fc3ecd5385a2779e8d34|
362100|C1316|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
362101|C1316|S|CAS_Registry|1199-18-4|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c2e2f878386fba29240f3038387fc15c|
362102|C1316|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
362103|C1316|S|DEFINITION|An antagonist of the neurotransmitter dopamine with potential antineoplastic activity. 6-Hydroxydopamine (6-HOD) can be taken up by selective adrenergic terminals, thereby causing acute degeneration of adrenergic terminals that leads to depletion of norepinephrine, and of dopamine in the dopamine-sensitive sites. This agent is auto-oxidated at physiological pH that leads to the formation of reactive free radicals, thereby leading to cytotoxicity in neural cells. 6-Hydroxydopamine is often used to induce CNS and sympathetic neural lesions that model aging and various nervous disorders in animal systems.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0ed0e1aa82bac336d909e424160c4c04|
362104|C1316|S|PDQ_Closed_Trial_Search_ID|41295|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f3a589d86446fc3ecd5385a2779e8d34|
362105|C1316|S|NSC_Code|233898|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f4fbc592d78b82b5de4c0991dc3d75e6|
362106|C1316|S|PubMedID_Primary_Reference|2511086|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||834cd6513a7839119a65f8a9e431b35f|
362107|C1316|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
362108|C1316|S|Chemical_Formula|C8H11NO3|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||63f9370487486b2c51b8c9b445b58a62|
365425|C39368|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
365426|C39368|S|DEFINITION|The Computer Retrieval of Information on Scientific Projects Database (CRISP) is a searchable database of federally funded biomedical research projects maintained by the Office of Extramural Research at NIH. It includes projects funded by NIH, Substance Abuse and Mental Health Services Administration, Health Resources and Services Administration, Food and Drug Administration, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, and Office of Assistant Secretary of Health.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e1b29d2849e660c2fffef48fe7fb9202|
366482|C24514|S|DEFINITION|This gene plays a role in insulin and glucose regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||308104accc58196860e85855302d2ae2|
366483|C24514|S|OMIM_Number|176730|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||578e066071162e5c0d266d7c86e09d6f|
366484|C24514|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
372417|C125211|S|DEFINITION|This gene may be involved in the regulation of voltage-gated calcium transport.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5af2b81c0e17f6b30731dde717000ba9|
372418|C125211|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
372738|C103896|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
372739|C103896|S|DEFINITION|This gene is involved in the catabolism of phytoceramides.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d6d7d0924d8945a0dc7145e13a594999|
372931|C82871|S|DEFINITION|This gene plays a role in lipid metabolism.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fa692ba7276edabab0f62438fc4639bc|
372932|C82871|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
372933|C82871|S|OMIM_Number|606885|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3f9bfb7bbf16c3b1fdd11a4d22ff3046|
375133|C11294|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
375240|C20047|C|SEMANTIC_TYPE|Clinical Attribute|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||35dd6afd22954270f575d65985eef752|
375241|C20047|S|DEFINITION|A characteristic of an organism that contributes to the diagnosis or treatment of a disease or to the prediction of clinical outcomes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||65409a0287c1f9cb40de74bd2c347189|
375423|C641|S|CHEBI_ID|CHEBI:50673|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e96e58286efff3e19ff7d2eccc861c25|
375424|C641|S|NSC_Code|38608|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||394b2ea01aac6d1546deb0c976216f3a|
375425|C641|S|FDA_UNII_Code|554Z48XN5E|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4d508a8e6f5c5d900de50591dd1c4b8b|
375426|C641|S|CAS_Registry|60-56-0|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||09db73ddc4053ff6f8c95f9c0df4f37b|
375427|C641|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
375428|C641|S|Chemical_Formula|C4H6N2S|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0bec061fde1f8c8ed6a02e73bddb63fe|
375429|C641|S|PDQ_Closed_Trial_Search_ID|39287|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c0d96addd9586c3e7db70766763ba310|
375430|C641|S|PDQ_Open_Trial_Search_ID|39287|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c0d96addd9586c3e7db70766763ba310|
375431|C641|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
375432|C641|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
375433|C641|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
376903|C106083|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
376904|C106083|S|OMIM_Number|611184|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fe7c8d6c115c468820594f9301abd6db|
376905|C106083|S|DEFINITION|This gene plays a role in ion transport.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0e2a759b561d0a761b626eb461abde6e|
377166|C18589|S|DEFINITION|This gene is involved in the metabolism of catecholamine drugs and neurotransmitters.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||917b7e1d718a46d6558e2e97b016ca1c|
377167|C18589|S|OMIM_Number|116790|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b8fa9aac4738af0a9799619ff1a88302|
377168|C18589|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
377420|C18368|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
377421|C18368|S|OMIM_Number|191160|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6b8b3f0f311c8cd69d7e6303c3f00743|
377422|C18368|S|DEFINITION|This gene is involved in apoptosis, cell growth and cell proliferation. It also plays a role in immune and inflammatory responses.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||deff68222dc3faaf3e68e879e22ec534|
377508|C20917|S|Gene_Encodes_Product|Cell Cycle Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1b84eb16f70a356729e43baf3d2d2ba5|
377509|C20917|S|DEFINITION|Cell Cycle Genes encode Cell Cycle Proteins, which control the cell division cycle. This family of proteins, classified on the basis of related function, includes a wide variety of classes, including cyclin-dependent kinases, mitogen-activated kinases, cyclins, and phosphoprotein phosphatases, as well as their putative substrates, such as chromatin-associated proteins, cytoskeletal proteins, and transcription factors. (NCI)|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0114a228eceb33ba81e836580f771ffc|
377510|C20917|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
378713|C74437|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
378714|C74437|S|DEFINITION|This gene may be involved in both neuronal development and transcriptional regulation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9d16154987d523e259af5c833d5e6be3|
378715|C74437|S|OMIM_Number|601546|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||65a01da92182fdce902fb67a5c32eb39|
380038|C13292|S|DEFINITION|A sequence of nucleotides in that contains no termination codons and so can potentially translate as a polypeptide chain.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4b106c433a6b5175476cca45cef4558f|
380039|C13292|C|SEMANTIC_TYPE|Nucleotide Sequence|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5b520cf7246b1ea899fae46e128d2ab5|
380145|C47619|S|Chemical_Formula|C14H14N2O|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||11a570cd46492b2cda669ff8cc12e9ad|
380146|C47619|S|CHEBI_ID|CHEBI:44241|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1d87656612dc62886f3e9d9f38e67db4|
380147|C47619|S|DEFINITION|A pyridine derivative and a glucocorticoid synthesis inhibitor. Metyrapone inhibits 11-beta-hydroxylase, thereby inhibiting synthesis of cortisol from 11-deoxycortisol and corticosterone from desoxycorticosterone in the adrenal gland. Removal of the negative feedback mechanism exerted by cortisol results in increased adrenocorticotropic hormone (ACTH) secretion by the pituitary gland. In turn, continuing stimulation of adrenal gland by ACTH results in accumulation of corticoid precursors, 11-desoxycortisol and desoxycorticosterone. These metabolites are excreted in urine that maybe used as indicators for pituitary responsiveness.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||52cdf5fede884f949dbeafa1d0ff5ffb|
380148|C47619|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
380149|C47619|S|FDA_UNII_Code|ZS9KD92H6V|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9f9f7db833ec579541ea468da9b91f4e|
380150|C47619|S|NSC_Code|25265|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a5de315acb973b8e6da83458c9e456d3|
380151|C47619|S|CAS_Registry|54-36-4|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4e4c30a88ec1bea82db338ced725a5a9|
380152|C47619|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
381313|C106286|S|DEFINITION|This gene has no known function.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dd9b9e9499ff7000130570377ffe86c4|
381314|C106286|S|OMIM_Number|600928|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||8f8a67768bd6953f80f544f519be5024|
381315|C106286|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
381524|C73669|S|OMIM_Number|610881|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||98e46b584f134c2181ee3d8860c07ca8|
381525|C73669|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
381526|C73669|S|DEFINITION|This gene is involved in epigenetic control of gene expression.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||4e0115880884502def8df25264f9e3d6|
381722|C93063|S|OMIM_Number|605715|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||41a23d5740ed204d2a0df58a78450e28|
381723|C93063|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
381724|C93063|S|DEFINITION|This gene is involved in the regulation of T cell immune responses.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b3f103e325b768a9367416e767144148|
381959|C34557|S|DEFINITION|A disorder of the skin characterized by loss or reduction of the skin color. It is caused by loss of melanocytes or abnormalities in melanin production.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||cc3de020affb206a6a360134f99b1830|
381960|C34557|C|SEMANTIC_TYPE|Disease or Syndrome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||1a9af6d60c17b70a7ae1b63514b5ae88|
382175|C28635|S|OMIM_Number|176797|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9b5eeffae3ecda157fe35a871fa7faa6|
382176|C28635|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
382177|C28635|S|DEFINITION|This gene plays a role in apoptosis and regulation of transcription. It is also involved in cell organization/biogenesis and megakaryocytic development.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0e6adb4024f079f5f691eb467a9bb932|
384694|C46074|S|OMIM_Number|605325|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e4973dc7420fba05f8579e0969db2060|
384695|C46074|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
384696|C46074|S|DEFINITION|This gene is involved in the metabolism of fatty acids, steroids, drugs and xenobiotics. It also plays a role in the metabolism of sex hormones.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||43aee6046c18a6de8826aa0f59e612a0|
385850|C21229|S|OMIM_Number|188350|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||990cdccc1100e0afef4eadb62e552ec8|
385851|C21229|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
385852|C21229|S|DEFINITION|This gene is involved in DNA replication and repair.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||a6e40cc5a5527e47b88e1ed0dbabe074|
387871|C106297|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
387872|C106297|S|DEFINITION|Tumor classification based on pre-treatment information obtained from the physical examination, radiology tests, and biopsies.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6db13e9d1246a4a625c6e0fbc49baeb5|
389898|C99723|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
389899|C99723|S|DEFINITION|A 5 point scale devised to assess the response to treatment of Hodgkins and Aggressive Non-Hodgkins Lymphoma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||094155c07fd99b3d4d34b1eed1d757e4|
390096|C106304|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
390097|C106304|S|DEFINITION|A pathologic grading system used to evaluate the tumor response to preoperative chemotherapy and radiation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||0bc5fd3a56afb42e333adf66adee1d47|
391617|C17253|S|DEFINITION|The total complement of hereditary material in a virus, which can be composed of either DNA or RNA.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||182fe0cd9f567edeb915a565fa794dcc|
391618|C17253|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
392379|C63621|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
392380|C63621|S|DEFINITION|A regimen comprised of a prephase (or cytoreductive phase), followed by two different chemotherapy regimens, given on an alternating schedule and used to treat adult L3 acute lymphoblastic leukemia (ALL3 or Burkitt's-type) and adult small non-cleaved cell (Burkitt's) lymphoma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7b3318559fe8fe788c64b42839461ce0|
395085|C43816|S|DEFINITION|The National Cancer Institute (NCI) reference terminology and ontology. NCI Thesaurus (NCIt) provides controlled terminology for clinical care, translational and basic research, public dissemination of information and associated administrative activities. NCIt is updated monthly to support precise coding of data based on the most recent developments in the cancer and biomedical research community. NCIt has rich textual and formal logic descriptions of biomedical concepts, including full text definitions, synonyms, a true is_a taxonomic structure, polyhierarchy, inferred partonomy, and other features that make it suitable for supporting accurate human understanding and complex computer processing. NCIt has been produced by NCI Enterprise Vocabulary Services (EVS) since 1997, and adopted since then for use by numerous federal agencies, standards development and research organizations.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||98c015d8af9ee48ff28c703e6ed2a0a4|
395086|C43816|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
396233|C24881|S|OMIM_Number|603372|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ee6fd04e49bfba61a80e430df35c35b2|
396234|C24881|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
396235|C24881|S|DEFINITION|This gene plays an important role in the regulation of thyroid cell metabolism.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||39b709a0409387b9b156d0dd0cd8335d|
396695|C20744|S|Gene_Encodes_Product|Structural Protein|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||27c458f30eeb6d5eeb01abb245ddd3f5|
396696|C20744|S|DEFINITION|A gene that encodes a protein with a chief function as part of a physical structure within a cell. This is in contrast to genes that encode proteins with a function that is enzymatic or regulatory.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5cdec42fde2369a64b08ab0e7af5ae77|
396697|C20744|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
397579|C70895|C|SEMANTIC_TYPE|Classification|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5c9335b28e6277ddbe0137f04e5e58a7|
397580|C70895|S|DEFINITION|A systematized collection of concepts that define corresponding codes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6bff3079a7b939e283ebd6cd6448909c|
397609|C43817|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3d9e88091cf4ebbab774e90c8f6d4052|
397610|C43817|S|DEFINITION|The purpose of NLM's Unified Medical Language System (UMLS) is to facilitate the development of computer systems that behave as if they "understand" the meaning of the language of biomedicine and health. To that end, NLM produces and distributes the UMLS Knowledge Sources and associated software tools for use in building or enhancing electronic information systems that create, process, retrieve, integrate, and/or aggregate biomedical and health data and information, as well as in informatics research. The UMLS Knowledge Sources are multi-purpose and can be applied in systems that perform a range of functions involving one or more types of information, e.g., patient records, scientific literature, guidelines, public health data. The associated software tools assist developers in customizing or using the UMLS Knowledge Sources. There are three UMLS Knowledge Sources: the Metathesaurus, the Semantic Network, and the SPECIALIST lexicon.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||b1802afabac7d2e1f3b7bb32981d64ef|
398062|C63465|S|DEFINITION|A chemoimmunotherapy regimen consisting of rituximab, ifosfamide, carboplatin and etoposide used to treat indolent and aggressive forms of non-Hodgkin's lymphoma; also used to treat relapsed and refractory non-Hodgkin's lymphoma.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||708d48c26692b011aea98908eedd09e6|
398063|C63465|C|SEMANTIC_TYPE|Therapeutic or Preventive Procedure|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||96ce741d6450beca9058dd0c28fa3e76|
398500|C103159|C|SEMANTIC_TYPE|Idea or Concept|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2f755f6dc7d9df8a3595549b8e5f7d28|
398501|C103159|S|DEFINITION|The act or process of gathering data for testing or research purposes.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||fc654d2301c6562298a9ee3cb6aa3997|
399595|C18308|S|DEFINITION|A family of low affinity receptors for aggregates of gamma immunoglobulins (IgG). These receptors are expressed on the surface of monocytes, macrophages, polymorphonuclear cells, natural killer cells, T- and B-lymphocytes, and platelets. IgG binding initiates cellular responses against foreign pathogens and soluble antigens, induces phagocytosis of antigen-antibody complexes, and modulates antibody production.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||04dc4890e803eb0123893168451373df|
399596|C18308|C|SEMANTIC_TYPE|Immunologic Factor|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||6d164910819b81a287d635fc7dec7f87|
399597|C18308|C|SEMANTIC_TYPE|Receptor|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||551c2471bfb3cefe5ef9d94d39d589ad|
399833|C691|S|NSC_Code|5065|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||ac0b236e346da355400a90fcc7e28be6|
399834|C691|S|CHEBI_ID|CHEBI:17688|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||5de9f1eaae565dadce23191860075a79|
399835|C691|S|Accepted_Therapeutic_Use_For|Smoking Cessation|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||226ccb6129d555f7aa356b3ba8a0e4e6|
399836|C691|S|DEFINITION|A plant alkaloid, found in the tobacco plant, and addictive central nervous system (CNS) stimulant that causes either ganglionic stimulation in low doses or ganglionic blockage in high doses. Nicotine acts as an agonist at the nicotinic cholinergic receptors in the autonomic ganglia, at neuromuscular junctions, and in the adrenal medulla and the brain. Nicotine's CNS-stimulating activities may be mediated through the release of several neurotransmitters, including acetylcholine, beta-endorphin, dopamine, norepinephrine, serotonin, and ACTH. As a result, peripheral vasoconstriction, tachycardia, and elevated blood pressure may be observed with nicotine intake. This agent may also stimulate the chemoreceptor trigger zone, thereby inducing nausea and vomiting.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||dfc25ae63cce336b4f022bb1131e069e|
399837|C691|S|FDA_UNII_Code|6M3C89ZY6R|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||d013b7387917b34f0af8be0a2b4f69f7|
399838|C691|C|SEMANTIC_TYPE|Pharmacologic Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f2d6dd6b0e78d83a64d168510c54ee04|
399839|C691|S|Chemical_Formula|C10H14N2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f923e2629a60cad33ba6763c74a1f360|
399840|C691|S|DEFINITION|An addictive, poisonous chemical found in tobacco. It can also be made in the laboratory. When it enters the body, nicotine causes an increased heart rate and use of oxygen by the heart, and a sense of well-being and relaxation. It is also used as an insecticide.|NCI-GLOSS_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2b9211740ba65f5b8ed7c4f64f6a1a9d|
399841|C691|S|PDQ_Open_Trial_Search_ID|42243|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9cfe5db52ec297b4edb475fd437b3530|
399842|C691|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
399843|C691|S|CAS_Registry|54-11-5|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||798de1ce2d36c8a71f4f47fa36e3c5a5|
399844|C691|S|Contributing_Source|CTRP|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||3cc55bef4d99a2785de4d022496e6b70|
399845|C691|S|PDQ_Closed_Trial_Search_ID|42243|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||9cfe5db52ec297b4edb475fd437b3530|
399846|C691|C|SEMANTIC_TYPE|Organic Chemical|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c593a332b19da2e7028b43295f41be14|
400447|C48697|S|DEFINITION|A set of terms that are selected and defined based on the requirements set out by the user group, usually a set of vocabulary is chosen to promote consistency across data collection projects.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f90663de89a3d322fef6a8aa8e01b72a|
400448|C48697|C|SEMANTIC_TYPE|Conceptual Entity|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||e398d0876941a4c1d8b263b841f639b7|
400681|C26504|S|OMIM_Number|600930|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c5c99e7df407b8f7374d304de98b0f12|
400682|C26504|S|DEFINITION|This gene plays a role in the modulation of cell adhesion of spermatozoa.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||52e2098b6a740cc6ecdc27636a49539d|
400683|C26504|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
401145|C22190|S|DEFINITION|An engineered gene consisting at least of a regulatory element and a coding sequence; regulatory element and coding sequence can come from different species.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||af69ee9805da3a202b052d1e68a774da|
401146|C22190|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
401366|C62025|S|DEFINITION|A monoamine compound with positive inotropic activity. Dopamine is a naturally occurring catecholamine formed by decarboxylation of dehydroxyphenylalanine and a precursor of norepinephrine and epinephrine. Dopamine binds to alpha-1 and beta-1 adrenergic receptors. Mediated through myocardial beta-1 adrenergic receptors, dopamine increase heart rate and force, thereby increasing cardiac output. Alpha-1 adrenergic receptor stimulation on vascular smooth muscle, leads to vasoconstriction and results in an increase in systemic vascular resistance. Stimulation of dopaminergic receptors in renal vasculature, leads to renal blood vessel dilation, and an increase in glomerular filtration rate, renal blood flow, sodium excretion, and urine output.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||bffe3deb5e807b0e96772a3853c38706|
401367|C62025|C|SEMANTIC_TYPE|Biologically Active Substance|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||f73bee4df25325311c725e8884117d4b|
401368|C62025|S|FDA_UNII_Code|VTD58H1Z2X|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||de53ae467099d9e02a95b31216c8641b|
401369|C62025|S|Contributing_Source|FDA|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||274c68ab4977fafeda9d04c1646554f4|
401370|C62025|S|CAS_Registry|51-61-6|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||37d29a17969cf903357b88aa967ad78d|
401371|C62025|S|Chemical_Formula|C8H11NO2|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||c7f5a60f923d693463ba55244d1a3713|
401372|C62025|S|CHEBI_ID|CHEBI:18243|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||696bdd9825f86299181476146cd4922f|
401434|C38582|C|SEMANTIC_TYPE|Gene or Genome|E-NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||7aa1cb9e6089827c730821b7639580ef|
401435|C38582|S|OMIM_Number|602959|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||2ad2e3c902666a56b6001175692e846c|
401436|C38582|S|DEFINITION|This gene is involved in nucleotide binding and protein translation.|NCI_2016_05E|R|Y|N|N|SOURCE_CUI|NCI_2016_05E||32786b1aa5e460e32518e72364b01f2b|
1|362166237|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
2|362166239|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
3|362166241|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
4|362166243|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
5|362166245|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
6|362166247|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
7|362166249|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
8|362166251|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
9|362166253|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
10|362166255|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
11|362166257|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
12|362166259|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
13|362166261|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
14|362166263|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
15|362166265|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
16|362166267|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
17|362166269|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
18|362166271|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
19|362166273|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
20|362166275|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
21|362166277|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
22|362166279|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
23|362166281|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
24|362166283|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
25|362166285|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
26|362166287|C|SEMANTIC_TYPE|Intellectual Product|SRC|R|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
13340556|381548367|S|MAPSETSID|447562003|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||c1bb150020d064227a154e6a6fceaeea|
13340557|381548367|S|MAPSETNAME|ICD-10 complex map reference set|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||f8c0f246705f3b3267c2aa75455c1223|
13340558|381548367|S|MAPSETVERSION|20160901|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||1c7dbfbc9a039cdb9da1ab565cb177de|
13340559|381548367|S|MAPSETXRTARGETID|100051|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||3898b7be8009532088697f0b7fb2990f|
13340560|381548367|S|MAPSETRSAB|NCI|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||884109cc354de5898f20a682dc37ad20|
13340561|381548367|S|MAPSETVSAB|NCI_2016_05E|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||4e149dcf5076232e888b08c64a8fa8d4|
13340562|381548367|S|FROMRSAB|SNOMEDCT_US|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||884109cc354de5898f20a682dc37ad20|
13340563|381548367|S|FROMVSAB|SNOMEDCT_US_2016_09_01|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||4e149dcf5076232e888b08c64a8fa8d4|
13340564|381548367|S|TORSAB|ICD10|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||40cdcac3a2c1865ee15aeb762ff7aebb|
13340565|381548367|S|TOVSAB|ICD10_2010|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||e7f011a514b6d05aeeaa12e928501572|
13340566|381548367|S|SOS|This set maps SNOMEDCT_US concept identifiers to ICD-10 codes; a single SNOMEDCT_US concept id may be mapped to one or more ICD-10 codes|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||85a72a3dfd4640f034f3fd055f1585af|
13340567|381548367|S|MTH_MAPSETCOMPLEXITY|N_TO_N|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||7c33c2eebe9172af97a34f119bb4b3b1|
13340568|381548367|S|MTH_MAPFROMCOMPLEXITY|SINGLE SCUI|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||2c9947e02d6b6c19ec71a812323431ea|
13340569|381548367|S|MTH_MAPTOCOMPLEXITY|SINGLE SDUI, MULTIPLE SDUI|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||019b9ce93dff919f115fd8474dd02d17|
13340570|381548367|S|MTH_MAPFROMEXHAUSTIVE|N|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||8d9c307cb7f3c4a32822a51922d1ceaa|
13340571|381548367|S|MTH_MAPTOEXHAUSTIVE|N|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||8d9c307cb7f3c4a32822a51922d1ceaa|
13340579|381548367|S|XMAP|1~1~109006~RT~mapped_to~F41.9~TRUE~447637006~ACTIVE~1~9e7d5fa1-c489-5ba4-a1df-b153527c5423~ALWAYS F41.9|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||d1f221fa60439d18734b8a534e0534a1|
13340580|381548367|S|XMAPFROM|109006~~109006~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||3e766148ef891e9a500c5367851c5a9d|
13340581|381548367|S|XMAPTO|F41.9~~F41.9~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||c5343982680e1c8f21b40f04b35a6bde|
13340589|381548367|S|XMAP|1~1~122003~RT~mapped_to~H31.3~TRUE~447637006~ACTIVE~1~0231a9fc-d6bb-5a44-98bb-6ab5b0135a20~ALWAYS H31.3|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||31f4a1a1426247fc77532e293a15a6a0|
13340590|381548367|S|XMAPFROM|122003~~122003~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||ad6e829f30005669b813daa095c081fe|
13340591|381548367|S|XMAPTO|H31.3~~H31.3~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||cb1b7896a2e6a02bc67109384907edbd|
13340599|381548367|S|XMAP|1~1~127009~RT~mapped_to~O03.8~TRUE~447637006~ACTIVE~1~1d507f04-26a6-5a9d-8f3c-abb34b971a61~ALWAYS O03.8|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||d01e2b9a8d990aada8bd8a63727fd933|
13340600|381548367|S|XMAPFROM|127009~~127009~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||c9e4891be4045de88fdceb6656c167d1|
13340601|381548367|S|XMAPTO|O03.8~~O03.8~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||81bd0ecb500e3aa489e526733fc6e5c0|
13340609|381548367|S|XMAP|2~1~127009~RT~mapped_to~O08.6~TRUE~447637006~ACTIVE~1~49361643-765b-54e7-8033-9b8f8426f081~ALWAYS O08.6|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||b9f292b9a7204e8244dfb39412bb2625|
13340610|381548367|S|XMAPTO|O08.6~~O08.6~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||bc3b5d7caf389096c778f467de96f10e|
13340618|381548367|S|XMAP|1~1~129007~XR~mapped_to~100051~TRUE~447638001~ACTIVE~1~8298b45e-a342-5fe3-b8b9-ec1a2cd8faa5~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||12acea3d2be095529e040ec9f1f81522|
13340619|381548367|S|XMAPFROM|129007~~129007~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||543ef45aa6ecf8834f8c9885772c0131|
13340620|381548367|S|XMAPTO|100051~~~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||1ae6b83304e0dfc700350b17f53c5c0d|
13340628|381548367|S|XMAP|1~1~134006~XR~mapped_to~100051~TRUE~447638001~ACTIVE~1~87a3925a-7ca4-50f6-810f-86df0e9605d3~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||6679b7ec999f63e0a5fd0b2b3ff3000f|
13340629|381548367|S|XMAPFROM|134006~~134006~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||d3d5249501310033838d6a08e4a31d21|
13340637|381548367|S|XMAP|1~1~140004~RT~mapped_to~J31.2~TRUE~447637006~ACTIVE~1~3e90edf3-90a9-5165-a482-ebe92b2158ec~ALWAYS J31.2|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||9a86cf49dc184c1e51151047c663a8ba|
13340638|381548367|S|XMAPFROM|140004~~140004~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||48f77d0eea0d8d30090c31eff79f2a3f|
13340639|381548367|S|XMAPTO|J31.2~~J31.2~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||e3a24c273d0ab7dc90d7dd2eb9422617|
13340668|381548367|S|XMAP|1~1~144008~XR~mapped_to~100051~TRUE~447638001~ACTIVE~1~eddb58e4-3c84-5c96-a188-fb63f41c69ea~MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||f711a328b02abf1546d0322f9f1a59fa|
13340669|381548367|S|XMAPFROM|144008~~144008~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||1f0e40f7d1ea945f435b0adef8941efb|
13340684|381548367|S|XMAP|1~1~147001~RT~mapped_to~S30.8~TRUE~447637006~ACTIVE~1~de4fa726-4480-553e-a11a-4b738252a1f2~ALWAYS S30.8|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||8c900f4d12186a034dc9c10b50c19bf3|
13340685|381548367|S|XMAPFROM|147001~~147001~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||cd80d30498df84f1abffa0364af0c643|
13340686|381548367|S|XMAPTO|S30.8~~S30.8~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||aa6341618040ffd1ea2ee5759ac838c6|
13340694|381548367|S|XMAP|2~1~147001~RT~mapped_to~L08.9~TRUE~447637006~ACTIVE~1~1207e3f2-ea9a-5a1c-bc0b-9c4f8067f474~ALWAYS L08.9 &#x7C; POSSIBLE REQUIREMENT FOR CAUSATIVE AGENT CODE|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||4dd86907c5f89b6126834f21a784a93e|
13340695|381548367|S|XMAPTO|L08.9~~L08.9~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||d72ff2b0ca948154f9c7c64369ca72f8|
13340710|381548367|S|XMAP|3~1~147001~RT~mapped_to~W45~TRUE~447637006~ACTIVE~1~18c841ff-139a-5083-b793-58f9038c1072~ALWAYS W45 &#x7C; POSSIBLE REQUIREMENT FOR PLACE OF OCCURRENCE|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||0da3c7d9b2baacedf439b332155446c3|
13340711|381548367|S|XMAPTO|W45~~W45~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||980706de0ef1d9302da0ccdb06244979|
14710318|381548368|S|MAPSETSID|6011000124106|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||9c0b5cc18835e144f8af6dce6780d93a|
14710319|381548368|S|MAPSETNAME|ICD-10-CM complex map reference set|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||05a72bb0ccf5fd059196c7d2edb947e5|
14710320|381548368|S|MAPSETVERSION|20160901|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||1c7dbfbc9a039cdb9da1ab565cb177de|
14710321|381548368|S|MAPSETXRTARGETID|100051|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||3898b7be8009532088697f0b7fb2990f|
14710322|381548368|S|MAPSETRSAB|NCI|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||884109cc354de5898f20a682dc37ad20|
14710323|381548368|S|MAPSETVSAB|NCI_2016_05E|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||4e149dcf5076232e888b08c64a8fa8d4|
14710324|381548368|S|FROMRSAB|SNOMEDCT_US|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||884109cc354de5898f20a682dc37ad20|
14710325|381548368|S|FROMVSAB|SNOMEDCT_US_2016_09_01|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||4e149dcf5076232e888b08c64a8fa8d4|
14710326|381548368|S|TORSAB|ICD10CM|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||a74577e77c14c7ca263ba1e1ba180ec9|
14710327|381548368|S|TOVSAB|ICD10CM_2014|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||067cb4250ff248f36f8c7e95d23ce342|
14710328|381548368|S|SOS|This set maps SNOMEDCT_US concept identifiers to ICD-10-CM codes; a single SNOMEDCT_US concept id may be mapped to one or more ICD-10-CM codes|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||6ab364e8e4e7b0a87a828a6dde6c9eb7|
14710329|381548368|S|MTH_MAPSETCOMPLEXITY|N_TO_N|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||7c33c2eebe9172af97a34f119bb4b3b1|
14710330|381548368|S|MTH_MAPFROMCOMPLEXITY|SINGLE SCUI|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||2c9947e02d6b6c19ec71a812323431ea|
14710331|381548368|S|MTH_MAPTOCOMPLEXITY|SINGLE SDUI, MULTIPLE SDUI|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||019b9ce93dff919f115fd8474dd02d17|
14710332|381548368|S|MTH_MAPFROMEXHAUSTIVE|N|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||8d9c307cb7f3c4a32822a51922d1ceaa|
14710333|381548368|S|MTH_MAPTOEXHAUSTIVE|N|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||8d9c307cb7f3c4a32822a51922d1ceaa|
14710341|381548368|S|XMAP|1~1~109006~RT~mapped_to~F93.0~IFA 11806006 &#x7C; Separation anxiety disorder of childhood (disorder) &#x7C;~447639009~ACTIVE~1~6ef753fb-bdd5-5b13-974a-45bbc1cb7e90~IF SEPARATION ANXIETY DISORDER OF CHILDHOOD CHOOSE F93.0 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||b2a07b12154040ebab0327e2aa53e448|
14710342|381548368|S|XMAPFROM|109006~~109006~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||3e766148ef891e9a500c5367851c5a9d|
14710343|381548368|S|XMAPTO|F93.0~~F93.0~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||6a539d051ddc3144bf78515aec5fbaca|
14710351|381548368|S|XMAP|1~2~109006~RT~mapped_to~F40.8~IFA 192611004 &#x7C; Childhood phobic anxiety disorder (disorder) &#x7C;~447639009~ACTIVE~1~6d902d90-5139-5fbd-9325-9815b1d98e3b~IF CHILDHOOD PHOBIC ANXIETY DISORDER CHOOSE F40.8 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||3fba412ba231f488f7087b39e7622128|
14710352|381548368|S|XMAPTO|F40.8~~F40.8~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||78bedcb50838961491002d03814766bb|
14710360|381548368|S|XMAP|1~3~109006~RT~mapped_to~F94.8~IFA 37872007 &#x7C; Avoidant disorder of childhood OR adolescence (disorder) &#x7C;~447639009~ACTIVE~1~ca966523-3b09-5481-a61f-b7b789336673~IF AVOIDANT DISORDER OF CHILDHOOD OR ADOLESCENCE CHOOSE F94.8 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||fc9e89d305974044bd82cec800a5ef22|
14710361|381548368|S|XMAPTO|F94.8~~F94.8~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||8a107eb8476f56415ec176a4f011b260|
14710369|381548368|S|XMAP|1~4~109006~RT~mapped_to~F94.8~IFA 64165008 &#x7C; Avoidant disorder of childhood (disorder) &#x7C;~447639009~ACTIVE~1~0027fa37-650e-53a2-b7ca-7d8bde4cd644~IF AVOIDANT DISORDER OF CHILDHOOD CHOOSE F94.8 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||24a0e79277641019b1418fbaadcec4e5|
14710377|381548368|S|XMAP|1~5~109006~RT~mapped_to~F40.10~IFA 83253003 &#x7C; Shyness disorder of childhood (disorder) &#x7C;~447639009~ACTIVE~1~d3acbd40-0103-53aa-9c06-e4cf83611f93~IF SHYNESS DISORDER OF CHILDHOOD CHOOSE F40.10 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||8c3358302497baf5be298a3bcb1cd38e|
14710378|381548368|S|XMAPTO|F40.10~~F40.10~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||c9cb8fcabd3fe4cf32de8cf9e5aaa130|
14710386|381548368|S|XMAP|1~6~109006~RT~mapped_to~F94.8~IFA 90790003 &#x7C; Avoidant disorder of adolescence (disorder) &#x7C;~447639009~ACTIVE~1~7b9bad44-f505-5e5b-be4d-91ffdb3c7824~IF AVOIDANT DISORDER OF ADOLESCENCE CHOOSE F94.8 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||a8536348b6c3046e3431f4ca425bde8f|
14710394|381548368|S|XMAP|1~7~109006~RT~mapped_to~F93.8~OTHERWISE TRUE~447637006~ACTIVE~1~3d3a39f1-a5ab-5525-9518-8f1e4005c36e~ALWAYS F93.8|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||6ad8d53ecbf9061b8531042335b51c52|
14710395|381548368|S|XMAPTO|F93.8~~F93.8~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||8feaf2f537127c5979c93b2492445087|
14710403|381548368|S|XMAP|1~1~122003~RT~mapped_to~H31.319~IFA 11623000 &#x7C; Expulsive choroidal hemorrhage (disorder) &#x7C;~447639009~ACTIVE~1~2d18a576-957e-514c-9b9b-4c1b1b584523~IF EXPULSIVE CHOROIDAL HEMORRHAGE CHOOSE H31.319 &#x7C; CONSIDER LATERALITY SPECIFICATION &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||b3482674b7d4a7463d8e425deb65cf53|
14710404|381548368|S|XMAPFROM|122003~~122003~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||ad6e829f30005669b813daa095c081fe|
14710405|381548368|S|XMAPTO|H31.319~~H31.319~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||0a69056372cd4ae02338aa899a4e4087|
14710413|381548368|S|XMAP|1~2~122003~RT~mapped_to~H31.309~OTHERWISE TRUE~447637006~ACTIVE~1~fcc75d45-5b71-5aef-871a-8c5e8c427f8c~ALWAYS H31.309 &#x7C; CONSIDER LATERALITY SPECIFICATION|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||fc9aedf33a671f8596cb4b8fda18c761|
14710414|381548368|S|XMAPTO|H31.309~~H31.309~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||2ec00aa9ccb13d3acd9370136d69f5aa|
14710422|381548368|S|XMAP|1~1~127009~RT~mapped_to~O03.84~TRUE~447637006~ACTIVE~1~cae98951-5e99-5267-8433-0812e6e5bb42~ALWAYS O03.84|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||e4c21b49a34c268e8da5b5a420b0d9ac|
14710423|381548368|S|XMAPFROM|127009~~127009~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||c9e4891be4045de88fdceb6656c167d1|
14710424|381548368|S|XMAPTO|O03.84~~O03.84~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||a8d4529ec795e886796e20bf51c4b233|
14710432|381548368|S|XMAP|1~1~140004~RT~mapped_to~J31.2~TRUE~447637006~ACTIVE~1~14690842-f337-5536-9b68-035034649f81~ALWAYS J31.2 &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE &#x7C; DESCENDANTS NOT EXHAUSTIVELY MAPPED|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||1c9f76af0e657d096e6f1435ba618f48|
14710433|381548368|S|XMAPFROM|140004~~140004~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||48f77d0eea0d8d30090c31eff79f2a3f|
14710434|381548368|S|XMAPTO|J31.2~~J31.2~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||e3a24c273d0ab7dc90d7dd2eb9422617|
14710477|381548368|S|XMAP|1~1~147001~RT~mapped_to~S30.853?~TRUE~447637006~ACTIVE~1~d7325c47-0c40-5729-bbdd-1fd1df425c20~ALWAYS S30.853? &#x7C; EPISODE OF CARE INFORMATION NEEDED &#x7C; POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||ac51c41f3ddf486229d0621f4699a1b5|
14710478|381548368|S|XMAPFROM|147001~~147001~SCUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||cd80d30498df84f1abffa0364af0c643|
14710479|381548368|S|XMAPTO|S30.853?~~S30.853?~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||322d9efe9a8f105a0dc0e2203f24f41c|
14710487|381548368|S|XMAP|2~1~147001~RT~mapped_to~N49.2~TRUE~447637006~ACTIVE~1~a11c9889-164a-5e2a-9217-62eb428122ef~ALWAYS N49.2 &#x7C; CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||4f56efaa6f69c0771000c80b7262aa9f|
14710488|381548368|S|XMAPTO|N49.2~~N49.2~SDUI~~|NCI_2016_05E|R|Y|N|N|SRC_ATOM_ID|||e989ff479d55a2695972ced4126cd868|
18054291|381548367|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|N|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|
18537439|381548368|C|SEMANTIC_TYPE|Intellectual Product|E-NCI_2016_05E|N|Y|N|N|SRC_ATOM_ID|||3d9e88091cf4ebbab774e90c8f6d4052|